ouabain/NN rat/NN induced/VBN designed/VBN models/NNS arrhythmia/NN
aconitine/NN using/VBG designed/VBN models/NNS arrhythmia/NN
ouabain/NN aconitine/NN induced/VBN rat/NN arrhythmic/JJ
aconitine/NN induced/VBN rat/NN arrhythmic/JJ
CBDCA/NNP use/NN cause/VB damage/NN peripheral/JJ
CBDCA/NNP use/NN cause/VB damage/NN nervous/JJ
CBDCA/NNP use/NN cause/VB damage/NN system/NN
CBDCA/NNP use/NN cause/VB damage/NN
CBDCA/NNP dose/NN neurotoxicity/NN peripheral/JJ
CBDCA/NNP dose/NN neurotoxicity/NN
doxorubicin/NN cardiomyopathy/NN
doxorubicin/NN produced/VBN cardiomyopathy/NN
doxorubicin/NN produced/VBN cardiomyopathy/NN CM/NNP
doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN myocardial/JJ
doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN
DXR/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN
DXR/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN CM/NNP
DXR/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN myocardial/JJ
DXR/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN
Adriamycin/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN
Adriamycin/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN CM/NNP
Adriamycin/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN myocardial/JJ
Adriamycin/NNP doxorubicin/NN produced/VBN cardiomyopathy/NN provides/VBZ opportunity/NN analyze/VB dose/NN relationships/NNS development/NN disease/NN
DXR/NNP proportional/JJ damage/NN CM/NNP
DXR/NNP proportional/JJ damage/NN myocardial/JJ
DXR/NNP proportional/JJ damage/NN
DXR/NNP dose/NN insult/NN degree/NN proportional/JJ damage/NN CM/NNP
DXR/NNP dose/NN insult/NN degree/NN proportional/JJ damage/NN myocardial/JJ
DXR/NNP dose/NN insult/NN degree/NN proportional/JJ damage/NN
propranolol/JJ toxicity/NN associated/VBN syndrome/NN Amnestic/JJ
propranolol/JJ toxicity/NN associated/VBN syndrome/NN
warfarin/NN model/NN hemorrhage/VB associated/JJ hemorrhage/NN intracerebral/JJ
warfarin/NN model/NN hemorrhage/VB associated/JJ hemorrhage/NN
Warfarin/NNP associated/VBN type/NN hemorrhage/NN intracerebral/JJ
Warfarin/NNP associated/VBN type/NN hemorrhage/NN
Warfarin/NNP associated/VBN type/NN hemorrhage/NN W/NNP ICH/NNP
Cocaine/NNP induced/VBN seizures/NNS
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/NN duration/NN induced/VBN catalepsy/RB
phenylephrine/NN indicate/VBP instituted/VBD hypertension/NN
dietary/JJ supplementation/NN effect/NN importantly/RB contributes/VBZ treated/VBD rats/NNS hypertensive/JJ
sodium/NN supplementation/NN effect/NN importantly/RB contributes/VBZ treated/VBD rats/NNS hypertensive/JJ
chloride/NN supplementation/NN effect/NN importantly/RB contributes/VBZ treated/VBD rats/NNS hypertensive/JJ
dietary/JJ supplementation/NN effect/NN hypertensive/JJ
sodium/NN supplementation/NN effect/NN hypertensive/JJ
chloride/NN supplementation/NN effect/NN hypertensive/JJ
dietary/JJ increase/NN
dietary/JJ increase/NN eliminated/VBD MAP/NNP in/IN
dietary/JJ increase/NN eliminated/VBD MAP/NNP
sodium/NN increase/NN
sodium/NN increase/NN eliminated/VBD MAP/NNP in/IN
sodium/NN increase/NN eliminated/VBD MAP/NNP
chloride/NN increase/NN
chloride/NN increase/NN eliminated/VBD MAP/NNP in/IN
chloride/NN increase/NN eliminated/VBD MAP/NNP
combined/VBN contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN venous/JJ
combined/VBN contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN
oral/JJ contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN venous/JJ
oral/JJ contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN
contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN venous/JJ
contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN
combined/VBN contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN VTE/NNP
oral/JJ contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN VTE/NNP
contraceptives/NNS women/NNS thromboembolism/NN' thromboembolism/NN VTE/NNP
COCs/NNP thromboembolism/NN venous/JJ
COCs/NNP thromboembolism/NN
COCs/NNP thromboembolism/NN VTE/NNP
COCs/NNP had/VBN while/NN VTE/NNP
COCs/NNP women/NNS years/NNS 2/CD years/NNS COCs/NNP 1/CD women/NNS risk/NN VTE/NNP
COCs/NNP 1/CD women/NNS risk/NN VTE/NNP
COCs/NNP women/NNS VTE/NNP
Puromycin/NNP aminonucleoside/NNP administered/VBN induce/VB proteinuria/NN
aminonucleoside/NNP administered/VBN induce/VB proteinuria/NN
PAN/NNP aminonucleoside/NNP administered/VBN induce/VB proteinuria/NN
Haloperidol/NNP induced/VBN rigidity/NN muscle/NN
Haloperidol/NNP induced/VBN rigidity/NN
haloperidol/NN diminished/NNS rigidity/NN muscle/NN
haloperidol/NN diminished/NNS rigidity/NN
azidothymidine/NN mice/NNS treatment/NN produces/VBZ myelodysplasia/NN
AZT/NNP treatment/NN produces/VBZ myelodysplasia/NN
AZT/NNP induced/VBN anemia/NN macrocytic/JJ
AZT/NNP induced/VBN anemia/NN
AZT/NNP therapy/NNP induced/VBN anemia/NN macrocytic/JJ
AZT/NNP therapy/NNP induced/VBN anemia/NN
AZT/NNP incorporation/NNP induced/VBN mentioned/VBD cells/NNS known/VBN seen/VBN syndrome/NN myelodysplastic/JJ
AZT/NNP incorporation/NNP induced/VBN mentioned/VBD cells/NNS known/VBN seen/VBN syndrome/NN
morphine/NN cord/NN changes/NNS 801/CD MK/NNP induced/VBN paraparesis/NNS spastic/JJ
morphine/NN cord/NN changes/NNS 801/CD MK/NNP induced/VBN paraparesis/NNS
morphine/NN reduced/VBD paraparesis/NNS spastic/JJ
morphine/NN reduced/VBD paraparesis/NNS
morphine/RB induces/VBZ paraparesis/NNS spastic/JJ
morphine/RB induces/VBZ paraparesis/NNS
ribavirin/NN interferon/NN therapy/NN events/NNS one/CD anemia/NNP Hemolytic/NNP
ribavirin/NN interferon/NN therapy/NN events/NNS one/CD anemia/NNP
interferon/NN therapy/NN events/NNS one/CD anemia/NNP Hemolytic/NNP
interferon/NN therapy/NN events/NNS one/CD anemia/NNP
ribavirin/NNP anemia/NN hemolytic/JJ
ribavirin/NNP anemia/NN
rifampicin/NN administration/NN subsequent/JJ Acute/VB
rifampicin/NN administration/NN subsequent/JJ failure/NN renal/JJ
rifampicin/NN administration/NN subsequent/JJ failure/NN
dilevalol/NN mechanism/NN hepatitis/NN
dilevalol/NN mechanism/NN reaction/NN Hypersensitivity/RB
dilevalol/NN assess/VB induced/VBN injury/NN liver/NN
dilevalol/NN assess/VB induced/VBN injury/NN
dilevalol/JJ antigens/NNS containing/VBG serum/VB assess/VB induced/VBN injury/NN liver/NN
dilevalol/JJ antigens/NNS containing/VBG serum/VB assess/VB induced/VBN injury/NN
dilevalol/NN case/NN antigens/NNS containing/VBG serum/VB assess/VB induced/VBN injury/NN liver/NN
dilevalol/NN case/NN antigens/NNS containing/VBG serum/VB assess/VB induced/VBN injury/NN
dilevalol/NN diagnosis/NN woman/NN year/NN injury/NN liver/NN
dilevalol/NN diagnosis/NN woman/NN year/NN injury/NN
dilevalol/JJ antigens/NNS prepared/VBN used/VBN injury/NN liver/NN
dilevalol/JJ antigens/NNS prepared/VBN used/VBN injury/NN
dilevalol/NN mechanism/NN involvement/NN suggesting/VBG prepared/VBN used/VBN injury/NN liver/NN
dilevalol/NN mechanism/NN involvement/NN suggesting/VBG prepared/VBN used/VBN injury/NN
cocaine/NN Absence/VB associated/JJ hemorrhage/NN subarachnoid/JJ
cocaine/NN Absence/VB associated/JJ hemorrhage/NN
cocaine/NN patients/NNS angiograms/NNS obtained/VBN associated/JJ hemorrhage/NN subarachnoid/JJ
cocaine/NN patients/NNS angiograms/NNS obtained/VBN associated/JJ hemorrhage/NN
cocaine/NN patients/NNS angiograms/NNS obtained/VBN associated/JJ hemorrhage/NN SAH/NNP
cocaine/NN use/NN underwent/VBD hemorrhage/NN subarachnoid/JJ
cocaine/NN use/NN underwent/VBD hemorrhage/NN
cocaine/NN use/NN underwent/VBD hemorrhage/NN SAH/NNP
cocaine/NN toxicology/NN identified/VBD screened/VBD retrospectively/NN SAH/NNP
cocaine/NN use/NN associated/VBN SAH/NNP
cocaine/NN use/NN associated/VBN SAH/NNP aneurysmal/NNP
5/CD undergoing/VBG assess/VB incidence/NN changes/NNS ischemic/JJ
FU/NNP infusion/NNP 5/CD undergoing/VBG assess/VB incidence/NN changes/NNS ischemic/JJ
5/CD infusion/NNP angina/VBN rare/JJ episodes/NNS Anginal/JJ
FU/NNP infusion/NNP angina/VBN rare/JJ episodes/NNS Anginal/JJ
5/CD infusion/NNP angina/VBN
FU/NNP infusion/NNP angina/VBN
5/CD 02/CD 0/NN 13/CD 0/CD +/VBD 0/NNP incidence/NN episodes/NNS ischemic/JJ
FU/NNP 0/NN 13/CD 0/CD +/VBD 0/NNP incidence/NN episodes/NNS ischemic/JJ
5/CD 03/CD +/VBD 0/NNP incidence/NN episodes/NNS ischemic/JJ
FU/NNP infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
5/CD hour/NN minutes/NNS +/NNS duration/NN less/JJR P/VB infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
FU/RB v/NN +/CD minutes/NNS +/NNS duration/NN less/JJR P/VB infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
5/CD hour/NN patient/NN minutes/NNS +/CD minutes/NNS +/NNS duration/NN less/JJR P/VB infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
FU/NNP P/NNP minutes/NNS +/CD minutes/NNS +/NNS duration/NN less/JJR P/VB infusion/NNP 0/NNP incidence/NN episodes/NNS ischemic/JJ
5/CD infusion/NN associated/VBN increase/NN ischemia/NN
-/NNP infusion/NN associated/VBN increase/NN ischemia/NN
FU/NNP infusion/NN associated/VBN increase/NN ischemia/NN
epinephrine/NN overflow/NN stimulus/NN induced/VBN mediated/VBN rats/NNS hypertensive/JJ
Amphotericin/NNP B/NNP induced/VBN seizures/NNS
B/NNP induced/VBN seizures/NNS
amphotericin/JJ infusion/NN patent/NN report/VB case/NN episodes/NNS activity/NN seizure/NN
B/NN infusion/NN patent/NN report/VB case/NN episodes/NNS activity/NN seizure/NN
amphotericin/NNP B/NNP infusion/NN experienced/VBD stopped/VBN seizures/NNS
B/NNP infusion/NN experienced/VBD stopped/VBN seizures/NNS
amphotercin/JJ administration/NN occurred/VBD persisted/VBD seizures/NNS
B/NN administration/NN occurred/VBD persisted/VBD seizures/NNS
amphotericin/NNP B/NNP cause/NN seizures/NNS
B/NNP cause/NN seizures/NNS
Amphotericin/NNP B/NNP seems/VBZ cause/NN seizures/NNS
B/NNP seems/VBZ cause/NN seizures/NNS
amphotericin/NNP B/NNP associated/VBN seizures/NNS
B/NNP associated/VBN seizures/NNS
scopolamine/NN amnesia/NN
scopolamine/NN ritanserin/NN effect/NN amnesia/NN
scopolamine/NN amnesia/NN
penicillamine/NN Immunopathology/NNP disease/NN glomerular/NN
penicillamine/NN Immunopathology/NNP disease/NN
D/NNP developed/VBD proteinuria/NN
penicillamine/NN D/NNP developed/VBD proteinuria/NN
morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN
morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP of/IN
morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP Oddi/NNP
morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP
prostigmine/NN morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN
prostigmine/NN morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP of/IN
prostigmine/NN morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP Oddi/NNP
prostigmine/NN morphine/NN trinitrate/NN effect/NN induced/VBN evaluated/VBN patients/NNS sphincter/NN dyskinesia/NNP
morphine/JJ provocation/NN caused/VBD indicating/VBG spasm/NN
Prostigmine/NNP RESULTS/NNS caused/VBD indicating/VBG spasm/NN
morphine/NN effect/NN overcome/VB able/JJ relevance/NN treatment/NN sphincter/NN
morphine/NN effect/NN overcome/VB able/JJ relevance/NN treatment/NN sphincter/NN dyskinesia/NNP of/IN
morphine/NN effect/NN overcome/VB able/JJ relevance/NN treatment/NN sphincter/NN dyskinesia/NNP Oddi/NNP
morphine/NN effect/NN overcome/VB able/JJ relevance/NN treatment/NN sphincter/NN dyskinesia/NNP
Ethambutol/NNP associated/VBN neuropathy/NN optic/JJ
Ethambutol/NNP associated/VBN neuropathy/NN
Ethambutol/NNP used/VBN treatment/NN prevalent/JJ associated/VBN loss/NN visual/JJ
Ethambutol/NNP used/VBN treatment/NN prevalent/JJ associated/VBN loss/NN
ethambutol/NN patients/NNS PICTURE/NNP associated/VBN neuropathy/NN optic/JJ
ethambutol/NN patients/NNS PICTURE/NNP associated/VBN neuropathy/NN
Ethambutol/NNP usage/NN associated/VBN loss/NN visual/JJ
Ethambutol/NNP usage/NN associated/VBN loss/NN
dobutamine/JJ stress/NN spasm/NN coronary/JJ
dobutamine/JJ stress/NN spasm/NN artery/NN
dobutamine/JJ stress/NN spasm/NN
dobutamine/NN induced/VBN ischemia/NN due/JJ spasm/NN coronary/JJ
dobutamine/NN induced/VBN ischemia/NN due/JJ spasm/NN
dobutamine/NN provoke/VB patients/NNS angina/NN coronary/JJ
dobutamine/NN provoke/VB patients/NNS angina/NN spastic/JJ
dobutamine/NN provoke/VB patients/NNS angina/NN
dobutamine/NN provoke/VB spasm/NN coronary/JJ
dobutamine/NN provoke/VB spasm/NN
propofol/NN Assessment/NNP onset/NN amnesia/NN
Vasopressin/NNP hypotension/NN
milrinone/NN treatment/NN Vasopressin/NNP hypotension/NN
milrinone/NN inhibitors/NNS use/NN restricted/VBN cause/VBP vasodilation/NN hypotension/NN
vasopressin/NN doses/NNS restored/VBD patients/NNS failure/NN hypotension/NN
milrinone/NN treatment/NN hypotension/NN
milrinone/NN effect/NN inhibiting/VBG restored/VBD patients/NNS failure/NN hypotension/NN
amphetamine/NN reflects/VBZ rotation/NN contralateral/JJ
amphetamine/NN reflects/VBZ rotation/NN
amphetamine/NN examined/VBD clarify/VB nature/NN rotation/NN contralateral/JJ
amphetamine/NN examined/VBD clarify/VB nature/NN rotation/NN
amphetamine/NN induced/VBN behavior/NN rotational/JJ
amphetamine/NN induced/VBN behavior/NN
amphetamine/NN administered/VBN days/NNS lesioning/VBG involvement/NN cells/NNS rotation/NN contralateral/JJ
amphetamine/NN administered/VBN days/NNS lesioning/VBG involvement/NN cells/NNS rotation/NN
amphetamine/JJ dose/NN volume/NN recovery/NN duration/NN regardless/RB tended/VBD rotation/NN
amphetamine/RB duration/NN regardless/RB tended/VBD rotation/NN
amphetamine/NN injections/NNS circled/VBD tended/VBD rotation/NN
amphetamine/NN has/VBZ suggest/VBP pool/VBP contributing/VBG rotation/NN contralateral/JJ
amphetamine/NN has/VBZ suggest/VBP pool/VBP contributing/VBG rotation/NN
Clarithromycin/NNP induced/VBN tachycardia/NN ventricular/NN
Clarithromycin/NNP induced/VBN tachycardia/NN
erythromycin/NN profile/NN established/VBN gastroenteritis/NNS
Phenobarbital/NNP dyskinesia/NN
phenobarbital/JJ therapy/NN starting/VBG soon/RB dyskinesia/NN
phenobarbital/NN challenge/NN recurred/VBD dyskinesia/NN
pilocarpine/NN latency/NN indicated/VBN increased/VBN seizures/NNS
pilocarpine/NN latency/NN indicated/VBN increased/VBN seizures/NNS
acetaminophen/NN hepatotoxicity/NN
acetaminophen/NN hepatitis/NN
acetaminophen/NN suffering/VBG suggesting/VBG involves/VBZ injury/NN liver/NN
acetaminophen/NN suffering/VBG suggesting/VBG involves/VBZ injury/NN
AAP/NNP acetaminophen/NN hepatitis/NN
AAP/NNP acetaminophen/NN suffering/VBG suggesting/VBG involves/VBZ injury/NN liver/NN
AAP/NNP acetaminophen/NN suffering/VBG suggesting/VBG involves/VBZ injury/NN
AAP/NNP injury/NN involves/VBZ suggesting/VBG suffering/VBG acetaminophen/NN hepatitis/NN
AAP/NNP injury/NN liver/NN
AAP/NNP injury/NN
AAP/NNP hepatitis/NNP
ethanol/NN consumption/NN influence/NN evaluates/VBZ investigates/VBZ effects/NNS diet/NN substrate/NN acts/VBZ hepatitis/NNP
AAP/NNP presence/NN measured/VBN inhibited/VBN damage/NN liver/NN
AAP/NNP presence/NN measured/VBN inhibited/VBN damage/NN
ethanol/NN caused/VBN exacerbation/NN inhibited/VBN damage/NN liver/NN
ethanol/NN caused/VBN exacerbation/NN inhibited/VBN damage/NN
ethanol/NN inhibited/VBN damage/NN liver/NN
ethanol/NN inhibited/VBN damage/NN
AAP/NNP mice/NNS given/VBN observed/JJ reduction/NN hepatitis/NN
ethanol/JJ mice/NNS given/VBN observed/JJ reduction/NN hepatitis/NN
AAP/NNP hepatitis/NNP
ethanol/NN exacerbation/NN AAP/NNP hepatitis/NNP
acetaminophen/NN preparations/NNS use/NN see/VBP avoid/VB damage/NN hepatic/JJ
acetaminophen/NN preparations/NNS use/NN see/VBP avoid/VB damage/NN
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/JJ induced/NNS reverse/VB catalepsy/RB
Cyclophosphamide/NNP induced/VBN cystitis/NNS
Cyclophosphamide/NNP used/VBN induce/VB cystitis/NNS
CP/NNP Cyclophosphamide/NNP used/VBN induce/VB cystitis/NNS
CP/NNP model/NN induced/VBN model/NN allowing/VBG understanding/NN syndromes/NNS painful/JJ
CP/NNP model/NN induced/VBN model/NN allowing/VBG understanding/NN syndromes/NNS
CP/NNP model/NN induced/VBN model/NN cystitis/NNS
adriamycin/NN activity/NN Detection/NNP induced/VBN cardiomyopathy/RB
adriamycin/NN induced/VBN cardiomyopathy/RB
adriamycin/NN model/NN Using/VBG tested/VBD hypothesis/NNS appear/VB exacerbated/VBN cardiomyopathy/NN
adriamycin/NN cardiomyopathy/NN exacerbated/VBN appear/VB hypothesis/NNS tested/VBD Using/VBG model/NN adriamycin/NN induced/VBN cardiomyopathy/RB
adriamycin/NN cardiomyopathy/NN
adriamycin/NN detection/NN method/NN indicates/VBZ appearance/NN presence/NN impairment/NN myocardial/JJ
adriamycin/NN detection/NN method/NN indicates/VBZ appearance/NN presence/NN impairment/NN
adriamycin/NN induced/VBN cardiomyopathy/RB
methysergide/NNP woman/NN ingestion/NN secondary/JJ described/VBN case/NN vasospasm/NN
ergot/NN history/NN discussion/NN includes/VBZ caused/VBN ages/NNS role/NN management/NN headache/NN migraine/JJ
ergot/NN history/NN discussion/NN includes/VBZ caused/VBN ages/NNS role/NN management/NN headache/NN
ergot/NN preparations/NNS continue/VBP play/VB therapy/NN migraine/JJ
bendrofluazide/JJ treatment/NN impotence/NN
bendrofluazide/JJ treatment/NN association/NN show/VBP occurred/VBD impotence/NN
propranolol/NN taking/VBG patients/NNS occurred/VBD show/VBP association/NN treatment/NN impotence/NN
propranolol/NN taking/VBG patients/NNS occurred/VBD impotence/NN
propranolol/JJ taking/VBG phenomenon/NN Raynaud/NNP
propranolol/JJ taking/VBG phenomenon/NN Raynaud/NNP '/POS
propranolol/JJ taking/VBG phenomenon/NN s/VBZ
propranolol/JJ taking/VBG phenomenon/NN
bendrofluazide/JJ treatment/NN associated/VBN men/NNS gout/NN
bendrofluazide/JJ treatment/NN associated/VBN men/NNS gout/NN tolerance/NN impaired/VBN
bendrofluazide/JJ treatment/NN associated/VBN men/NNS gout/NN tolerance/NN glucose/NN
bendrofluazide/JJ treatment/NN associated/VBN men/NNS gout/NN tolerance/NN
propranolol/JJ taking/VBG phenomenon/NN dyspnoea/NN
steroid/JJ therapy/NN term/NN defect/NN ventricular/NN
steroid/JJ therapy/NN term/NN defect/NN septal/NN
steroid/JJ therapy/NN term/NN defect/NN
steroid/VBD ventricular/VBP
steroid/VBD ventricular/VBP rupture/NN septal/JJ
steroid/VBD ventricular/VBP rupture/NN
steroid/JJ therapy/NN rupture/NN septal/NN
steroid/JJ therapy/NN rupture/NN
Clarithromycin/NNP associated/VBN hallucinations/NNS visual/JJ
Clarithromycin/NNP associated/VBN hallucinations/NNS
clarithromycin/NN antibiotic/NN occurring/VBG hallucinations/NNS visual/JJ
clarithromycin/NN antibiotic/NN occurring/VBG hallucinations/NNS
warfarin/NN discontinued/VBN available/JJ patients/NNS lesions/NNS LV/NNP
warfarin/NN discontinued/VBN available/JJ patients/NNS lesions/NNS Cutaneous/NNP
warfarin/NN discontinued/VBN available/JJ patients/NNS lesions/NNS
paracetamol/NNP survivors/NNS Long/NNP induced/NNP failure/NN acute/JJ
paracetamol/NNP survivors/NNS Long/NNP induced/NNP failure/NN liver/NN
paracetamol/NNP survivors/NNS Long/NNP induced/NNP failure/NN
paracetamol/NNP survivors/NNS prognosis/NN BACKGROUND/NNP induced/VBD remains/VBZ failure/NN acute/JJ
paracetamol/NNP survivors/NNS prognosis/NN BACKGROUND/NNP induced/VBD remains/VBZ failure/NN liver/NN
paracetamol/NNP survivors/NNS prognosis/NN BACKGROUND/NNP induced/VBD remains/VBZ failure/NN
paracetamol/NNP induced/VBN increases/NNS acute/JJ
paracetamol/NNP induced/VBN increases/NNS liver/NN
paracetamol/NNP induced/VBN increases/NNS failure/NN
paracetamol/NNS caused/VBN ratio/NN acute/JJ
paracetamol/NNS caused/VBN ratio/NN liver/NN
paracetamol/NNS caused/VBN ratio/NN failure/NN
paracetamol/NNS caused/VBN higher/JJR age/VBP age/NN died/VBD survivors/NNS failure/NN acute/JJ
paracetamol/NNS caused/VBN higher/JJR age/VBP age/NN died/VBD survivors/NNS failure/NN liver/NN
paracetamol/NNS caused/VBN higher/JJR age/VBP age/NN died/VBD survivors/NNS failure/NN
Paracetamol/NNP CONCLUSIONS/NNS affect/VB failure/NN acute/JJ
Paracetamol/NNP CONCLUSIONS/NNS affect/VB failure/NN liver/NN
Paracetamol/NNP CONCLUSIONS/NNS affect/VB failure/NN
heparin/NN treatment/NN ancrod/NN Failure/NN thrombosis/NNS
heparin/NN associated/VBN remain/VBP thrombosis/NNS
heparin/NN used/VBN prophylaxis/NNS development/NN thrombosis/NNS
heparin/NN used/VBN defined/VBN success/NN patients/NNS developed/VBN syndrome/NN thrombosis/JJ
heparin/NN require/VBP aggregation/NN induced/VBN heparin/NN used/VBN prophylaxis/NNS development/NN thrombosis/NNS
heparin/NN require/VBP aggregation/NN induced/VBN heparin/NN used/VBN defined/VBN success/NN patients/NNS developed/VBN syndrome/NN thrombosis/JJ
heparin/NN patient/NN present/VBP thrombosis/NNS
Chlorpropamide/NNP induced/VBN neuropathy/NN optic/JJ
Chlorpropamide/NNP induced/VBN neuropathy/NN
chlorpropamide/NN treated/VBN diabetes/NN had/VBD neuropathy/NN toxic/JJ
chlorpropamide/NN treated/VBN diabetes/NN had/VBD neuropathy/NN optic/JJ
chlorpropamide/NN treated/VBN diabetes/NN had/VBD neuropathy/NN
Diabenese/NNP diabetes/NN had/VBD neuropathy/NN toxic/JJ
Diabenese/NNP diabetes/NN had/VBD neuropathy/NN optic/JJ
Diabenese/NNP diabetes/NN had/VBD neuropathy/NN
chlorpropamide/JJ therapy/NN discontinuation/NN resolved/VBN neuropathy/NN toxic/JJ
chlorpropamide/JJ therapy/NN discontinuation/NN resolved/VBN neuropathy/NN optic/JJ
chlorpropamide/JJ therapy/NN discontinuation/NN resolved/VBN neuropathy/NN
succinylcholine/NN myalgia/NN Postoperative/JJ
succinylcholine/NN myalgia/NN
succinylcholine/NN associated/VBN effect/NN myalgia/NN postoperative/JJ
succinylcholine/NN associated/VBN effect/NN myalgia/NN
succinylcholine/NN incidence/NN determined/VBN myalgia/NN
succinylcholine/NN pretreated/VBN patients/NNS determined/VBN myalgia/NN
succinylcholine/NN origin/NN evidence/NN myalgia/NN
succinylcholine/NN effective/JJ Administration/NNP IMPLICATIONS/NNS induced/VBN myalgia/NN postoperative/JJ
succinylcholine/NN effective/JJ Administration/NNP IMPLICATIONS/NNS induced/VBN myalgia/NN
succinylcholine/NN severity/NN incidence/NN decreasing/VBG effective/JJ Administration/NNP IMPLICATIONS/NNS induced/VBN myalgia/NN postoperative/JJ
succinylcholine/NN severity/NN incidence/NN decreasing/VBG effective/JJ Administration/NNP IMPLICATIONS/NNS induced/VBN myalgia/NN
succinylcholine/NN prevent/VB myalgia/NN postoperative/JJ
succinylcholine/NN prevent/VB myalgia/NN
estrogens/NNS treatment/NN implicated/VBN development/NN cancer/NN endometrial/JJ
estrogens/NNS treatment/NN implicated/VBN development/NN cancer/NN
estrogens/NNS women/NNS have/VB risk/NN carcinoma/NN endometrial/JJ
estrogens/NNS women/NNS have/VB risk/NN carcinoma/NN
pilocarpine/JJ model/NN epilepsy/NN temporal/JJ
pilocarpine/JJ model/NN epilepsy/NN lobe/NN
pilocarpine/JJ model/NN epilepsy/NN
PILO/NNP model/NN TLE/NNP
tranexamic/JJ Acid/NN associated/VBN seizures/NNS
Acid/NN associated/VBN seizures/NNS
TXA/NNP usage/NN seizures/NNS
TXA/NNP doses/NNS received/VBD patients/NNS seizures/NNS
TXA/NNP high/JJ surgery/NN use/NN associated/VBN seizures/NNS
paracetamol/NNP overdose/NN due/JJ ALF/NNP
paracetamol/NNP overdose/NNP due/JJ defect/NN ALF/NNP
risperidone/NN Treatment/NNP hyperprolactinemia/NN
Risperidone/NNP associated/VBN hyperprolactinemia/NN
risperidone/NN treatment/NN report/VBP induced/VBN hyperprolactinemia/NN
risperidone/NN children/NNS review/NN hyperprolactinemia/NN
risperidone/NN treatment/NN hyperprolactinemia/NN
LiCl/NNP pre/NNP administered/VBN Tacrine/NNP induces/VBZ seizures/NNS
LiCl/NNP pre/NNP administered/VBN Tacrine/NNP induces/VBZ seizures/NNS damage/NN hippocampal/JJ
LiCl/NNP pre/NNP administered/VBN Tacrine/NNP induces/VBZ seizures/NNS damage/NN
Tacrine/NNP induces/VBZ seizures/NNS damage/NN hippocampal/JJ
Tacrine/NNP induces/VBZ seizures/NNS damage/NN
Tacrine/NNP induces/VBZ seizures/NNS
tacrine/NN administration/NN induced/VBN damage/NN
tacrine/NN administration/NN induced/VBN damage/NN cells/NNS of/IN
tacrine/NN administration/NN induced/VBN damage/NN cells/NNS neuronal/JJ
tacrine/NN administration/NN induced/VBN damage/NN cells/NNS
tacrine/NN solution/NN treated/VBD tacrine/NN administration/NN induced/VBN damage/NN
tacrine/NN solution/NN treated/VBD tacrine/NN administration/NN induced/VBN damage/NN cells/NNS of/IN
tacrine/NN solution/NN treated/VBD tacrine/NN administration/NN induced/VBN damage/NN cells/NNS neuronal/JJ
tacrine/NN solution/NN treated/VBD tacrine/NN administration/NN induced/VBN damage/NN cells/NNS
penicillin/NN potassium/NN induced/VBN focus/NN epileptic/JJ
G/NNP potassium/NN induced/VBN focus/NN epileptic/JJ
potassium/NN induced/VBN focus/NN epileptic/JJ
diclofenac/VBN etoricoxib/NN lower/JJR rate/NN due/JJ AEs/NNP GI/NNP
diclofenac/VBN etoricoxib/NN lower/JJR rate/NN due/JJ AEs/NNP
etoricoxib/NN higher/JJR incidence/NN discontinuations/NNS hypertension/NN
etoricoxib/NN %/NN 0/NNP 001/NNP hypertension/NN
etoricoxib/NN higher/JJR incidence/NN discontinuations/NNS related/VBN oedema/JJ
etoricoxib/NN %/NN 0/NNP 001/NNP 01/NNP oedema/NN
diclofenac/JJ Discontinuations/NNP AEs/NNP GI/NNP
diclofenac/JJ Discontinuations/NNP AEs/NNP
diclofenac/JJ Discontinuations/NNP AEs/NNP higher/JJR common/JJ discontinuations/NNS AEs/NNP GI/NNP
diclofenac/JJ Discontinuations/NNP AEs/NNP higher/JJR common/JJ discontinuations/NNS AEs/NNP
metformin/NN use/NN associated/VBN jaundice/NN Cholestatic/JJ
metformin/NN use/NN associated/VBN jaundice/NN
metformin/NN hydrochloride/NN developed/VBD jaundice/NN cholestatic/JJ
metformin/NN hydrochloride/NN developed/VBD jaundice/NN
hydrochloride/NN developed/VBD jaundice/NN cholestatic/JJ
hydrochloride/NN developed/VBD jaundice/NN
succinylcholine/JJ apnoea/NN
succinylcholine/NN hours/NNS apnoea/NN
succinylcholine/JJ apnoea/NN
Amiodarone/NNP agent/NN effects/NNS pneumonitis/NNS
doxorubicin/NN +/NN daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN hematologic/JJ
doxorubicin/NN +/NN daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN
daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN hematologic/JJ
daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN
etoposide/NN daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN hematologic/JJ
etoposide/NN daunorubicin/NN Sensitivity/NNP investigated/VBN toxicity/NN
etoposide/NN daunorubicin/NN reduced/VBD loss/NN myelosuppression/NN weight/NN
etoposide/NN daunorubicin/NN reduced/VBD loss/NN
etoposide/NN daunorubicin/NN reduced/VBD antagonized/VBD dexrazoxane/VB myelosuppression/NN loss/NN weight/NN
etoposide/NN daunorubicin/NN reduced/VBD antagonized/VBD dexrazoxane/VB myelosuppression/NN loss/NN
doxorubicin/NN cytotoxicity/NN myelosuppression/NN dexrazoxane/VB antagonized/VBD reduced/VBD loss/NN myelosuppression/NN weight/NN
doxorubicin/NN cytotoxicity/NN myelosuppression/NN dexrazoxane/VB antagonized/VBD reduced/VBD loss/NN
doxorubicin/NN cytotoxicity/NN myelosuppression/NN loss/NN weight/NN
doxorubicin/NN cytotoxicity/NN myelosuppression/NN loss/NN
daunorubicin/NN reduced/VBD loss/NN myelosuppression/NN weight/NN
daunorubicin/NN reduced/VBD loss/NN
daunorubicin/NN reduced/VBD antagonized/VBD dexrazoxane/VB myelosuppression/NN loss/NN weight/NN
daunorubicin/NN reduced/VBD antagonized/VBD dexrazoxane/VB myelosuppression/NN loss/NN
etoposide/NN doses/NNS combining/VBG metastases/NNS patients/NNS trials/NNS ongoing/JJ aim/NN improving/VBG toxicity/NN hematologic/JJ
etoposide/NN doses/NNS combining/VBG metastases/NNS patients/NNS trials/NNS ongoing/JJ aim/NN improving/VBG toxicity/NN
amiodarone/NN secondary/JJ hypothyroidism/NN
amiodarone/NN CHF/NNP Patients/NNS suffer/VB hypothyroidism/NN
furosemide/NN Tetany/JJ
furosemide/NN Tetany/JJ rhabdomyolysis/JJ
ribavirin/NNP strategies/NNS anemia/NN hemolytic/JJ
ribavirin/NNP strategies/NNS anemia/NN
ribavirin/NNP anemia/NN hemolytic/JJ
ribavirin/NNP anemia/NN
ribavirin/NNP anemia/NN RIHA/NNP
ribavirin/NNP dosage/NN reduction/NN standard/NN care/NN management/NN RIHA/NNP
ribavirin/NNP dose/NN incidence/NN RIHA/NNP
DEN/NNP given/VBN reduced/VBN number/NN size/NN foci/NNS preneoplastic/JJ
DEN/NNP given/VBN reduced/VBN number/NN size/NN foci/NNS
bupropion/NN hydrochloride/NN increasing/VBG Effect/NN seizures/NNS
hydrochloride/NN increasing/VBG Effect/NN seizures/NNS
bupropion/NN relationship/NN seizures/NNS
bupropion/NNP HCl/NNP mg/NN kg/NN dose/NN convulsive/JJ
HCl/NNP mg/NN kg/NN dose/NN convulsive/JJ
bupropion/NNP HCl/NNP mg/NN induced/VBN convulsions/NNS
HCl/NNP mg/NN induced/VBN convulsions/NNS
bupropion/NN severity/NN kg/NN dose/NN convulsive/JJ
bupropion/NN severity/NN kg/NN mg/NN induced/VBN convulsions/NNS
bupropion/JJ mg/NN administration/NN kg/NN induced/VBN convulsions/NNS
HCl/NN mg/NN administration/NN kg/NN induced/VBN convulsions/NNS
bupropion/JJ mg/NN administration/NN associated/VBN odds/NNS convulsions/NNS
HCl/NN mg/NN administration/NN associated/VBN odds/NNS convulsions/NNS
bupropion/JJ mg/NN time/NN increasing/VBG revealed/VBD group/NN induced/VBN convulsions/NNS
HCl/NN mg/NN time/NN increasing/VBG revealed/VBD group/NN induced/VBN convulsions/NNS
bupropion/JJ mg/NN time/NN increasing/VBG revealed/VBD group/NN induced/VBN kg/NN administration/NN associated/VBN odds/NNS convulsions/NNS
HCl/NN mg/NN time/NN increasing/VBG revealed/VBD group/NN induced/VBN kg/NN administration/NN associated/VBN odds/NNS convulsions/NNS
bupropion/NN dose/NN fixed/JJ convulsive/JJ
bupropion/NN dose/NN risk/NN convulsions/NNS
androgen/NN administration/NN sleep/VBP Induction/NNP obstructive/NN
androgen/NN administration/NN sleep/VBP
androgen/NN administration/NN sleep/VBP syndrome/NN apnea/NN
androgen/NN administration/NN sleep/VBP syndrome/NN
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN apnea/NN of/IN
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN apnea/NN obstructive/JJ
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN apnea/NN sleep/NN
androgens/NNS exogenous/VBZ developed/VBN changes/NNS syndrome/NN apnea/NN
androgen/NN rechallenge/NN produced/VBD symptoms/NNS apnea/NN obstructive/JJ
androgen/NN rechallenge/NN produced/VBD symptoms/NNS apnea/NN sleep/NN
androgen/NN rechallenge/NN produced/VBD symptoms/NNS apnea/NN
androgen/NN therapy/NN effect/NN considered/VBN Development/NNP syndrome/NN obstructive/JJ
androgen/NN therapy/NN effect/NN considered/VBN Development/NNP syndrome/NN sleep/NN
androgen/NN therapy/NN effect/NN considered/VBN Development/NNP syndrome/NN apnea/NN
androgen/NN therapy/NN effect/NN considered/VBN Development/NNP syndrome/NN
metoclopramide/NN arrest/NN Cardiac/NNP
metoclopramide/NN arrest/NN
metoclopramide/NN arrest/NN case/NN injections/NNS metoclopramide/NN causing/VBG episodes/NNS arrest/NN cardiac/JJ
metoclopramide/NN arrest/NN case/NN injections/NNS metoclopramide/NN causing/VBG episodes/NNS arrest/NN
metoclopramide/NN injections/NNS case/NN arrest/NN Cardiac/NNP
metoclopramide/NN injections/NNS case/NN arrest/NN
metoclopramide/NN causing/VBG episodes/NNS arrest/NN cardiac/JJ
metoclopramide/NN causing/VBG episodes/NNS arrest/NN
metoclopramide/NN injection/NN followed/VBN asystole/NN
metoclopramide/NN administration/NN followed/VBN asystole/NN
metoclopramide/NN caused/VBN arrest/NN cardiac/JJ
metoclopramide/NN caused/VBN arrest/NN
levodopa/NN patients/NNS selected/VBN dyskinesias/NNS
clomipramine/NN effects/NNS sexual/JJ
clomipramine/NN effects/NNS side/NN
clomipramine/NN effects/NNS
folic/JJ acid/NN activity/NN induces/VBZ SLE/NNP
acid/NN activity/NN induces/VBZ SLE/NNP
folic/JJ acid/NN SLE/NNP
acid/NN SLE/NNP
folic/JJ acid/NN dose/NN barrier/NN triggered/VBD disease/NN drug/NN lupus/NNS
acid/NN dose/NN barrier/NN triggered/VBD disease/NN drug/NN lupus/NNS
folic/JJ acid/NN dose/NN barrier/NN triggered/VBD cluster/NN seizures/NNS
acid/NN dose/NN barrier/NN triggered/VBD cluster/NN seizures/NNS
epsilon/NN induce/VB myopathy/RB
aminocaproic/JJ acid/NN epsilon/NN induce/VB myopathy/RB
acid/NN epsilon/NN induce/VB myopathy/RB
EACA/NNP epsilon/NN induce/VB myopathy/RB
Valproate/NNP induced/VBN chorea/NN encephalopathy/NN
Valproate/NNP induced/VBN chorea/NN
valproate/JJ therapy/NN initiation/NN have/VB hyperglycinemia/NN presentation/NN encephalopathy/NN
valproate/JJ therapy/NN initiation/NN have/VB hyperglycinemia/NN presentation/NN encephalopathy/NN chorea/NN
nimesulide/NN Tolerability/NNP urticaria/NN angioedema/NN
NSAID/NNP Tolerability/NNP urticaria/NN angioedema/NN
paracetamol/NN nimesulide/NN Tolerability/NNP urticaria/NN angioedema/NN
nimesulide/NN angioedema/NN
NSAID/NNP history/NN number/NN paracetamol/JJ nimesulide/NN angioedema/NN
paracetamol/JJ nimesulide/NN angioedema/NN
nimesulide/NN procedure/NN applied/VBN patients/NNS history/NN angioedema/NN
NSAID/NNP angioedema/NN
paracetamol/NN nimesulide/NN procedure/NN applied/VBN patients/NNS history/NN angioedema/NN
NSAID/NNP history/NN subjects/NNS %/NN induced/VBN angioedema/NN
NSAID/NNP history/NN subjects/NNS %/NN induced/VBN angioedema/NN angioedema/NN
nimesulide/NN tolerability/NN confirm/VBP patients/NNS experienced/VBD angioedema/NN
NSAIDs/NNP caused/VBN angioedema/NN
paracetamol/NN nimesulide/NN tolerability/NN confirm/VBP patients/NNS experienced/VBD angioedema/NN
NSAID/NNP history/NN angioedema/NN
carboplatin/NN chemotherapy/NN Acute/VB
carboplatin/NN chemotherapy/NN Acute/VB failure/NN renal/JJ
carboplatin/NN chemotherapy/NN Acute/VB failure/NN
Carboplatin/NNP reported/VBN cause/VB failure/NN acute/JJ
Carboplatin/NNP reported/VBN cause/VB failure/NN renal/JJ
Carboplatin/NNP reported/VBN cause/VB failure/NN
amphotericin/NNP B/NNP prevention/NN drug/NN it/PRP hypokalemia/NN
B/NNP prevention/NN drug/NN it/PRP hypokalemia/NN
AmB/NNP treatment/NN patients/NNS prevent/VB hypokalemia/NN
AmB/NNP treatment/NN patients/NNS reducing/VBG prevent/VB hypokalemia/NN
enflurane/NN resulted/VBD seizures/NNS
enflurane/NN delineated/VBN foci/NNS ablated/VBN seizure/JJ
sulfasalazine/NN associated/VBN Hepatotoxicity/NNP
sulfasalazine/NN hepatotoxicity/NN
sulfasalazine/NN hepatotoxicity/NN
sulfasalazine/NN hepatotoxicity/NN
sulfasalazine/NN associated/VBN hepatotoxicity/NN
fluphenazine/JJ enanthate/NN induced/VBN parkinsonism/NN
enanthate/NN induced/VBN parkinsonism/NN
benztropine/NN treated/VBD had/VBD increase/NN dyskinesia/NN tardive/JJ
benztropine/NN treated/VBD had/VBD increase/NN dyskinesia/NN
benztropine/NN treated/VBD had/VBD condition/NN anxiety/NN depression/NN
benztropine/NN treated/VBD had/VBD condition/NN anxiety/NN
PTZ/NNP suppressed/VBD increased/VBD amplitude/NN startle/NN
PTZ/NNP suppressed/VBD increased/VBD suppressed/VBD startle/NN
PTZ/NNP suppressed/VBD startle/NN
yohimbine/NN increased/VBD amplitude/NN startle/NN
yohimbine/NN increased/VBD suppressed/VBD startle/NN
yohimbine/NN increased/VBD suppressed/VBD startle/NN
mCPP/NN suppressed/VBD increased/VBD amplitude/NN startle/NN
mCPP/NN suppressed/VBD startle/NN
mCPP/NN suppressed/VBD increased/VBD suppressed/VBD startle/NN
doxorubicin/NN nephrosis/NNS
sodium/NN powders/NNS ate/VBD reported/VBN case/NN two/CD nephrolithiasis/NNS
bicarbonate/NN powders/NNS ate/VBD reported/VBN case/NN two/CD nephrolithiasis/NNS
calcium/NN carbon/NN amounts/NNS consumed/VBN patients/NNS reported/VBN case/NN hypercalcaemia/NN
carbon/NN amounts/NNS consumed/VBN patients/NNS reported/VBN case/NN hypercalcaemia/NN
ate/VBD reported/VBN case/NN hypercalcaemia/NN
calcium/NN carbon/NN amounts/NNS consumed/VBN patients/NNS reported/VBN case/NN two/CD nephrolithiasis/NNS
carbon/NN amounts/NNS consumed/VBN patients/NNS reported/VBN case/NN two/CD nephrolithiasis/NNS
ate/VBD reported/VBN case/NN two/CD nephrolithiasis/NNS
sodium/NN powders/NNS ate/VBD reported/VBN case/NN hypercalcaemia/NN
bicarbonate/NN powders/NNS ate/VBD reported/VBN case/NN hypercalcaemia/NN
terbutaline/NN relationship/NN induced/VBN hypokalemia/NN
terbutaline/NN concentrations/NNS spite/NN antagonized/VBN hypokalemia/NN
puromycin/NN aminonucleoside/NN hypoxia/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN hypoxia/NN syndrome/NN
aminonucleoside/NN hypoxia/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN hypoxia/NN syndrome/NN
puromycin/NN aminonucleoside/NN hypoxia/NN
aminonucleoside/NN hypoxia/NN
puromycin/NN aminonucleoside/NN hypoxia/NN hypoxia/NN
aminonucleoside/NN hypoxia/NN hypoxia/NN
puromycin/NN model/NN weeks/NNS fold/CD reaching/VBG increased/VBD Expression/NNP hypoxia/NN
aminonucleoside/NN model/NN weeks/NNS fold/CD reaching/VBG increased/VBD Expression/NNP hypoxia/NN
norfloxacin/JJ ciprofloxacin/JJ rats/NNS showed/VBD behaviour/NN anxious/JJ
norfloxacin/JJ ciprofloxacin/JJ rats/NNS showed/VBD behaviour/NN
ciprofloxacin/JJ rats/NNS showed/VBD behaviour/NN anxious/JJ
ciprofloxacin/JJ rats/NNS showed/VBD behaviour/NN
warfarin/NN juice/NN haemopericardium/NN haemorrhage/NN gastrointestinal/NN
warfarin/NN juice/NN haemopericardium/NN haemorrhage/NN
ketamine/NN combinations/NNS induced/JJ potentiation/NN Catalepsy/RB
morphine/NN ketamine/NN combinations/NNS induced/JJ potentiation/NN Catalepsy/RB
ketamine/JJ induced/NN analgesia/JJ catalepsy/JJ
morphine/JJ ketamine/JJ induced/NN analgesia/JJ catalepsy/JJ
ketamine/NN treatment/NN Pre/NNP tolerance/VBZ ketamine/VB augmented/VB response/NN cataleptic/JJ
ketamine/VB augmented/VB response/NN cataleptic/JJ
morphine/VB tolerance/JJ cross/NN produced/VBN treatment/NN Pre/NNP tolerance/VBZ ketamine/VB augmented/VB response/NN cataleptic/JJ
morphine/NN pretreatment/NN induce/VB produced/VBN treatment/NN Pre/NNP tolerance/VBZ ketamine/VB augmented/VB response/NN cataleptic/JJ
morphine/NN attributed/VBN tolerance/VBZ ketamine/VB augmented/VB response/NN cataleptic/JJ
ribavirin/NNP prodrug/NN liver/NN has/VBZ potential/NN maintain/VB decreasing/VBG risk/NN anemia/NN hemolytic/JJ
ribavirin/NNP prodrug/NN liver/NN has/VBZ potential/NN maintain/VB decreasing/VBG risk/NN anemia/NN
ribavirin/NNP efficacy/NN maintain/VB decreasing/VBG risk/NN anemia/NN hemolytic/JJ
ribavirin/NNP efficacy/NN maintain/VB decreasing/VBG risk/NN anemia/NN
vancomycin/NN course/NN receiving/VBG Acute/VB
vancomycin/NN course/NN receiving/VBG Acute/VB failure/NN renal/JJ
vancomycin/NN course/NN receiving/VBG Acute/VB failure/NN
clomiphene/JJ citrate/NN associated/VBN infarction/NN Myocardial/JJ
clomiphene/JJ citrate/NN associated/VBN infarction/NN
citrate/NN associated/VBN infarction/NN Myocardial/JJ
citrate/NN associated/VBN infarction/NN
CC/NNP reported/VBN complication/NN rare/JJ Thromboembolism/NNP
CC/NNP infarction/NN myocardial/JJ
CC/NNP infarction/NN
Mellaril/NNP appeared/VBD responsible/JJ cases/NNS tachycardia/NN ventricular/NN
Mellaril/NNP appeared/VBD responsible/JJ cases/NNS tachycardia/NN
thioridazine/NN Mellaril/NNP appeared/VBD responsible/JJ cases/NNS tachycardia/NN ventricular/NN
thioridazine/NN Mellaril/NNP appeared/VBD responsible/JJ cases/NNS tachycardia/NN
Aventyl/NNP produced/VBD block/NN left/JJ
Aventyl/NNP produced/VBD block/NN bundle/NN
Aventyl/NNP produced/VBD block/NN branch/NN
Aventyl/NNP produced/VBD block/NN
nortriptyline/NN Aventyl/NNP produced/VBD block/NN left/JJ
nortriptyline/NN Aventyl/NNP produced/VBD block/NN bundle/NN
nortriptyline/NN Aventyl/NNP produced/VBD block/NN branch/NN
nortriptyline/NN Aventyl/NNP produced/VBD block/NN
Elavil/NNP Aventyl/NNP produced/VBD block/NN left/JJ
Elavil/NNP Aventyl/NNP produced/VBD block/NN bundle/NN
Elavil/NNP Aventyl/NNP produced/VBD block/NN branch/NN
Elavil/NNP Aventyl/NNP produced/VBD block/NN
amitriptyline/NNP Elavil/NNP Aventyl/NNP produced/VBD block/NN left/JJ
amitriptyline/NNP Elavil/NNP Aventyl/NNP produced/VBD block/NN bundle/NN
amitriptyline/NNP Elavil/NNP Aventyl/NNP produced/VBD block/NN branch/NN
amitriptyline/NNP Elavil/NNP Aventyl/NNP produced/VBD block/NN
caffeine/NN men/NNS hypertension/NN
caffeine/NN actions/NNS enhanced/VBN persons/NNS hypertensive/JJ
caffeine/NN ingestion/NN achieved/VBD levels/NNS hypertensive/JJ
caffeine/NN were/VBD men/NNS hypertensive/NN
caffeine/NN were/VBD replicated/VBN protocols/CD representative/NN hypertensives/NNS
levomepromazine/JJ treatment/NN induced/VBN Seizures/NNS
fluvoxamine/NN treatment/NN induced/VBN Seizures/NNS
levomepromazine/NN induced/VBN seizures/NNS
fluvoxamine/JJ treatment/NN levomepromazine/NN induced/VBN seizures/NNS
tramadol/NN intake/NN Nightmares/NNS hallucinations/NNS
tramadol/NN drugs/NNS hallucinations/NNS
doxorubicin/NN heart/NN derivative/JJ induced/VBN cardiomyopathy/RB
doxorubicin/NN courses/NNS received/VBD Animals/NNS demonstrated/VBD changes/NNS decrease/NN cardiomyopathy/NN
doxorubicin/NN cardiomyopathy/NN
terbutaline/NN metoprolol/NN antagonism/NN hypokalemia/NN
diphenylhydantoin/NN toxicity/NN manifestation/NN hemiparesis/NNS
diphenylhydantoin/NNP overdose/NN effects/NNS encountered/VBD those/DT dysfunction/NN cerebellar/NN
diphenylhydantoin/NNP overdose/NN effects/NNS encountered/VBD those/DT dysfunction/NN
DPH/NNP overdose/NN effects/NNS encountered/VBD those/DT dysfunction/NN cerebellar/NN
DPH/NNP overdose/NN effects/NNS encountered/VBD those/DT dysfunction/NN
diphenylhydantoin/NNP overdose/NN
DPH/NNP overdose/NN
DPH/NNP overdose/NN
DPH/NNP overdose/NN due/JJ hemiparesis/NNS
metrizoate/NN lower/JJR Frequencies/NNS fibrillation/NN ventricular/NN
metrizoate/NN lower/JJR Frequencies/NNS fibrillation/NN
ropivacaine/JJ levobupivacaine/JJ seizures/NNS
levobupivacaine/JJ seizures/NNS
ropivacaine/NN doses/NNS smaller/JJR doses/NNS levobupivacaine/NN produced/VBD dysrhythmias/JJ
levobupivacaine/NN produced/VBD dysrhythmias/JJ
levobupivacaine/NN produced/VBD dysrhythmias/JJ asystole/JJ
ropivacaine/NN doses/NNS smaller/JJR doses/NNS levobupivacaine/NN produced/VBD dysrhythmias/JJ asystole/JJ
levobupivacaine/NN toxicity/NN intermediate/JJ conclude/VBP appears/VBZ arrest/NN cardiac/JJ
levobupivacaine/NN toxicity/NN intermediate/JJ conclude/VBP appears/VBZ arrest/NN
levobupivacaine/NN bupivacaine/NN induced/VBN that/DT treatment/NN susceptible/JJ appears/VBZ arrest/NN cardiac/JJ
levobupivacaine/NN bupivacaine/NN induced/VBN that/DT treatment/NN susceptible/JJ appears/VBZ arrest/NN
ropivacaine/NN that/DT intermediate/JJ conclude/VBP appears/VBZ arrest/NN cardiac/JJ
ropivacaine/NN that/DT intermediate/JJ conclude/VBP appears/VBZ arrest/NN
ropivacaine/NN rate/NN administered/VBN intermediate/JJ conclude/VBP appears/VBZ arrest/NN cardiac/JJ
ropivacaine/NN rate/NN administered/VBN intermediate/JJ conclude/VBP appears/VBZ arrest/NN
gentamicin/NN induced/VBN failure/NN acute/JJ
gentamicin/NN induced/VBN failure/NN renal/JJ
gentamicin/NN induced/VBN failure/NN
pimecrolimus/NNS tacrolimus/NNS immunomodulators/NNS use/NN regarded/VBN cause/NN dermatitis/NNS
Heparin/NNP induced/VBN thrombocytopenia/NN hemorrhage/NN
Heparin/NNP induced/VBN thrombocytopenia/NN
heparin/NN patients/NNS Sixty/CD induced/VBD reported/VBN thrombocytopenia/NN
heparin/NN receiving/VBG hemorrhage/JJ
heparin/NN receiving/VBG hemorrhage/JJ events/NNS thromboembolic/JJ
carbachol/NN produced/VBD mydriasis/NNS
carbachol/NN produced/VBD mydriasis/NNS tremor/NN
eserine/NN carbachol/NN produced/VBD mydriasis/NNS clonic/NNS
eserine/NN carbachol/NN produced/VBD convulsions/NNS tonic/NN
eserine/NN carbachol/NN produced/VBD convulsions/NNS
eserine/NN carbachol/NN produced/VBD mydriasis/NNS
carbachol/NN produced/VBD mydriasis/NNS clonic/NNS
carbachol/NN produced/VBD convulsions/NNS tonic/NN
carbachol/NN produced/VBD convulsions/NNS
eserine/NN carbachol/NN produced/VBD mydriasis/NNS tremor/NN
carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN mydriasis/NNS
carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN tremor/NN
eserine/NN carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN clonic/NN
eserine/NN carbachol/NN evoked/VBN convulsions/NNS tonic/NN
eserine/NN carbachol/NN evoked/VBN convulsions/NNS
eserine/NN carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN mydriasis/NNS
carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN clonic/NN
carbachol/NN evoked/VBN convulsions/NNS tonic/NN
carbachol/NN evoked/VBN convulsions/NNS
eserine/NN carbachol/NN evoked/VBN convulsions/NNS changed/VBN hand/NN tremor/NN
carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS
carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS tremor/NN
eserine/NN carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS clonic/NN
eserine/NN carbachol/NN caused/VBN convulsions/NNS tonic/NN
eserine/NN carbachol/NN caused/VBN convulsions/NNS
eserine/NN carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS
carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS clonic/NN
carbachol/NN caused/VBN convulsions/NNS tonic/NN
carbachol/NN caused/VBN convulsions/NNS
eserine/NN carbachol/NN caused/VBN convulsions/NNS phenomena/NNS mydriasis/NNS tremor/NN
metoprolol/JJ treatment/NN SR/NNP block/VBP shock/NN heart/NN
metoprolol/JJ treatment/NN SR/NNP block/VBP
verapamil/NNP SR/NNP block/VBP shock/NN heart/NN
verapamil/NNP SR/NNP block/VBP
metoprolol/NN use/NN verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN heart/NN
metoprolol/NN use/NN verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN
verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN heart/NN
verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN
verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN hypotension/NN
metoprolol/NN use/NN verapamil/NN seventy/NN eight/CD year/NN woman/NN presented/VBN block/NN hypotension/NN
dextromethorphan/NN abuse/NN deterioration/NN Cognitive/JJ
dextromethorphan/NN abuse/NN deterioration/NN
DM/NNP use/NN resulting/VBG deterioration/NN cognitive/JJ
DM/NNP use/NN resulting/VBG deterioration/NN
FK/NNP A/NN Nephrotoxicity/NNP
506/CD FK/NNP A/NN Nephrotoxicity/NNP
cyclosporin/NN A/NN Nephrotoxicity/NNP
A/NN Nephrotoxicity/NNP
FK/NNP CsA/NNP 506/NNP effects/NNS nephrotoxic/JJ
506/NNP effects/NNS nephrotoxic/JJ
CsA/NNP 506/NNP effects/NNS nephrotoxic/JJ
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
puromycin/NN aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
PAN/NNP aminonucleoside/NN butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
2/CD butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
bromoethylamine/NN administration/NN produced/VBN models/NNS
bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
BEA/NNP bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
hexachloro/JJ bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
1/CD 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS Acute/JJ
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS experimental/JJ
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN of/IN
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN renal/JJ
HCBD/NNP butadiene/NN 3/CD bromoethylamine/NN administration/NN produced/VBN models/NNS damage/NN
droperidol/JJ administration/NN associated/VBN Angioedema/NNP
droperidol/NN dose/NN administration/NN minutes/NNS developed/VBN protrusion/NN year/NN man/NN allergies/NNS angioedema/NN
ethambutol/NN induced/VBN neuropathy/NN optic/JJ
ethambutol/NN induced/VBN neuropathy/NN
ethambutol/NN map/VB induced/VBN neuropathy/NN optic/JJ
ethambutol/NN map/VB induced/VBN neuropathy/NN
ethambutol/NN complication/NN neuropathy/NN optic/JJ
ethambutol/NN complication/NN neuropathy/NN
ethambutol/NN history/NN subjects/NNS METHODS/NNP long/RB administered/VBN deficits/NNS visual/JJ
ethambutol/NN history/NN subjects/NNS METHODS/NNP long/RB administered/VBN deficits/NNS
EMB/NNP ethambutol/NN history/NN subjects/NNS METHODS/NNP long/RB administered/VBN deficits/NNS visual/JJ
EMB/NNP ethambutol/NN history/NN subjects/NNS METHODS/NNP long/RB administered/VBN deficits/NNS
ethambutol/NN history/NN subjects/NNS METHODS/NNP induced/VBN neuropathy/NN optic/JJ
ethambutol/NN history/NN subjects/NNS METHODS/NNP induced/VBN neuropathy/NN
EMB/NNP ethambutol/NN history/NN subjects/NNS METHODS/NNP induced/VBN neuropathy/NN optic/JJ
EMB/NNP ethambutol/NN history/NN subjects/NNS METHODS/NNP induced/VBN neuropathy/NN
EMB/NNP history/NN subjects/NNS was/VBD loss/NN A/NN recovery/NN patient/JJ B/NNP deficits/NNS visual/JJ
EMB/NNP history/NN subjects/NNS was/VBD loss/NN A/NN recovery/NN patient/JJ B/NNP deficits/NNS
EMB/NNP history/NN subjects/NNS was/VBD loss/NN A/NN recovery/NN deficits/NNS visual/JJ
EMB/NNP history/NN subjects/NNS was/VBD loss/NN A/NN recovery/NN deficits/NNS
EMB/NNP history/NN neuropathy/NN optic/JJ
EMB/NNP history/NN neuropathy/NN
EMB/NNP patients/NNS results/NNS CONCLUSIONS/NNS induced/VBN show/VB neuropathy/NN optic/JJ
EMB/NNP patients/NNS results/NNS CONCLUSIONS/NNS induced/VBN show/VB neuropathy/NN
EMB/NNP induced/VBN neuropathy/NN optic/JJ
EMB/NNP induced/VBN neuropathy/NN
ethambutol/JJ dosing/NN manage/VB important/JJ terms/NNS management/NN EMB/NNP induced/VBN neuropathy/NN optic/JJ
ethambutol/JJ dosing/NN manage/VB important/JJ terms/NNS management/NN EMB/NNP induced/VBN neuropathy/NN
gentamicin/NN failure/NN acute/JJ
gentamicin/NN failure/NN renal/JJ
gentamicin/NN failure/NN
ifosfamide/NN Treatment/NNP toxicity/NN urothelial/JJ
ifosfamide/NN Treatment/NNP toxicity/NN
ifosfamide/NN induced/VBN toxicity/NN urothelial/JJ
ifosfamide/NN induced/VBN toxicity/NN
IF/NNP effect/NN sodium/NN sulphonate/JJ toxicity/NN urothelial/JJ
IF/NNP effect/NN sodium/NN sulphonate/JJ toxicity/NN
IF/NNP treatment/NN tested/VBN effect/NN sodium/NN sulphonate/JJ toxicity/NN urothelial/JJ
IF/NNP treatment/NN tested/VBN effect/NN sodium/NN sulphonate/JJ toxicity/NN
methylprednisolone/NN cause/VB was/VBD mention/NN possibility/NN myopathy/NN
methylprednisolone/NN offers/VBZ protection/NN recording/NN recovers/VBZ myopathy/NN
methylprednisolone/NN offers/VBZ protection/NN recording/NN recovery/NN myopathy/NN
methylprednisolone/NN cause/VB myopathy/NN
tamoxifen/NN use/NN associated/VBN tumor/NN Granulosa/NNP
tamoxifen/NN use/NN associated/VBN tumor/NN cell/NN
tamoxifen/NN use/NN associated/VBN tumor/NN
tamoxifen/NN use/NN associated/VBN tumor/NN ovary/NN of/IN
tamoxifen/NN use/NN associated/VBN tumor/NN ovary/NN the/DT
tamoxifen/NN use/NN associated/VBN tumor/NN ovary/NN
tamoxifen/NN Patients/NNS CONCLUSION/NNP induced/VBD risk/NN dysfunction/NN liver/NN
tamoxifen/NN Patients/NNS CONCLUSION/NNP induced/VBD risk/NN dysfunction/NN
tamoxifen/NN metabolism/NN alterations/NNS tumors/NNS risk/NN dysfunction/NN liver/NN
tamoxifen/NN metabolism/NN alterations/NNS tumors/NNS risk/NN dysfunction/NN
Li/NNP events/NNS DVP/NNP EPS/NNP
Li/NNP DVP/NNP different/JJ DVP/NNP EPS/NNP
haloperidol/NN treated/VBN events/NNS related/VBN EPS/NNP
haloperidol/NN treated/VBN experienced/VBD events/NNS related/VBN EPS/NNP
lithium/NN treated/VBN patients/NNS 26/NNP experienced/VBD treated/VBN events/NNS related/VBN EPS/NNP
lithium/NN treated/VBN patients/NNS 26/NNP experienced/VBD events/NNS related/VBN EPS/NNP
Lithium/NNP associated/VBN incidence/NN tremor/NN
Lithium/NNP associated/VBN contributed/VBN tremor/NN
Lithium/NNP associated/VBN contributed/VBN rate/NN tremor/NN
lithium/NN effect/NN tremor/NN contributed/VBN associated/VBN incidence/NN tremor/NN
lithium/NN effect/NN tremor/NN
lithium/NN effect/NN tremor/NN contributed/VBN rate/NN tremor/NN
lithium/NN therapy/NN receiving/VBG patients/NNS contributed/VBN associated/VBN incidence/NN tremor/NN
lithium/NN therapy/NN receiving/VBG patients/NNS contributed/VBN tremor/NN
lithium/NN therapy/NN receiving/VBG patients/NNS contributed/VBN rate/NN tremor/NN
Haloperidol/NNP induced/VBN incidence/NN akathisia/NN syndrome/NN extrapyramidal/JJ
Haloperidol/NNP induced/VBN incidence/NN akathisia/NN syndrome/NN
Haloperidol/NNP induced/VBN incidence/NN akathisia/NN tremor/NN
Haloperidol/NNP induced/VBN incidence/NN akathisia/NN
Dexamethasone/NNP induced/VBN hypertension/NN ocular/NN
Dexamethasone/NNP induced/VBN hypertension/NN
dexamethasone/NN treated/VBD thickened/VBN eyes/NNS hypertensive/JJ
dexamethasone/NN treated/VBD thickened/VBN eyes/NNS
Dexamethasone/JJ treatment/NN eyes/NNS led/VBN generation/NN hypertension/NN ocular/NN
Dexamethasone/JJ treatment/NN eyes/NNS led/VBN generation/NN hypertension/NN
dexamethasone/NN %/NN led/VBN generation/NN hypertension/NN ocular/NN
dexamethasone/NN %/NN led/VBN generation/NN hypertension/NN
etomidate/NN reduces/VBZ myoclonus/NNS
etomidate/NN induction/NN compare/VB incidence/NN myoclonus/NNS
etomidate/JJ administration/NN associated/VBN incidence/NN myoclonus/NNS
etomidate/JJ induction/NN reduced/VBD myoclonus/NNS
etomidate/JJ administration/NN increased/VBD incidence/NN myoclonus/NNS
adriamycin/NN injection/NN induced/VBN syndrome/NN nephrotic/JJ
adriamycin/NN injection/NN induced/VBN syndrome/NN
ADR/NNP adriamycin/NN injection/NN induced/VBN syndrome/NN nephrotic/JJ
ADR/NNP adriamycin/NN injection/NN induced/VBN syndrome/NN
paracetamol/NNP overdose/NN survived/VBD failure/NN fulminant/JJ
paracetamol/NNP overdose/NN survived/VBD failure/NN hepatic/JJ
paracetamol/NNP overdose/NN survived/VBD failure/NN
paracetamol/NNP overdose/NN survived/VBD increased/VBN patients/NNS failure/NN fulminant/JJ
paracetamol/NNP overdose/NN survived/VBD increased/VBN patients/NNS failure/NN hepatic/JJ
paracetamol/NNP overdose/NN survived/VBD increased/VBN patients/NNS failure/NN
Dexatrim/NNP cause/NN infarction/NN myocardial/JJ
Dexatrim/NNP cause/NN infarction/NN
Phenylpropanolamine/NNP Dexatrim/NNP cause/NN infarction/NN myocardial/JJ
Phenylpropanolamine/NNP Dexatrim/NNP cause/NN infarction/NN
Reserpine/NNP produced/VBD chewing/VBG mice/NNS signs/NNS dyskinesia/NN tardive/JJ
Reserpine/NNP produced/VBD chewing/VBG mice/NNS signs/NNS dyskinesia/NN
Reserpine/NNP produced/VBD tremor/NN catalepsy/NN
Reserpine/NNP produced/VBD tremor/NN
reserpine/NN induced/VBN catalepsy/RB
reserpine/NN produced/VBN increase/NN tremor/NN
reserpine/JJ induced/NNS increases/VBZ tremor/NN catalepsy/NN
reserpine/JJ induced/NNS increases/VBZ tremor/NN
reserpine/NN induced/VBN catalepsy/NN
reserpine/NN induced/VBN catalepsy/NN tremor/NN
reserpine/JJ protrusion/NN increases/NNS tremor/NN catalepsy/NN
reserpine/NN effects/NNS reversed/VBD Pretreatment/NNP protrusion/NN increases/NNS tremor/NN catalepsy/NN
reserpine/JJ protrusion/NN increases/NNS tremor/NN
reserpine/NN effects/NNS reversed/VBD Pretreatment/NNP protrusion/NN increases/NNS tremor/NN
reserpine/NN produces/VBZ movements/NNS different/JJ abnormal/JJ
reserpine/NN produces/VBZ movements/NNS
reserpine/NN produces/VBZ considered/VBN like/VB tardive/VB
reserpine/NN produces/VBZ considered/VBN like/VB signs/NNS dsykinesia/NN
magnesium/NN blockade/NN Neuromuscular/JJ
magnesium/NN blockade/NN
sulfate/VBP blockade/NN Neuromuscular/JJ
sulfate/VBP blockade/NN
nifedipine/VBP sulfate/VBP blockade/NN Neuromuscular/JJ
nifedipine/VBP sulfate/VBP blockade/NN
magnesium/NN sulfate/NN mg/NN administered/VBN developed/VBD blockade/NN neuromuscular/NN
magnesium/NN sulfate/NN mg/NN administered/VBN developed/VBD blockade/NN
sulfate/NN mg/NN administered/VBN developed/VBD blockade/NN neuromuscular/NN
sulfate/NN mg/NN administered/VBN developed/VBD blockade/NN
nifedipine/NN received/VBD patient/NN developed/VBD blockade/NN neuromuscular/NN
nifedipine/NN received/VBD patient/NN developed/VBD blockade/NN
levodopa/NN Worsening/NN dyskinesias/NNS
apomorphine/NN dose/NN administration/NN dyskinesia/NN study/NN included/VBN patients/NNS had/VBD dyskinesia/NN
apomorphine/NN dose/NN administration/NN dyskinesia/NN
doxorubicin/NN development/NN failure/NN heart/NN
doxorubicin/NN development/NN failure/NN
fentanyl/JJ administration/NN rigidity/NN
fentanyl/NN dose/NN received/VBD period/NN case/NN rigidity/NN
oxytocin/NN administration/NN associated/VBN intoxication/NNP Water/NNP
oxytocin/NN administration/NN associated/VBN intoxication/NNP
oxytocin/NN administration/NN intoxication/VBN cases/NNS water/NN
oxytocin/NN administration/NN intoxication/VBN
Oxytocin/NN administration/NN advocated/VBN carried/VBN aware/JJ symptoms/NNS intoxication/NN water/NN
Oxytocin/NN administration/NN advocated/VBN carried/VBN aware/JJ symptoms/NNS intoxication/NN
tiazofurin/NN usage/NN associated/VBN lesions/NNS cerebral/JJ
tiazofurin/NN usage/NN associated/VBN lesions/NNS
methamphetamine/NN induced/VBN neurotoxicity/RB
METH/NNP reverse/VB dihydroxyphenylalanine/VBP show/VBP confounded/VBN neurotoxicity/RB
METH/VB neurotoxicity/RB
METH/NNP effects/NNS preserved/VBN long/RB METH/VB neurotoxicity/RB
METH/NNP development/NN essential/JJ neurotoxicity/RB
ammonium/NN Pretreatment/NNP doubled/VBD increased/VBD incoordination/NN
acetate/NN approximately/RB doubled/VBD increased/VBD incoordination/NN
NH/CD 4/CD Ac/NNS acetate/NN approximately/RB doubled/VBD increased/VBD incoordination/NN
4/CD Ac/NNS acetate/NN approximately/RB doubled/VBD increased/VBD incoordination/NN
Ac/NNS acetate/NN approximately/RB doubled/VBD increased/VBD incoordination/NN
NH/CD 4/CD treatment/NN had/VBD doubled/VBD increased/VBD incoordination/NN
4/CD treatment/NN had/VBD doubled/VBD increased/VBD incoordination/NN
Ac/NN treatment/NN had/VBD doubled/VBD increased/VBD incoordination/NN
diazepam/NN increased/VBD incoordination/NN
NH/CD 4/CD activity/NN analgesia/JJ diazepam/JJ incoordination/NN
4/CD activity/NN analgesia/JJ diazepam/JJ incoordination/NN
Ac/JJ activity/NN analgesia/JJ diazepam/JJ incoordination/NN
NH/JJ verapamil/JJ mg/NN activity/NN analgesia/JJ diazepam/JJ incoordination/NN
4/CD Ac/JJ verapamil/NN mg/NN activity/NN analgesia/JJ diazepam/JJ incoordination/NN
Ac/JJ verapamil/NN mg/NN activity/NN analgesia/JJ diazepam/JJ incoordination/NN
diazepam/JJ incoordination/NN
naproxen/NN due/JJ necrosis/VBZ Renal/NNP
naproxen/NN due/JJ necrosis/VBZ papillary/RB
naproxen/NN due/JJ necrosis/VBZ
naproxen/NN therapy/NN institution/NN developed/VBD necrosis/NNS renal/JJ
naproxen/NN therapy/NN institution/NN developed/VBD necrosis/NNS papillary/NN
naproxen/NN therapy/NN institution/NN developed/VBD necrosis/NNS
naproxen/NN therapy/NN institution/NN developed/VBD necrosis/NNS RPN/NNP
All/DT induced/VBN nodosum/NN erythema/NN
All/DT induced/VBN nodosum/NN
trans/NNS All/DT induced/VBN nodosum/NN erythema/NN
trans/NNS All/DT induced/VBN nodosum/NN
retinoic/JJ acid/NN trans/NNS All/DT induced/VBN nodosum/NN erythema/NN
retinoic/JJ acid/NN trans/NNS All/DT induced/VBN nodosum/NN
acid/NN trans/NNS All/DT induced/VBN nodosum/NN erythema/NN
acid/NN trans/NNS All/DT induced/VBN nodosum/NN
all/DT acid/NN associated/VBN nodosum/NNP Erythema/NNP
all/DT acid/NN associated/VBN nodosum/NNP
trans/JJ acid/NN associated/VBN nodosum/NNP Erythema/NNP
trans/JJ acid/NN associated/VBN nodosum/NNP
retinoic/JJ acid/NN associated/VBN nodosum/NNP Erythema/NNP
retinoic/JJ acid/NN associated/VBN nodosum/NNP
acid/NN associated/VBN nodosum/NNP Erythema/NNP
acid/NN associated/VBN nodosum/NNP
ATRA/NNP acid/NN associated/VBN nodosum/NNP Erythema/NNP
ATRA/NNP acid/NN associated/VBN nodosum/NNP
ATRA/NNP therapy/NN developed/VBD nodosum/NN erythema/NN
ATRA/NNP therapy/NN developed/VBD nodosum/NN
ATRA/NNP therapy/NN developed/VBD nodules/NNS erythematous/NN
ATRA/NNP therapy/NN developed/VBD nodules/NNS
ATRA/NNP therapy/NN developed/VBD nodules/NNS Fever/NN
ATRA/NNP seemed/VBD etiology/NN nodosum/NN erythema/NN
ATRA/NNP seemed/VBD etiology/NN nodosum/NN
ATRA/NNP effective/JJ induced/VBN nodosum/NN erythema/NN
ATRA/NNP effective/JJ induced/VBN nodosum/NN
ziprasidone/NN induced/VBN syndrome/NN Neuroleptic/JJ
ziprasidone/NN induced/VBN syndrome/NN malignant/JJ
ziprasidone/NN induced/VBN syndrome/NN
ziprasidone/NN use/NN associated/VBN syndrome/NN neuroleptic/JJ
ziprasidone/NN use/NN associated/VBN syndrome/NN malignant/JJ
ziprasidone/NN use/NN associated/VBN syndrome/NN
ziprasidone/NN use/NN associated/VBN syndrome/NN NMS/NNP
ziprasidone/NN drugs/NNS cause/NN associated/VBN NMS/NNP
ziprasidone/NN dose/NN developed/VBD signs/NNS NMS/NNP
ziprasidone/VB due/JJ NMS/VBP
Hydrocortisone/NNP hypertension/NN
hydrocortisone/NN rise/NN
hydrocortisone/NN rise/NN pressure/NN in/IN
hydrocortisone/NN rise/NN pressure/NN resting/JJ
hydrocortisone/NN rise/NN pressure/NN blood/NN
hydrocortisone/NN rise/NN pressure/NN
lignocaine/NN involving/VBG anaesthesia/NN back/VB Leg/VB
lignocaine/NN involving/VBG anaesthesia/NN back/VB Leg/VB and/CC
lignocaine/NN involving/VBG anaesthesia/NN back/VB
lignocaine/NN involving/VBG anaesthesia/NN back/VB pain/NN
lignocaine/NN use/NN associated/VBN Leg/NNP
lignocaine/NN use/NN associated/VBN Leg/NNP and/CC
lignocaine/NN use/NN associated/VBN Leg/NNP //NNP
lignocaine/NN use/NN associated/VBN Leg/NNP or/CC
lignocaine/NN use/NN associated/VBN Leg/NNP pain/NN back/JJ
lignocaine/NN use/NN associated/VBN Leg/NNP pain/NN
tamoxifen/NN use/NN association/NN cancer/NN endometrial/JJ
tamoxifen/NN use/NN association/NN cancer/NN
tamoxifen/NN received/VBN Women/NNP likely/JJ have/VB cancer/NN endometrial/JJ
tamoxifen/NN received/VBN Women/NNP likely/JJ have/VB cancer/NN
tamoxifen/NN received/VBN had/VBD cancer/NN endometrial/JJ
tamoxifen/NN received/VBN had/VBD cancer/NN
tamoxifen/NN received/VBN had/VBD Women/NNP had/VBD those/DT cancer/NN endometrial/JJ
tamoxifen/NN received/VBN had/VBD Women/NNP had/VBD those/DT cancer/NN
tamoxifen/NN role/NN suggest/VBP cancer/NN endometrial/JJ
tamoxifen/NN role/NN suggest/VBP cancer/NN
tamoxifen/NN treated/VBN women/NNS diagnosed/VBN cancers/NNS Endometrial/JJ
tamoxifen/NN treated/VBN women/NNS diagnosed/VBN cancers/NNS
lead/NN course/NN expression/NN hypertension/NN
lead/NN rats/NNS increased/VBN reduced/VBN hypertension/NN
lead/NN NOx/NN hypertension/NN
lead/NN hypertension/NN
lead/NN inactivation/NN actions/NNS stress/NN associated/VBN hypertension/NN
cyclophosphamide/NN mice/NNS mediators/NNS expression/NN induced/VBN cystitis/NNS
CYP/NNP expression/NN induced/VBN cystitis/NNS
cyclophosphamide/NN cystitis/NNS
CYP/NNP cyclophosphamide/NN cystitis/NNS
CYP/NNP VIP/VB induced/VB cystitis/NNS
Tac/NN nephrotoxicity/NN
Tac/NN toxicity/NN CsA/NN CsA/NN nephrotoxicity/NN
CsA/NN nephrotoxicity/NN
CsA/NN CsA/NN nephrotoxicity/NN
methadone/NN treated/VBN patients/NNS prolongation/VBN Syncope/NNP
methadone/NN treated/VBN patients/NNS prolongation/VBN Syncope/NNP QT/NNP
methadone/NN treated/VBN patients/NNS prolongation/VBN
methadone/NN effect/NN caused/VBN attribute/VB episodes/NNS syncope/NN
methadone/JJ dose/NN syncope/NN
methadone/NN treated/VBN subjects/NNS had/VBD interval/NN prolonged/JJ
methadone/NN treated/VBN subjects/NNS had/VBD interval/NN QTc/NN
methadone/NN treated/VBN subjects/NNS had/VBD interval/NN
methadone/NN dose/NN mg/VBP associated/VBN odds/NNS syncope/NN
Methadone/NNP associated/VBN prolongation/NNP reporting/NN syncope/NN
Methadone/NNP associated/VBN prolongation/NNP QT/NNP
Methadone/NNP associated/VBN prolongation/NNP
Prednisolone/NNP induced/VBN caused/VBN dysfunction/NN muscle/NN
Prednisolone/NNP induced/VBN caused/VBN dysfunction/NN
prednisolone/NN dysfunction/NN dose/NN derives/VBZ atrophy/NN muscle/NN
prednisolone/NN dysfunction/NN dose/NN derives/VBZ atrophy/NN
suprofen/NN associated/VBN development/NN failure/NN acute/JJ
suprofen/NN associated/VBN development/NN failure/NN renal/JJ
suprofen/NN associated/VBN development/NN failure/NN
suprofen/NN causes/VBZ declines/NNS acute/JJ
suprofen/NN causes/VBZ declines/NNS
suprofen/NN causes/VBZ declines/NNS function/NN in/IN
suprofen/NN causes/VBZ declines/NNS function/NN renal/JJ
suprofen/NN causes/VBZ declines/NNS function/NN
dexamethasone/NN induced/VBN hypertension/NN
dexamethasone/NN assess/VB hypertension/NN
dex/NN dexamethasone/NN assess/VB hypertension/NN
dex/NN hypertension/NN
dex/NN 392/CD +/JJ superoxide/NN hypertension/NN
dex/NNPS </NNP 0001/CD 392/CD +/JJ superoxide/NN hypertension/NN
dexamethasone/NN induced/VBN hypertension/NN
aminonucleoside/JJ existing/VBG captopril/NN Effect/NN proteinuria/NN
puromycin/NN aminonucleoside/NN invoked/VBN proteinuria/NN
aminonucleoside/NN invoked/VBN proteinuria/NN
Glyceryl/JJ trinitrate/NN induces/VBZ attacks/NNS migraine/NN
Glyceryl/JJ trinitrate/NN induces/VBZ aura/NN without/IN
Glyceryl/JJ trinitrate/NN induces/VBZ aura/NN
trinitrate/NN induces/VBZ attacks/NNS migraine/NN
trinitrate/NN induces/VBZ aura/NN without/IN
trinitrate/NN induces/VBZ aura/NN
nitric/JJ oxide/NN involved/VBN mechanisms/NNS migraine/NN
nitric/JJ oxide/NN involved/VBN aura/NN without/IN
nitric/JJ oxide/NN involved/VBN aura/NN
oxide/NN involved/VBN mechanisms/NNS migraine/NN
oxide/NN involved/VBN aura/NN without/IN
oxide/NN involved/VBN aura/NN
NO/RB oxide/NN involved/VBN mechanisms/NNS migraine/NN
NO/RB oxide/NN involved/VBN aura/NN without/IN
NO/RB oxide/NN involved/VBN aura/NN
bendrofluazide/NN Amelioration/NNP hypokalemia/NN
bendrofluazide/NN treatment/NN hypokalemia/NN
alpha/NN induced/VBN mice/NNS Changes/NNS liver/NN hepatoma/NN
benzene/VBP Changes/NNS liver/NN hepatoma/NN
hexachloride/JJ benzene/VBP Changes/NNS liver/NN hepatoma/NN
alpha/NNS induced/VBN Peroxisomes/NNS lesions/NNS hepatomas/JJ
benzene/JJ hexachloride/NN examined/VBN induced/VBN Peroxisomes/NNS lesions/NNS hepatomas/JJ
hexachloride/NN examined/VBN induced/VBN Peroxisomes/NNS lesions/NNS hepatomas/JJ
prostaglandin/NN E/NN inhibition/NN dose/NN induced/VBN hyperalgesia/NN
E/NN inhibition/NN dose/NN induced/VBN hyperalgesia/NN
2/CD E/NN inhibition/NN dose/NN induced/VBN hyperalgesia/NN
8/CD induced/VBN hyperalgesia/NN
bromo/JJ monophosphate/NN hyperalgesia/NN
cyclic/JJ monophosphate/NN hyperalgesia/NN
adenosine/NN monophosphate/NN hyperalgesia/NN
monophosphate/NN hyperalgesia/NN
haloperidol/NN sensitization/NN impairment/NN cognitive/JJ
haloperidol/NN sensitization/NN impairment/NN
haloperidol/NN administration/NN observed/VBN Impairment/NNP
haloperidol/NN administration/NN observed/VBN Impairment/NNP function/NN of/IN
haloperidol/NN administration/NN observed/VBN Impairment/NNP function/NN cognitive/JJ
haloperidol/NN administration/NN observed/VBN Impairment/NNP function/NN
Haloperidol/NNP produced/VBD profile/NN impairment/NN cognitive/JJ
Haloperidol/NNP produced/VBD profile/NN impairment/NN
adriamycin/NN mitochondria/NN impairment/NN Structural/JJ
adriamycin/NN mitochondria/NN impairment/NN Structural/JJ and/CC
adriamycin/NN mitochondria/NN impairment/NN Structural/JJ functional/JJ
adriamycin/NN mitochondria/NN impairment/NN
adriamycin/NN mitochondria/NN of/IN
adriamycin/NN mitochondria/NN
ADR/NNP treatment/NN caused/VBD arrhythmias/NNS characterized/VBN bradycardia/NN
ADR/NNP effects/NNS involve/VBP impairment/NN mitochondrial/JJ
ADR/NNP effects/NNS involve/VBP impairment/NN structural/JJ
ADR/NNP effects/NNS involve/VBP impairment/NN structural/JJ and/CC
ADR/NNP effects/NNS involve/VBP impairment/NN structural/JJ functional/JJ
ADR/NNP effects/NNS involve/VBP impairment/NN
metoclopramide/NN induced/VBN pointes/VBZ de/NNP Torsade/NNP
metoclopramide/NN induced/VBN pointes/VBZ de/NNP
metoclopramide/NN induced/VBN pointes/VBZ
metoclopramide/NN administration/NN developed/VBD pointes/NNS torsade/JJ
metoclopramide/NN administration/NN developed/VBD pointes/NNS de/NNP
metoclopramide/NN administration/NN developed/VBD pointes/NNS
erythromycin/NN cisapride/NN given/VBN pointes/VBZ de/NNP torsade/NNP
erythromycin/NN cisapride/NN given/VBN pointes/VBZ de/NNP
erythromycin/NN cisapride/NN given/VBN pointes/VBZ
cisapride/NN given/VBN pointes/VBZ de/NNP torsade/NNP
cisapride/NN given/VBN pointes/VBZ de/NNP
cisapride/NN given/VBN pointes/VBZ
metoclopramide/JJ provokes/NNS torsade/VBP
metoclopramide/JJ provokes/NNS torsade/VBP clinically/NNS de/IN
metoclopramide/JJ provokes/NNS torsade/VBP clinically/NNS pointes/NN
Metoclopramide/NNP used/VBN patients/NNS risk/NN pointes/NNS torsade/JJ
Metoclopramide/NNP used/VBN patients/NNS risk/NN pointes/NNS de/NNP
Metoclopramide/NNP used/VBN patients/NNS risk/NN pointes/NNS
ifosfamide/VBP function/NN impaired/VBN
ifosfamide/VBP function/NN renal/JJ
ifosfamide/VBP function/NN
ifosfamide/VBP anuria/NNP
ifosfamide/JJ sixty/NN developed/VBD anuria/NN
Ifosfamide/NNP drug/NN nephrotoxic/JJ
Ifosfamide/NNP drug/NN tubulopathies/NNS
ifosfamide/VB due/JJ anuria/NN
ifosfamide/NN use/NN recommend/VBP patients/NNS pretreated/VBN chemotherapy/NN nephrotoxic/JJ
edrophonium/NN min/NN stability/NN provided/VBD kg/NN induced/VBN bradycardias/NNS
edrophonium/NN induced/VBN bradycardias/NNS
Cefotetan/NNP induced/VBN anemia/NN hemolytic/JJ
Cefotetan/NNP induced/VBN anemia/NN
desipramine/NN IP/VBP produce/VB hypotension/NN
desipramine/NN IP/VBP produce/VB hypotension/NN bradycardia/NN
CaCl/NNP group/NN incidence/NN arrhythmias/NNS ventricular/NN
CaCl/NNP group/NN incidence/NN arrhythmias/NNS
2/CD group/NN incidence/NN arrhythmias/NNS ventricular/NN
2/CD group/NN incidence/NN arrhythmias/NNS
lithium/NN case/NN pathology/NN insipidus/NNS diabetes/NN
lithium/NN case/NN pathology/NN insipidus/NNS
lithium/NN case/NN reported/VBN insipidus/NNS diabetes/NN
lithium/NN case/NN reported/VBN insipidus/NNS
ouabain/NN administration/NN falls/VBZ conclude/VBP disease/NN failure/NN left/VBN
ouabain/NN administration/NN falls/VBZ conclude/VBP disease/NN failure/NN left/VBN end/NN ventricular/NN
ouabain/NN administration/NN falls/VBZ conclude/VBP disease/NN failure/NN left/VBN end/NN
ouabain/NN administration/NN falls/VBZ volume/NN diastolic/JJ
ouabain/NN administration/NN falls/VBZ volume/NN
ouabain/NN administration/NN falls/VBZ
Oxytocin/NNP uterotonic/NN cause/VB hypotension/NN
Oxytocin/NNP attributed/VBN hypotension/NN
oxytocin/NN response/NN Hypotension/NNP
Pentamidine/JJ isethionate/NN associated/VBN pointes/NNS torsade/JJ
Pentamidine/JJ isethionate/NN associated/VBN pointes/NNS de/NNP
Pentamidine/JJ isethionate/NN associated/VBN pointes/NNS
isethionate/NN associated/VBN pointes/NNS torsade/JJ
isethionate/NN associated/VBN pointes/NNS de/NNP
isethionate/NN associated/VBN pointes/NNS
Pentamidine/NNP induced/VBN related/VBN pointes/NNS torsade/JJ
Pentamidine/NNP induced/VBN related/VBN pointes/NNS de/NNP
Pentamidine/NNP induced/VBN related/VBN pointes/NNS
pentamidine/NN occurred/VBD pointes/NNS Torsade/NNP
pentamidine/NN occurred/VBD pointes/NNS de/NNP
pentamidine/NN occurred/VBD pointes/NNS
pentamidine/NN discontinuation/NN recognized/VBD treated/VBN pointes/NNS Torsade/NNP
pentamidine/NN discontinuation/NN recognized/VBD treated/VBN pointes/NNS de/NNP
pentamidine/NN discontinuation/NN recognized/VBD treated/VBN pointes/NNS
diltiazem/NN threatening/VBG induced/VBN tetany/RB
diltiazem/NN infusion/NN developed/VBD tetany/RB
diltiazem/NN administration/NN accompany/VB life/NN tetany/NN
propofol/JJ controlled/VBN Reduction/NN pain/NN
propofol/NN injection/NN Pain/NNP
propofol/JJ pain/NN
propofol/JJ infusion/NN starting/VBG infusing/VBG prevented/VBN pain/NN
propofol/NN caused/VBN pain/NN
propofol/JJ infusion/NN scale/NN four/CD using/VBG evaluated/VBN pain/NN
propofol/NN TCI/NNP anaesthesia/NN induction/NN achieved/VBN reduction/NN pain/NN
propofol/JJ pain/NN
cyclophosphamide/NN used/VBN damage/NN heart/NN
cyclophosphamide/NN used/VBN damage/NN
mitoxantrone/NN cyclophosphamide/NN used/VBN damage/NN heart/NN
mitoxantrone/NN cyclophosphamide/NN used/VBN damage/NN
bupropion/VBN release/NN associated/VBN Seizure/JJ
bupropion/NN use/VBP describes/VBZ seizure/NN
bupropion/NN use/NN weeks/NNS experienced/VBD seizure/NN
bupropion/NN risk/NN seizures/NNS
scopolamine/JJ induced/VBN amnesia/NN
scopolamine/JJ amnesia/JJ
phenobarbital/JJ therapy/NN term/NN Hepatonecrosis/NNS cholangitis/NNS
Phenobarbital/NNP has/VBZ believed/VBN indicate/VB development/NN disease/NN liver/NN
Phenobarbital/NNP has/VBZ believed/VBN indicate/VB development/NN disease/NN
PB/NNP Phenobarbital/NNP has/VBZ believed/VBN indicate/VB development/NN disease/NN liver/NN
PB/NNP Phenobarbital/NNP has/VBZ believed/VBN indicate/VB development/NN disease/NN
PB/NNP indicate/VB development/NN disease/NN liver/NN
PB/NNP indicate/VB development/NN disease/NN
PB/NNP associated/VBN damage/NN liver/NN
PB/NNP associated/VBN damage/NN
haloperidol/NN models/NNS catalepsy/NN
reserpine/NN model/NN catalepsy/NN models/NNS akinesia/NN
gentamicin/NN died/VBD failure/NN acute/JJ
gentamicin/NN died/VBD failure/NN renal/JJ
gentamicin/NN died/VBD failure/NN
caffeine/NN pretreatment/NN related/VBN case/NN tachycardia/NN ventricular/NN
caffeine/NN pretreatment/NN related/VBN case/NN tachycardia/NN
caffeine/NN used/VBN improve/VB duration/NN seizure/NN
caffeine/NN used/VBN tolerated/VBN reports/NNS ectopy/NN ventricular/NN
caffeine/NN used/VBN tolerated/VBN reports/NNS ectopy/NN
caffeine/NN administration/NN developed/VBD bigeminy/NN runs/NNS tachycardia/NN ventricular/NN
caffeine/NN administration/NN developed/VBD bigeminy/NN runs/NNS tachycardia/NN
carbamazepine/NN induced/VBN block/NN patient/JJ bradycardia/NN
carbamazepine/NN induced/VBN block/NN patient/JJ bradycardia/NN atrioventricular/NN
carbamazepine/NN induced/VBN block/NN
carbamazepine/NN overdose/NN setting/NN developed/VBD tachycardias/NNS sinus/JJ
carbamazepine/NN overdose/NN setting/NN developed/VBD tachycardias/NNS
carbamazepine/JJ levels/NNS elevated/VBD developed/VBD threatening/JJ delay/NN bradyarrhythmias/JJ
carbamazepine/JJ levels/NNS elevated/VBD developed/VBD threatening/JJ delay/NN bradyarrhythmias/JJ atrioventricular/NN
carbamazepine/JJ levels/NNS elevated/VBD developed/VBD threatening/JJ delay/NN conduction/NN
carbamazepine/JJ levels/NNS elevated/VBD developed/VBD threatening/JJ delay/NN
vitamin/NNP C/NNP increase/VB risk/NN cardiovascular/JJ
vitamin/NNP C/NNP increase/VB risk/NN disease/NN
C/NNP increase/VB risk/NN cardiovascular/JJ
C/NNP increase/VB risk/NN disease/NN
vitamin/NNP intake/NNP relation/NN examine/VB disease/NN cardiovascular/JJ
vitamin/NNP intake/NNP relation/NN examine/VB disease/NN
C/NNP intake/NNP relation/NN examine/VB disease/NN cardiovascular/JJ
C/NNP intake/NNP relation/NN examine/VB disease/NN
vitamin/NNP intake/NN relation/NN mortality/NN disease/NN cardiovascular/JJ
vitamin/NNP intake/NN relation/NN mortality/NN disease/NN
C/NNP intake/NN relation/NN mortality/NN disease/NN cardiovascular/JJ
C/NNP intake/NN relation/NN mortality/NN disease/NN
vitamin/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD adjustment/NN factors/NNS cardiovascular/JJ
vitamin/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD adjustment/NN factors/NNS disease/NN
C/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD adjustment/NN factors/NNS cardiovascular/JJ
C/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD adjustment/NN factors/NNS disease/NN
vitamin/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD type/NN medication/NN intakes/NNS carotene/NN mortality/NN adjusted/VBN risks/NNS disease/NN cardiovascular/JJ
vitamin/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD type/NN medication/NN intakes/NNS carotene/NN mortality/NN adjusted/VBN risks/NNS disease/NN
C/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD type/NN medication/NN intakes/NNS carotene/NN mortality/NN adjusted/VBN risks/NNS disease/NN cardiovascular/JJ
C/NNP intake/NN quintiles/NNS 0/CD </VBG trend/NN P/NNP 1/CD type/NN medication/NN intakes/NNS carotene/NN mortality/NN adjusted/VBN risks/NNS disease/NN
Vitamin/NNP intake/NNP unrelated/JJ disease/NN cardiovascular/JJ
Vitamin/NNP intake/NNP unrelated/JJ disease/NN
C/NNP intake/NNP unrelated/JJ disease/NN cardiovascular/JJ
C/NNP intake/NNP unrelated/JJ disease/NN
vitamin/NNP intake/NN associated/VBN risk/NN mortality/NN cardiovascular/JJ
vitamin/NNP intake/NN associated/VBN risk/NN mortality/NN disease/NN
C/NNP intake/NN associated/VBN risk/NN mortality/NN cardiovascular/JJ
C/NNP intake/NN associated/VBN risk/NN mortality/NN disease/NN
trihexyphenidyl/JJ Bradycardia/NNP
hydrochloride/VBP Bradycardia/NNP
heparin/NN therapy/NN receiving/VBG patients/NNS thromboembolism/NN induced/VBN thrombocytopenia/NN
heparin/NN associated/VBN complication/NN thromboembolism/NN induced/VBN thrombocytopenia/NN
heparin/NN therapy/NN initiation/NN days/NNS occurring/VBG ischemia/NN thrombi/NNS occlusion/NN arterial/JJ
heparin/NN therapy/NN initiation/NN days/NNS occurring/VBG ischemia/NN thrombi/NNS occlusion/NN
heparin/NN therapy/NN initiation/NN days/NNS preceded/VBN thrombocytopenia/NN
heparin/NN factor/NN relating/VBG thromboembolism/NN thrombocytopenia/NN
Prostaglandin/NNP E/NNP hyperactivity/NN bladder/NN
Prostaglandin/NNP E/NNP hyperactivity/NN
E/NNP hyperactivity/NN bladder/NN
E/NNP hyperactivity/NN
2/CD E/NNP hyperactivity/NN bladder/NN
2/CD E/NNP hyperactivity/NN
flumazenil/JJ group/NN nausea/NN vomiting/VBG
flumazenil/JJ group/NN nausea/NN
flumazenil/JJ group/NN nausea/NN
azathioprine/JJ therapy/NN injury/NN cholestasis/VBZ
azathioprine/JJ therapy/NN injury/NN bile/NN
azathioprine/JJ therapy/NN injury/NN duct/NN
azathioprine/JJ therapy/NN injury/NN
azathioprine/JJ therapy/NN initiation/NN developed/VBD features/NNS cholestasis/NNS
azathioprine/NN case/NN cholestasis/NNS
azathioprine/NN case/NN cholestasis/NNS associated/VBN evidence/NN injury/NN bile/NN
azathioprine/NN case/NN cholestasis/NNS associated/VBN evidence/NN injury/NN duct/NN
azathioprine/NN case/NN cholestasis/NNS associated/VBN evidence/NN injury/NN
cefotetan/NN use/NN associated/VBN anemia/NN hemolytic/JJ
cefotetan/NN use/NN associated/VBN anemia/NN
cefotetan/NN cephalosporins/NNS associated/VBN anemia/NN hemolytic/JJ
cefotetan/NN cephalosporins/NNS associated/VBN anemia/NN
cefotetan/NN cases/NNS anemias/NNS hemolytic/JJ
cefotetan/NN cases/NNS anemias/NNS
cefotetan/NN prophylactically/NN received/VBN patients/NNS 10/CD cases/NNS anemias/NNS hemolytic/JJ
cefotetan/NN prophylactically/NN received/VBN patients/NNS 10/CD cases/NNS anemias/NNS
MA/NN induced/VBN hyperthermia/NN
MA/NNP ameliorate/VBP induced/VBN damage/NN neuronal/JJ
MA/NNP ameliorate/VBP induced/VBN damage/NN
Methamphetamine/NNP causes/VBZ alterations/NNS pathways/NNS display/VBP aggressiveness/NN
methamphetamine/JJ abusers/NNS common/JJ suffer/VBP patients/NNS reported/VBN behaviors/NNS Aggressive/JJ
methamphetamine/JJ abusers/NNS common/JJ suffer/VBP patients/NNS reported/VBN behaviors/NNS
methamphetamine/JJ abusers/NNS common/JJ suffer/VBP disorders/NNS psychiatric/JJ
methamphetamine/JJ abusers/NNS common/JJ suffer/VBP disorders/NNS
METH/NNP abusers/NNS common/JJ suffer/VBP patients/NNS reported/VBN behaviors/NNS Aggressive/JJ
METH/NNP abusers/NNS common/JJ suffer/VBP patients/NNS reported/VBN behaviors/NNS
METH/NNP abusers/NNS common/JJ suffer/VBP disorders/NNS psychiatric/JJ
METH/NNP abusers/NNS common/JJ suffer/VBP disorders/NNS
METH/NNP injections/NNS increased/VBD aggressiveness/NN
METH/VB secondary/JJ increase/NN aggressiveness/NN
Chloroquine/JJ block/NN blindness/NN
chloroquine/NN ingestion/NN presented/VBN deterioration/NN dizziness/NN
chloroquine/NN ingestion/NN presented/VBN deterioration/NN fatiguability/JJ
chloroquine/NN ingestion/NN presented/VBN deterioration/NN dizziness/NN progressing/VBG attacks/NNS syncopal/JJ
chloroquine/NN ingestion/NN presented/VBN deterioration/NN dizziness/NN progressing/VBG attacks/NNS
chloroquine/NN ingestion/NN presented/VBN deterioration/NN dyspnoea/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD features/NNS failure/NN heart/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD features/NNS failure/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD pattern/NN right/JJ
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD pattern/NN bundle/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD pattern/NN branch/NN
chloroquine/JJ retinopathy/NN features/NNS revealed/VBD revealed/VBD pattern/NN block/NN
chloroquine/JJ retinopathy/NN
chloroquine/JJ discontinuation/NN resolved/VBN failure/NN heart/NN
chloroquine/JJ discontinuation/NN resolved/VBN failure/NN
contrast/NN media/NNS Risk/NN nephropathy/NN
media/NNS Risk/NN nephropathy/NN
contrast/NN media/NNS reports/NNS nephropathy/NN
media/NNS reports/NNS nephropathy/NN
contrast/NN media/NNS reports/NNS nephropathy/NN CIN/NNP
media/NNS reports/NNS nephropathy/NN CIN/NNP
iohexol/JJ iopromide/JJ incidence/NN CIN/NNP
contrast/NN media/NNS CIN/NNP
media/NNS CIN/NNP
CM/NNP media/NNS CIN/NNP
CM/NNP type/NN compared/VBD determined/VBD incidence/NN CIN/NNP
iopromide/JJ incidence/NN CIN/NNP
CM/NNP dosage/NN received/VBD those/DT 33/NNP patients/NNS CIN/NNP
CM/NNP dosage/NN received/VBD those/DT increased/VBD those/DT received/VBD difference/NN incidence/NN CIN/NNP
CM/NNP dosages/NNS related/VBN CIN/NNP incidence/NN difference/NN received/VBD those/DT increased/VBD those/DT 33/NNP patients/NNS CIN/NNP
CM/NNP dosages/NNS related/VBN CIN/NNP
CM/NN type/NN depends/VBZ' depends/VBZ needed/VBN reversible/JJ CIN/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP hepatitis/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP hepatitis/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP hepatitis/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP hepatitis/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN screening/NN B/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN hepatitis/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN B/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN hepatitis/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN B/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN hepatitis/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN B/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN hepatitis/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN dose/NN B/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN hepatitis/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN B/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN hepatitis/NNP
B/NNP antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN B/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN hepatitis/NNP
surface/NN antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN B/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN hepatitis/NNP
antigen/NN born/VBN infants/NNS done/VBN following/NN administration/NN globulin/NN B/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS received/VBD globulin/NN hepatitis/NNP
hepatitis/NNP antigen/NN born/VBN infants/NNS received/VBD globulin/NN B/NNP
B/NNP antigen/NN born/VBN infants/NNS received/VBD globulin/NN hepatitis/NNP
B/NNP antigen/NN born/VBN infants/NNS received/VBD globulin/NN B/NNP
surface/NN antigen/NN born/VBN infants/NNS received/VBD globulin/NN hepatitis/NNP
surface/NN antigen/NN born/VBN infants/NNS received/VBD globulin/NN B/NNP
antigen/NN born/VBN infants/NNS received/VBD globulin/NN hepatitis/NNP
antigen/NN born/VBN infants/NNS received/VBD globulin/NN B/NNP
doxorubicin/NN protects/VBZ demonstrate/VBP apoptosis/VBZ extent/NN failure/NN heart/NN
doxorubicin/NN protects/VBZ demonstrate/VBP apoptosis/VBZ extent/NN failure/NN
enflurane/JJ anesthetics/NNS associated/VBN allergic/NN injury/NN hepatic/JJ
enflurane/JJ anesthetics/NNS associated/VBN allergic/NN injury/NN
halothane/NN exposure/NN both/DT injury/NN hepatic/JJ
halothane/NN exposure/NN both/DT injury/NN
isoflurane/JJ enflurane/JJ anesthetics/NNS associated/VBN allergic/NN injury/NN hepatic/JJ
isoflurane/JJ enflurane/JJ anesthetics/NNS associated/VBN allergic/NN injury/NN
Halothane/NNP hepatitis/NNP
halothane/JJ patients/NNS hepatitis/NN
enflurane/NN produce/VB similar/JJ that/DT hepatitis/NN
halothane/JJ hepatitis/NN
halothane/JJ administration/NN subsequent/JJ produce/VB similar/JJ that/DT hepatitis/NN
isoflurane/NN //NN enflurane/NN produce/VB similar/JJ that/DT hepatitis/NN
Myocet/NNP improves/VBZ index/NN doxorubicin/NN reducing/VBG neutropenia/NN
doxorubicin/NN reducing/VBG neutropenia/NN
cyclophosphamide/NN used/VBN provides/VBZ improves/VBZ index/NN doxorubicin/NN reducing/VBG neutropenia/NN
puromycin/NN aminonucleoside/NN antithrombin/NN effects/NNS nephrosis/VBZ
aminonucleoside/NN antithrombin/NN effects/NNS nephrosis/VBZ
puromycin/NN aminonucleoside/NN rats/NNS nephrosis/NNS
aminonucleoside/NN rats/NNS nephrosis/NNS
Risperidone/NNP disturbances/NNS visual/JJ
Risperidone/NNP disturbances/NNS
risperidone/NN starting/VBG appeared/VBD disturbances/NNS visual/JJ
risperidone/NN starting/VBG appeared/VBD disturbances/NNS
Risperidone/JJ administration/NN continued/VBN wore/VBD disturbances/NNS visual/JJ
Risperidone/JJ administration/NN continued/VBN wore/VBD disturbances/NNS
diltiazem/NN overdose/NN arrest/NN asystolic/JJ
diltiazem/NN overdose/NN arrest/NN cardiac/JJ
diltiazem/NN overdose/NN arrest/NN
diltiazem/NN overdose/NN
diltiazem/NN nitrate/NN g/NN 8/CD overdose/NN
diltiazem/NN therapy/NN overdose/VBP onset/NN asystole/NN
diltiazem/NN therapy/NN overdose/VBP
diltiazem/NN overdose/NN considered/VBN early/RB cases/NNS arrest/NN cardiac/JJ
diltiazem/NN overdose/NN considered/VBN early/RB cases/NNS arrest/NN
diltiazem/NN overdose/NN
verapamil/NN fibrillation/NN atrial/JJ
verapamil/NN fibrillation/NN
verapamil/JJ administered/VBZ evaluate/VB mechanisms/NNS promotion/NN AF/NNP
Verapamil/NNP caused/VBD promotion/NN AF/NNP
Verapamil/NNP caused/VBD increasing/VBG mean/VB duration/NN induced/NNP AF/NNP
verapamil/JJ shortened/NNS mean/VBP decreased/VBD AF/NNP
verapamil/NN caused/VBN that/DT similar/JJ produced/VBD affect/VB ERP/NNP length/NN AF/NNP
verapamil/NN caused/VBN that/DT similar/JJ produced/VBD affect/VB ERP/NNP duration/NNP AF/NNP
verapamil/NN failed/VBD promote/VB AF/NNP
verapamil/NN promoted/VBN AF/NNP
Verapamil/NNP AF/NNP
cocaine/NN actions/NNS stimulatory/NN convulsive/JJ
cocaine/NN SM/NNP convulsions/NNS
cis/NN predicted/VBN included/VBD hypercalcemia/NN
RA/NNP levels/NNS cis/NN predicted/VBN included/VBD hypercalcemia/NN
Mitomycin/NNP C/NNP associated/JJ syndrome/NN hemolytic/JJ
Mitomycin/NNP C/NNP associated/JJ syndrome/NN uremic/JJ
Mitomycin/NNP C/NNP associated/JJ syndrome/NN
C/NNP associated/JJ syndrome/NN hemolytic/JJ
C/NNP associated/JJ syndrome/NN uremic/JJ
C/NNP associated/JJ syndrome/NN
Mitomycin/NNP C/NNP associated/VBN Syndrome/NNP Hemolytic/NNP
Mitomycin/NNP C/NNP associated/VBN Syndrome/NNP Uremic/NNP
Mitomycin/NNP C/NNP associated/VBN Syndrome/NNP
C/NNP associated/VBN Syndrome/NNP Hemolytic/NNP
C/NNP associated/VBN Syndrome/NNP Uremic/NNP
C/NNP associated/VBN Syndrome/NNP
Mitomycin/NNP C/NNP associated/VBN Syndrome/NNP HUS/NNP
C/NNP associated/VBN Syndrome/NNP HUS/NNP
mitomycin/JJ treatment/NN associated/VBN failure/NN renal/JJ
mitomycin/JJ treatment/NN associated/VBN failure/NN
C/NNP treatment/NN associated/VBN failure/NN renal/JJ
C/NNP treatment/NN associated/VBN failure/NN
mitomycin/JJ treatment/NN start/NN mth/NN 8/CD develops/VBZ failure/NN renal/JJ
mitomycin/JJ treatment/NN start/NN mth/NN 8/CD develops/VBZ failure/NN
C/NNP treatment/NN start/NN mth/NN 8/CD develops/VBZ failure/NN renal/JJ
C/NNP treatment/NN start/NN mth/NN 8/CD develops/VBZ failure/NN
mitomycin/JJ treatment/NN start/NN mth/NN 8/CD develops/VBZ %/NN failure/NN renal/JJ
mitomycin/JJ treatment/NN start/NN mth/NN 8/CD develops/VBZ %/NN failure/NN
C/NNP treatment/NN start/NN mth/NN 8/CD develops/VBZ %/NN failure/NN renal/JJ
C/NNP treatment/NN start/NN mth/NN 8/CD develops/VBZ %/NN failure/NN
mitomycin/NNP C/NNP developed/VBD failure/NN renal/JJ
mitomycin/NNP C/NNP developed/VBD failure/NN
C/NNP developed/VBD failure/NN renal/JJ
C/NNP developed/VBD failure/NN
ciprofloxacin/NN treatment/NN described/VBN followed/VBD failure/NN acute/JJ
ciprofloxacin/NN treatment/NN described/VBN followed/VBD failure/NN renal/JJ
ciprofloxacin/NN treatment/NN described/VBN followed/VBD failure/NN
ciprofloxacin/NN diagnosis/NN supports/VBZ followed/VBD improvement/NN induced/VBN failure/NN acute/JJ
ciprofloxacin/NN diagnosis/NN supports/VBZ followed/VBD improvement/NN induced/VBN failure/NN renal/JJ
ciprofloxacin/NN diagnosis/NN supports/VBZ followed/VBD improvement/NN induced/VBN failure/NN
echothiophate/JJ drops/NNS use/NN developed/VBD presented/VBD weakness/NN muscle/NN
echothiophate/JJ drops/NNS use/NN developed/VBD presented/VBD weakness/NN
iodide/JJ drops/NNS use/NN developed/VBD presented/VBD weakness/NN muscle/NN
iodide/JJ drops/NNS use/NN developed/VBD presented/VBD weakness/NN
levodopa/JJ pallidotomy/JJ dyskinesias/NNS
levodopa/JJ pallidotomy/JJ dyskinesias/NNS LID/NNP
levodopa/NN responsiveness/NNS found/VBD was/VBD correlation/NN improvement/NN LID/NNP
levodopa/NN responsiveness/NNS responsiveness/NNS found/VBD was/VBD correlation/NN improvement/NN LID/NNP
levodopa/NN responsiveness/NNS outcome/NN signs/NNS LID/NNP
levodopa/NN responsiveness/NNS outcome/NN correlations/NNS volume/NN dyskinesias/NNS
levodopa/NN responsiveness/NNS value/NN indicate/VBP dyskinesias/VBZ
vigabatrin/NN patients/NNS electroretinography/NN oculography/NN Electro/NNP attributed/VBD constriction/NN visual/JJ
vigabatrin/NN patients/NNS electroretinography/NN oculography/NN Electro/NNP attributed/VBD constriction/NN field/NN
vigabatrin/NN patients/NNS electroretinography/NN oculography/NN Electro/NNP attributed/VBD constriction/NN
vigabatrin/NN associated/VBN thought/VBN constriction/NN visual/JJ
vigabatrin/NN associated/VBN thought/VBN constriction/NN field/NN
vigabatrin/NN associated/VBN thought/VBN constriction/NN
vigabatrin/NN patients/NNS fields/NNS attributed/VBD loss/NN visual/JJ
vigabatrin/NN patients/NNS fields/NNS attributed/VBD loss/NN field/NN
vigabatrin/NN patients/NNS fields/NNS attributed/VBD loss/NN
vigabatrin/NN therapy/NN associated/VBN appears/VBZ constriction/NN visual/JJ
vigabatrin/NN therapy/NN associated/VBN appears/VBZ constriction/NN field/NN
vigabatrin/NN therapy/NN associated/VBN appears/VBZ constriction/NN
Diazepam/NNP facilitates/VBZ bradycardia/NN
adrenaline/NN infusion/NN produced/VBN bradycardia/NN
diazepam/NN rats/NNS pretreatment/NN enhance/VB adrenaline/NN induced/VBN bradycardia/NN
adrenaline/NN change/NN effect/NN causing/VBG pretreatment/NN enhance/VB adrenaline/NN induced/VBN bradycardia/NN
adrenaline/NN induced/VBN bradycardia/NN
diazepam/NN enhancement/NN adrenaline/NN induced/VBN bradycardia/NN
adrenaline/NN induced/VBN bradycardia/NN
diazepam/NN acts/VBZ facilitate/VB bradycardia/NN
trazodone/NN dose/NN block/NN heart/NN
trazodone/NN dose/NN block/NN
trazodone/NN dose/NN receiving/VBG minutes/NNS developed/VBD block/NN heart/NN
trazodone/NN dose/NN receiving/VBG minutes/NNS developed/VBD block/NN
D/NNP caused/VBD syndrome/NN nephrotic/JJ
D/NNP caused/VBD syndrome/NN
Penicillamine/NNP caused/VBD syndrome/NN nephrotic/JJ
Penicillamine/NNP caused/VBD syndrome/NN
D/NNP caused/VBD proteinuria/NN
Penicillamine/NNP caused/VBD proteinuria/NN
fluoxetine/JJ hydrochloride/NN induced/VBN hyperprolactinemia/NN
hydrochloride/NN induced/VBN hyperprolactinemia/NN
fluoxetine/JJ hydrochloride/NN induced/VBN hyperprolactinemia/NN effects/NNS model/NN adenomyosis/NNS
hydrochloride/NN induced/VBN hyperprolactinemia/NN effects/NNS model/NN adenomyosis/NNS
fluoxetine/JJ hydrochloride/NN induced/VBN induction/NN adenomyosis/JJ
hydrochloride/NN induced/VBN induction/NN adenomyosis/JJ
fluoxetine/NN caused/VBD hyperprolactinemia/NN
fluoxetine/NN caused/VBD adenomyosis/NNS
Fluoxetine/NNP given/VBN produce/VB hyperprolactinemia/NN
fluoxetine/NN receiving/VBG group/NN revealed/VBD cases/NNS adenomyosis/NNS
Methimazole/NNP induced/VBN jaundice/NN cholestatic/JJ
Methimazole/NNP induced/VBN jaundice/NN
methimazole/NN had/VBD jaundice/NN itching/NN
dipivalyl/NN thrombosis/NNS vein/NN
dipivalyl/NN thrombosis/NNS
epinephrine/VBP thrombosis/NNS vein/NN
epinephrine/VBP thrombosis/NNS
dipivalyl/JJ epinephrine/NN started/VBN day/NN seeing/VBG acquired/VBD thrombosis/NNS vein/NN
dipivalyl/JJ epinephrine/NN started/VBN day/NN seeing/VBG acquired/VBD thrombosis/NNS
epinephrine/NN started/VBN day/NN seeing/VBG acquired/VBD thrombosis/NNS vein/NN
epinephrine/NN started/VBN day/NN seeing/VBG acquired/VBD thrombosis/NNS
verapamil/NN therapy/NN hypotension/NN adrenergic/JJ failure/NN cardiac/JJ
verapamil/NN therapy/NN hypotension/NN adrenergic/JJ failure/NN
verapamil/NN therapy/NN hypotension/NN bradycardia/NN
beta/NN verapamil/NN therapy/NN hypotension/NN bradycardia/NN
adrenergic/JJ hypotension/NN bradycardia/NN
blocking/VBG developed/VBD failure/NN adrenergic/JJ hypotension/NN bradycardia/NN
drugs/NNS blocking/VBG developed/VBD failure/NN adrenergic/JJ hypotension/NN bradycardia/NN
verapamil/NN therapy/NN hypotension/NN
beta/NN verapamil/NN therapy/NN hypotension/NN
adrenergic/JJ hypotension/NN
blocking/VBG developed/VBD failure/NN adrenergic/JJ hypotension/NN
drugs/NNS blocking/VBG developed/VBD failure/NN adrenergic/JJ hypotension/NN
beta/NN verapamil/NN therapy/NN hypotension/NN adrenergic/JJ failure/NN cardiac/JJ
beta/NN verapamil/NN therapy/NN hypotension/NN adrenergic/JJ failure/NN
adrenergic/JJ failure/NN cardiac/JJ
adrenergic/JJ failure/NN
blocking/VBG developed/VBD failure/NN cardiac/JJ
blocking/VBG developed/VBD failure/NN
drugs/NNS blocking/VBG developed/VBD failure/NN cardiac/JJ
drugs/NNS blocking/VBG developed/VBD failure/NN
prazosin/NN blockade/NN 2/CD occurs/VBZ hypotension/NN Orthostatic/JJ
prazosin/NN blockade/NN 2/CD occurs/VBZ hypotension/NN
prazosin/NN treated/VBN hypotension/NN orthostatic/JJ
prazosin/NN treated/VBN hypotension/NN
prazosin/NN dosing/NN performed/VBD produce/VB hypotension/NN orthostatic/JJ
prazosin/NN dosing/NN performed/VBD produce/VB hypotension/NN
Abbott/NNP responses/NNS bradycardia/NN
53693/CD Abbott/NNP responses/NNS bradycardia/NN
noradrenaline/NN i/NNS micrograms/NNS responses/NNS bradycardia/NN
cirazoline/NN responses/NNS bradycardia/NN
cirazoline/NN effects/NNS bradycardia/NN
Abbott/NNP effects/NNS similar/JJ greater/JJR bradycardia/NN
53693/CD Abbott/NNP effects/NNS similar/JJ greater/JJR bradycardia/NN
noradrenaline/NN accompanied/VBD bradycardia/NN
iron/NN dextran/NN infusion/NN associated/VBN syndrome/NN Value/NNP methylprednisolone/NN prevention/NN arthralgia/NN
dextran/NN infusion/NN associated/VBN syndrome/NN Value/NNP methylprednisolone/NN prevention/NN arthralgia/NN
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN left/VBD
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN ventricular/JJ
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN apical/NN
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN ballooning/VBG
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN cardiomyopathy/NN Takotsubo/JJ
amphetamine/JJ use/NN setting/NN woman/NN syndrome/NN cardiomyopathy/NN
amphetamine/JJ use/NN occurring/VBG syndrome/NN apical/NN
amphetamine/JJ use/NN occurring/VBG syndrome/NN ballooning/VBG
amphetamine/JJ use/NN occurring/VBG syndrome/NN
Levodopa/NNP induced/VBN dyskinesia/NN
Levodopa/NNP alleviated/VBN dyskinesia/NN
levodopa/NN induced/VBN dyskinesias/NNS
flumazenil/JJ administration/NN Seizure/VB
flumazenil/NN administration/NN patient/NN seizure/NN occurrence/NN tonic/NN
flumazenil/NN administration/NN patient/NN seizure/NN clonic/JJ
flumazenil/NN administration/NN patient/NN seizure/NN
levodopa/NN dyskinesias/NNS
propofol/JJ sedation/NN underwent/VBD dementia/NN delirium/NN
amikacin/NN nephrotoxicity/NN
amikacin/NN associated/VBN nephrotoxicity/RB
amikacin/NN efficacy/NN increase/NN means/NNS nephrotoxicity/JJ
amphetamine/NN diagnosis/NN service/NN patients/NNS relationship/NN catecholamines/NNS symptoms/NNS psychotic/JJ
amphetamine/NN diagnosis/NN service/NN patients/NNS relationship/NN catecholamines/NNS symptoms/NNS
amphetamine/NN diagnosis/NN service/NN patients/NNS relationship/NN examine/VB interviewed/VBN psychosis/NNS
cocaine/NN relationship/NN catecholamines/NNS symptoms/NNS psychotic/JJ
cocaine/NN relationship/NN catecholamines/NNS symptoms/NNS
cocaine/NN relationship/NN examine/VB interviewed/VBN psychosis/NNS
Methamphetamine/JJ levels/NNS related/VBN scores/NNS rating/NN hyperkinesia/NN
amphetamine/JJ Methamphetamine/JJ levels/NNS related/VBN scores/NNS rating/NN hyperkinesia/NN
thiopentone/RB 4/CD mg/NN that/DT Somewhat/VB slower/JJR i/FW found/VBN lasted/VBD occurred/VBD apnoea/NN
midazolam/NNP mg/NN effect/NN inducing/VBG sleep/NN kg/VBP found/VBN lasted/VBD occurred/VBD apnoea/NN
midazolam/NN group/NN found/VBN lasted/VBD occurred/VBD apnoea/NN
midazolam/NN group/NN occurred/VBD apnoea/NN
amikacin/NN receiving/VBG patients/NNS associated/VBN outcome/NN nephrotoxicity/JJ
amikacin/NN treated/VBN patients/NNS Data/NNP analyzed/VBN factors/NNS associated/VBN nephrotoxicity/NN
malondialdehyde/NN dependence/NN oxypurines/VBZ nucleosides/VBZ ischemia/NN cerebral/JJ
malondialdehyde/NN dependence/NN oxypurines/VBZ nucleosides/VBZ ischemia/NN
nifedipine/NN induced/VBN telangiectasia/NN
nifedipine/NN starting/VBG months/NNS developed/VBD telangiectasia/NN
Adalat/NNP nifedipine/NN starting/VBG months/NNS developed/VBD telangiectasia/NN
amlodipine/NN commenced/VBD recurrence/NN telangiectasia/NN
nondepolarizing/VBG blocking/VBG implicated/VBN cause/NN weakness/NN muscle/NN
nondepolarizing/VBG blocking/VBG implicated/VBN cause/NN weakness/NN
neuromuscular/NN nondepolarizing/VBG blocking/VBG implicated/VBN cause/NN weakness/NN muscle/NN
neuromuscular/NN nondepolarizing/VBG blocking/VBG implicated/VBN cause/NN weakness/NN
blocking/VBG implicated/VBN cause/NN weakness/NN muscle/NN
blocking/VBG implicated/VBN cause/NN weakness/NN
agents/NNS implicated/VBN cause/NN weakness/NN muscle/NN
agents/NNS implicated/VBN cause/NN weakness/NN
ND/NNP agents/NNS implicated/VBN cause/NN weakness/NN muscle/NN
ND/NNP agents/NNS implicated/VBN cause/NN weakness/NN
NMBA/NNP ND/NNP agents/NNS implicated/VBN cause/NN weakness/NN muscle/NN
NMBA/NNP ND/NNP agents/NNS implicated/VBN cause/NN weakness/NN
ND/NNP discontinuation/NN weakness/NN
NMBAs/VBZ patients/NNS insufficiency/NN developed/VBD weakness/NN
ND/NNP likely/JJ junction/NN pathology/VB due/JJ weakness/NN
NMBA/NNP ND/NNP likely/JJ junction/NN pathology/VB due/JJ weakness/NN
ND/NNP likely/JJ junction/NN pathology/VB
ND/NNP likely/JJ junction/NN at/IN
ND/NNP likely/JJ junction/NN both/PDT
ND/NNP likely/JJ junction/NN the/DT
ND/NNP likely/JJ junction/NN neuromuscular/NN
ND/NNP likely/JJ junction/NN
NMBA/NNP ND/NNP likely/JJ junction/NN pathology/VB
NMBA/NNP ND/NNP likely/JJ junction/NN at/IN
NMBA/NNP ND/NNP likely/JJ junction/NN both/PDT
NMBA/NNP ND/NNP likely/JJ junction/NN the/DT
NMBA/NNP ND/NNP likely/JJ junction/NN neuromuscular/NN
NMBA/NNP ND/NNP likely/JJ junction/NN
doxorubicin/NN cycle/NN fibrillation/NN atrial/JJ
doxorubicin/NN cycle/NN fibrillation/NN
cimetidine/NN taking/VBG impotence/VBP
cimetidine/NN replaced/VBN disappeared/VBD developed/VBD impotence/VBP
hydroxychloroquine/NN chloroquine/NN used/VBD found/VBD case/NN drugs/NNS attributable/JJ chorioretinopathy/RB
ouabain/NN injection/NN intermittent/VBG induced/VBN arrhythmia/NN
adrenaline/JJ infusion/NN induced/VBN arrhythmia/NN Adrenaline/JJ
adrenaline/JJ infusion/NN induced/VBN arrhythmia/NN
adrenaline/JJ digitalis/JJ cibenzoline/VBP arrhythmias/NNS
adrenaline/JJ digitalis/JJ arrhythmias/NNS
adrenaline/NN suppress/VB needed/VBN dose/NN -/NNP cibenzoline/NN suppressed/VBN induced/VBN v/JJ arrhythmia/NN
adrenaline/NN arrhythmias/NNS
adrenaline/JJ digitalis/JJ arrhythmia/NNP
thiopental/NN produced/VBD involvement/NN reversal/NN paralysis/NN respiratory/JJ
thiopental/NN produced/VBD involvement/NN reversal/NN paralysis/NN
thiopental/NN induced/VBN paralysis/NN respiratory/JJ
thiopental/NN induced/VBN paralysis/NN
thiopental/NN produced/VBN paralysis/NN respiratory/JJ
thiopental/NN produced/VBN paralysis/NN
nicotine/NN mechanisms/NNS induced/VBN hyperactivity/NN locomotor/NN
nicotine/NN mechanisms/NNS induced/VBN hyperactivity/NN
nicotine/NN hyperactivity/NN locomotor/NN
nicotine/NN hyperactivity/NN
nicotine/NN treated/VBD develop/VB hyperactivity/NN locomotor/NN
nicotine/NN treated/VBD develop/VB hyperactivity/NN
nicotine/VB develop/VB hyperactivity/NN locomotor/NN
nicotine/VB develop/VB hyperactivity/NN
Prostaglandin/NNP D/NNP had/VBD action/NN hyperalgesic/JJ
D/NNP had/VBD action/NN hyperalgesic/JJ
2/CD had/VBD action/NN hyperalgesic/JJ
prostaglandin/NN D/NNP that/DT lasted/VBD showed/VBD effect/NN hyperalgesic/JJ
D/NNP that/DT lasted/VBD showed/VBD effect/NN hyperalgesic/JJ
2/CD D/NNP that/DT lasted/VBD showed/VBD effect/NN hyperalgesic/JJ
Prostaglandin/NNP E/NNP showed/VBD effect/NN hyperalgesic/JJ
E/NNP showed/VBD effect/NN hyperalgesic/JJ
2/CD E/NNP showed/VBD effect/NN hyperalgesic/JJ
prostaglandin/NN D/NNP effect/NN hyperalgesic/JJ
D/NNP effect/NN hyperalgesic/JJ
2/CD D/NNP effect/NN hyperalgesic/JJ
prostaglandin/NN induced/VBD blocked/VBN hyperalgesia/NN
E/CD 2/CD prostaglandin/NN induced/VBD blocked/VBN hyperalgesia/NN
2/CD prostaglandin/NN induced/VBD blocked/VBN hyperalgesia/NN
prostaglandin/NN D/VBZ hyperalgesia/NN
D/VBZ hyperalgesia/NN
2/CD hyperalgesia/NN
prostaglandin/CD 2/CD hyperalgesia/NN
E/NNP hyperalgesia/NN
2/CD hyperalgesia/NN
chondroitin/JJ sulfate/JJ derivative/NN elicit/VB response/NN hypotensive/JJ
sulfate/JJ derivative/NN elicit/VB response/NN hypotensive/JJ
Valproic/JJ I/NN course/NN biomarkers/NNS toxicity/NN liver/NN
Valproic/JJ I/NN course/NN biomarkers/NNS toxicity/NN
acid/JJ I/NN course/NN biomarkers/NNS toxicity/NN liver/NN
acid/JJ I/NN course/NN biomarkers/NNS toxicity/NN
valproic/JJ levels/NNS biomarkers/NNS toxicity/NN liver/NN
valproic/JJ levels/NNS biomarkers/NNS toxicity/NN
acid/JJ levels/NNS biomarkers/NNS toxicity/NN liver/NN
acid/JJ levels/NNS biomarkers/NNS toxicity/NN
VPA/NNP relationship/NN was/VBD determine/VB stress/NN hepatotoxicity/NN
VPA/NNP treated/VBN Sprague/NN stress/NN hepatotoxicity/NN
VPA/NNP results/NNS steatosis/VBZ
VPA/NNP results/NNS measured/VBN IsoP/NNP precedes/VBZ onset/NN necrosis/NNS
Topiramate/NNP induced/VBN nephrolithiasis/NNS
topiramate/NN cases/NNS nephrolithiasis/NNS
indomethacin/NN due/JJ anemia/NN aplastic/JJ
indomethacin/NN due/JJ anemia/NN
indomethacin/NN implicated/VBN cause/NN anemia/NN aplastic/JJ
indomethacin/NN implicated/VBN cause/NN anemia/NN
indomethacin/NN allopurinol/NN other/JJ given/VBN described/VBN case/NN anemia/NN aplastic/JJ
indomethacin/NN allopurinol/NN other/JJ given/VBN described/VBN case/NN anemia/NN
indomethacin/NN test/NN substantiates/VBZ role/NN drug/NN causing/VBG anemia/NN aplastic/JJ
indomethacin/NN test/NN substantiates/VBZ role/NN drug/NN causing/VBG anemia/NN
reserpine/NN induced/VBN dyskinesia/NN
reserpine/NN role/NN dyskinesia/NN
alfentanil/NNS induced/VBN rigidity/NN muscle/NN
alfentanil/NNS induced/VBN rigidity/NN
alfentanil/NN acting/VBG attenuated/VBD produced/VBD rigidity/NN muscle/NN
alfentanil/NN acting/VBG attenuated/VBD produced/VBD rigidity/NN
alfentanil/NN produced/VBN rigidity/NN
alfentanil/NN followed/VBN ketanserin/NN received/VBD animals/NNS motionless/JJ absence/NN rigidity/NN
alfentanil/NN receiving/VBG animals/NNS motionless/JJ absence/NN rigidity/NN
epinephrine/NN induced/VBN ischemia/NN myocardial/JJ
epinephrine/NN induced/VBN ischemia/NN
epinephrine/NN eliciting/VBG ischemia/NN myocardial/JJ
epinephrine/NN eliciting/VBG ischemia/NN
epinephrine/NN produced/VBD ischemia/NN myocardial/JJ
epinephrine/NN produced/VBD ischemia/NN
epinephrine/NN induced/VBN ischemia/NN myocardial/JJ
epinephrine/NN induced/VBN ischemia/NN
epinephrine/NN volume/NN product/NN rate/NN Exercise/NNP marked/VBN ischemia/NN myocardial/JJ
epinephrine/NN volume/NN product/NN rate/NN Exercise/NNP marked/VBN ischemia/NN
phenylpropanolamine/NN associated/VBN hemorrhage/NN Cerebral/JJ
phenylpropanolamine/NN associated/VBN hemorrhage/NN
caffeine/NN associated/VBN hemorrhage/NN Cerebral/JJ
caffeine/NN associated/VBN hemorrhage/NN
Phenylpropanolamine/NNP drug/NN associated/VBN effects/NNS stroke/NN
PPA/NNP Phenylpropanolamine/NNP drug/NN associated/VBN effects/NNS stroke/NN
PPA/NNP caffeine/NNP lead/VB stroke/NN
caffeine/NNP lead/VB stroke/NN normotensive/NN rats/NNS hypertensive/NN
PPA/NNP caffeine/NNP lead/VB stroke/NN normotensive/NN rats/NNS hypertensive/NN
caffeine/NN administration/NN lead/VBP hypertension/NN
caffeine/NN administration/NN lead/VBP hypertension/NN normotensive/JJ animals/NNS hypertensive/JJ
PPA/NNP administration/NN lead/VBP hypertension/NN
PPA/NNP administration/NN lead/VBP hypertension/NN normotensive/JJ animals/NNS hypertensive/JJ
PPA/NNP caffeine/NNP lead/VB hemorrhage/NN cerebral/JJ
PPA/NNP caffeine/NNP lead/VB hemorrhage/NN
caffeine/NNP lead/VB hemorrhage/NN cerebral/JJ
caffeine/NNP lead/VB hemorrhage/NN
caffeine/NNP lead/VB hemorrhage/NN animals/NNS hypertensive/JJ
PPA/NNP caffeine/NNP lead/VB hemorrhage/NN animals/NNS hypertensive/JJ
ouabain/NN arrhythmia/NN
levofloxacin/NN associated/VBN Seizures/NNS
levofloxacin/NN drug/NN initiating/VBG developed/VBD seizures/NNS
levofloxacin/NN drug/NN levofloxacin/NN induced/VBN seizures/NNS
levofloxacin/NN drug/NN initiating/VBG developed/VBD seizures/NNS
levofloxacin/NN induced/VBN seizures/NNS
levofloxacin/NN cases/NNS RESULTS/NNS induced/VBD reported/VBN seizures/NNS
ethinyl/JJ estradiol/NN acid/NN hydroxylation/NN sulfation/NN cholestasis/NNS
estradiol/NN acid/NN hydroxylation/NN sulfation/NN cholestasis/NNS
chlorthalidone/JJ phase/NN associated/VBN frequency/NN beats/NNS ventricular/JJ
chlorthalidone/JJ phase/NN associated/VBN frequency/NN beats/NNS ectopic/JJ
chlorthalidone/JJ phase/NN associated/VBN frequency/NN beats/NNS
quinine/NN ingestion/NN associated/VBN syndrome/NN Hemolytic/NNP
quinine/NN ingestion/NN associated/VBN syndrome/NN uremic/JJ
quinine/NN ingestion/NN associated/VBN syndrome/NN
quinine/JJ ingestion/NN syndrome/NN Hemolytic/NNP
quinine/JJ ingestion/NN syndrome/NN uremic/JJ
quinine/JJ ingestion/NN syndrome/NN
Quinine/RB occurs/VBZ associated/VBN hemolytic/JJ
Quinine/RB occurs/VBZ syndrome/NN uremic/JJ
Quinine/RB occurs/VBZ syndrome/NN
isoflurane/NN function/NN hypotension/NN
isoflurane/NN effect/NN hypotension/NN
isoflurane/JJ inspired/JJ concentration/NN increasing/VBG min/JJ //NNS 236/NNP induced/VBN Hypotension/NNP
isoflurane/NN induced/VBN hypotension/NN
labetalol/NN induced/VBN Effects/NNPS hypotension/NN
isoflurane/NN induced/VBN Effects/NNPS hypotension/NN
labetalol/NN induced/VBN hypotension/NN
labetalol/NN induced/VBN isoflurane/NN group/NN hypotensive/JJ
isoflurane/NN induced/VBN hypotension/NN
isoflurane/NN group/NN hypotensive/JJ
labetalol/NN induced/VBN hypotension/NN
isoflurane/NN induced/VBN hypotension/NN
scopolamine/NN prevention/NN rats/NNS sublethal/VB short/JJ amnesia/NN
scopolamine/NN prevention/NN rats/NNS sublethal/VB exposed/VBN rats/NNS response/NN protection/NN amnesia/NN
Fluconazole/NNP induced/VBN pointes/NNS torsade/JJ
Fluconazole/NNP induced/VBN pointes/NNS de/NNP
Fluconazole/NNP induced/VBN pointes/NNS
fluconazole/NN case/NN torsade/NN
fluconazole/NN case/NN torsade/NN pointes/NNS de/IN
fluconazole/NN case/NN torsade/NN pointes/NNS
fluconazole/NN case/NN torsade/NN pointes/NNS TDP/NNP
fluconazole/NN case/NN present/VB discuss/VB causing/VBG TDP/NNP
fluconazole/NN role/NN discuss/VB present/VB case/NN torsade/NN
fluconazole/NN role/NN discuss/VB present/VB case/NN torsade/NN pointes/NNS de/IN
fluconazole/NN role/NN discuss/VB present/VB case/NN torsade/NN pointes/NNS
fluconazole/NN role/NN discuss/VB present/VB case/NN torsade/NN pointes/NNS TDP/NNP
fluconazole/NN role/NN discuss/VB causing/VBG TDP/NNP
fluconazole/NN commencing/VBG days/NNS developed/VBN TDP/NNP
fluconazole/NN had/VBD TDP/NNP
fluconazole/NN commencing/VBG days/NNS developed/VBN abscess/NNS isolated/VBN glabrata/NNP woman/NN abnormalities/NNS was/VBD association/NN initiation/NN fluconazole/NNP TDP/NNP
fluconazole/NNP initiation/NN association/NN was/VBD abnormalities/NNS woman/NN glabrata/NNP isolated/VBN abscess/NNS developed/VBN TDP/NNP
fluconazole/NNP initiation/NN association/NN was/VBD abnormalities/NNS woman/NN glabrata/NNP isolated/VBN abscess/NNS developed/VBN days/NNS commencing/VBG fluconazole/NN had/VBD TDP/NNP
fluconazole/NNP TDP/NNP
fluconazole/NN discontinued/VBN resolved/VBD TDP/NNP
fluconazole/NN discontinued/VBN resolved/VBD indicates/VBZ relationship/NN use/NN development/NN TDP/NNP
fluconazole/NN use/NN relationship/NN indicates/VBZ resolved/VBD TDP/NNP
fluconazole/NN use/NN development/NN TDP/NNP
fluconazole/JJ suggests/VBZ was/VBD etiology/NN explain/VB TDP/VB
fluconazole/NN cause/VB leading/VBG TDP/NNP
olanzapine/NN induced/VBN syndrome/NN Hypomania/NNP
olanzapine/JJ treatment/NN introduction/NN developed/VBD hypomania/NN
lindane/JJ convulsions/NNS
lindane/JJ convulsions/NNS incidence/NN produce/VB pretreatment/VB increased/VBD incidence/NN convulsions/NNS
lindane/JJ convulsions/NNS incidence/NN increased/VBD pretreatment/VB produce/VB incidence/NN convulsions/NNS
lindane/JJ convulsions/NNS
lindane/NN blocked/VBN incidence/NN convulsions/NNS
lindane/NN treated/VBN animals/NNS increased/VBN P/NNP metabolism/NN lindane/NN blocked/VBN incidence/NN convulsions/NNS
lindane/NN se/FW indicating/VBG lindane/NN treated/VBN animals/NNS increased/VBN P/NNP metabolism/NN lindane/NN blocked/VBN incidence/NN convulsions/NNS
PTU/NNP associated/VBN vasculitis/NNS
propylthiouracil/NN vasculitis/NNS
PTU/NNP propylthiouracil/NN vasculitis/NNS
PTU/NNP withdrawal/NN symptoms/NNS resolution/NN observation/NN made/VBN diagnosis/NN propylthiouracil/NN vasculitis/NNS
lidocaine/NN cocaine/NN kindled/VBN seizures/NNS
cocaine/NN kindled/VBN seizures/NNS
lidocaine/JJ seizures/NNS
lidocaine/JJ seizures/NNS development/NN inhibited/VBD had/VBD effect/NN seizures/NNS
cocaine/JJ lidocaine/JJ seizures/NNS
cocaine/JJ lidocaine/JJ seizures/NNS development/NN inhibited/VBD had/VBD effect/NN seizures/NNS
cocaine/NN mortality/NN incidence/NN seizure/NN
lidocaine/NN induced/VBN seizures/NNS
cocaine/NN kindled/NNP lidocaine/NN induced/VBN seizures/NNS
lidocaine/JJ seizures/NNS
cocaine/JJ lidocaine/JJ seizures/NNS
amphetamine/NN induced/VBN hyperactivity/RB
fluvoxamine/NN treatment/NN potentiated/VBD amphetamine/NN induced/VBN hyperactivity/RB
nomifensine/NN induced/VBN hyperactivity/NN
fluvoxamine/NN remained/VBD hyperactivity/NN
clonidine/NN undergoing/VBG arrest/VB Cardiac/NNP
clonidine/NN undergoing/VBG arrest/VB
clonidine/NN reports/NNS arrest/NN cardiac/JJ
clonidine/NN reports/NNS arrest/NN
heparin/NN Delayed/JJ induced/VBN thrombocytopenia/NN
Heparin/NNP BACKGROUND/NNP presents/VBZ thrombocytopenia/NNP
heparin/NN exposure/NN presents/VBZ thrombocytopenia/NNP
heparin/NN recognition/NN contribute/VBP thrombocytopenia/NNP
heparin/NN manifestations/NNS thrombocytopenia/NN
heparin/NN thrombocytopenia/NN
heparin/NN exposure/NN included/VBN thrombocytopenia/NN
heparin/NN thrombocytopenia/NNS
heparin/NN thrombocytopenia/NN
heparin/JJ returns/NNS initiated/VBN thrombocytopenia/NN
carbimazole/NN therapy/NN bupropion/NN Acute/VB
carbimazole/NN therapy/NN bupropion/NN Acute/VB failure/NN liver/NN
carbimazole/NN therapy/NN bupropion/NN Acute/VB failure/NN
bupropion/NN Acute/VB
bupropion/NN Acute/VB failure/NN liver/NN
bupropion/NN Acute/VB failure/NN
bupropion/NN induced/VBN hepatotoxicity/RB
carbimazole/NN treatment/NN receiving/VBG resulted/VBN case/NN is/VBZ increasing/VBG evidence/NN hepatotoxicity/NN
carbimazole/NN treatment/NN receiving/VBG resulted/VBN failure/NN acute/JJ
carbimazole/NN treatment/NN receiving/VBG resulted/VBN failure/NN liver/NN
carbimazole/NN treatment/NN receiving/VBG resulted/VBN failure/NN
bupropion/NN induced/VBN hepatotoxicity/NN
bupropion/NN while/NN receiving/VBG resulted/VBN case/NN is/VBZ increasing/VBG evidence/NN hepatotoxicity/NN
bupropion/NN induced/VBN hepatotoxicity/NN evidence/NN increasing/VBG is/VBZ case/NN resulted/VBN failure/NN acute/JJ
bupropion/NN induced/VBN hepatotoxicity/NN evidence/NN increasing/VBG is/VBZ case/NN resulted/VBN failure/NN liver/NN
bupropion/NN induced/VBN hepatotoxicity/NN evidence/NN increasing/VBG is/VBZ case/NN resulted/VBN failure/NN
bupropion/NN while/NN receiving/VBG resulted/VBN failure/NN acute/JJ
bupropion/NN while/NN receiving/VBG resulted/VBN failure/NN liver/NN
bupropion/NN while/NN receiving/VBG resulted/VBN failure/NN
bupropion/NN given/VBN drugs/NNS hepatotoxic/JJ
bupropion/NN induced/VBN insult/NN acute/JJ
bupropion/NN induced/VBN insult/NN liver/NN
bupropion/NN induced/VBN insult/NN
azelastine/NN placebo/NN significantly/RB group/NN increased/VBN Drowsiness/NNS perception/NN altered/JJ
azelastine/NN placebo/NN significantly/RB group/NN increased/VBN Drowsiness/NNS perception/NN taste/NN
azelastine/NN placebo/NN significantly/RB group/NN increased/VBN Drowsiness/NNS perception/NN
azelastine/NN placebo/NN significantly/RB group/NN increased/VBN Drowsiness/NNS
isoniazid/JJ neuropathy/NN
isoniazid/NN dose/NN caused/VBN neuropathy/NN
pilocarpine/NN treated/VBN analyze/VBP occurrence/NN seizures/NNS
pilocarpine/NN induced/VBN result/NN seizures/NNS
KA/VB //VBZ pilocarpine/NN induced/VBN result/NN seizures/NNS
morphine/NN treated/VBN Hyperalgesia/NNS myoclonus/NNS
morphine/NN treated/VBN Hyperalgesia/NNS
morphine/NN doses/NNS treated/VBN disease/NN stages/NNS patients/NNS developed/VBD hyperalgesia/NN
morphine/NN doses/NNS relationship/NN myoclonus/NNS
morphine/NN plays/VBZ indicates/VBZ available/JJ descriptions/NNS relationship/NN myoclonus/NNS
morphine/NN doses/NNS relationship/NN myoclonus/NNS hyperalgesia/JJ
morphine/NN plays/VBZ indicates/VBZ available/JJ descriptions/NNS relationship/NN myoclonus/NNS hyperalgesia/JJ
chlorthalidone/JJ administration/NN loss/NN hypokalaemia/NN
Tiopronin/NNP due/JJ nephritis/NNS dermatitis/NNS
Tiopronin/NNP due/JJ due/JJ' dermatitis/NNS
gold/JJ thiosulphate/NN due/JJ dermatitis/NNS due/JJ' due/JJ nephritis/NNS dermatitis/NNS
gold/JJ thiosulphate/NN due/JJ dermatitis/NNS
Tiopronin/NNP due/JJ nephritis/NNS
Tiopronin/NNP group/NN nephritis/NNS
lidocaine/NN system/NN role/NN convulsion/NN
lidocaine/NN convulsions/NNS
lidocaine/NN convulsions/NNS
lidocaine/NN incidence/NN increased/VBN treatment/NN L/NNP induced/VBZ convulsions/NNS
lidocaine/NN mediator/NN convulsions/NNS
tamoxifen/NN women/NNS events/NNS vascular/NN
tamoxifen/NN women/NNS events/NNS
tamoxifen/NN women/NNS events/NNS hypertriglyceridaemia/NN
L/NNP patients/NNS overactivation/NN dose/NN dyskinesia/NN
dopa/NN overactivation/NN dose/NN dyskinesia/NN
L/NNP patients/NNS groups/NNS supplementary/NN task/NN execution/NN dopa/NN dyskinesia/NN
dopa/NN medication/NN execution/NN dopa/NN dyskinesia/NN
L/NNP patients/NNS groups/NNS supplementary/NN task/NN execution/NN other/JJ dyskinesia/NN
dopa/NN medication/NN execution/NN other/JJ dyskinesia/NN
L/NNP one/NN medication/NN execution/NN dopa/NN dyskinesia/NN
dopa/NN dyskinesia/NN
L/NNP one/NN medication/NN execution/NN other/JJ dyskinesia/NN
dopa/NN execution/NN other/JJ dyskinesia/NN
L/NNP movement/NN abnormal/JJ
L/NNP movement/NN involuntary/JJ
L/NNP movement/NN
dopa/NNP L/NNP movement/NN abnormal/JJ
dopa/NNP L/NNP movement/NN involuntary/JJ
dopa/NNP L/NNP movement/NN
L/NNP induced/VBN dyskinesia/NN
dopa/NNP L/NNP induced/VBN dyskinesia/NN
tolazamide/NN Wernicke/NNP
tolazamide/NN abnormality/NN encephalopathy/JJ s/VBZ
tolazamide/NN abnormality/NN encephalopathy/JJ
tolazamide/NN treated/VBN encephalopathy/JJ Wernicke/NNP
tolazamide/NN treated/VBN encephalopathy/JJ Wernicke/NNP '/POS
tolazamide/NN treated/VBN encephalopathy/JJ s/VBZ
tolazamide/NN treated/VBN encephalopathy/JJ
tolazamide/NN patient/NN syndrome/NN similarity/NN encephalopathy/NN Wernicke/NNP
tolazamide/NN patient/NN syndrome/NN similarity/NN encephalopathy/NN Wernicke/NNP '/POS
tolazamide/NN patient/NN syndrome/NN similarity/NN encephalopathy/NN s/JJ
tolazamide/NN patient/NN syndrome/NN similarity/NN encephalopathy/NN
methyldopa/NN effect/NN hypotensive/JJ
methyldopa/JJ neurons/NNS microinjection/NN elicits/VBZ response/NN hypotensive/JJ
methyldopa/NN microinjection/NN caused/VBD hypotension/NN
methyldopa/NN mediate/VB hypotension/NN
methyldopa/NN mediate/VB cells/NNS contribute/VBP action/NN hypotensive/JJ
methyldopa/NN action/NN contribute/VBP cells/NNS mediate/VB hypotension/NN
methyldopa/NN action/NN hypotensive/JJ
Lamotrigine/NNP associated/VBN myoclonus/NNS
lamotrigine/JJ exacerbation/NN appearance/NN jerks/NNS myoclonic/JJ
lamotrigine/JJ exacerbation/NN appearance/NN jerks/NNS
lamotrigine/JJ exacerbation/NN appearance/NN jerks/NNS MJ/NNP
LTG/NNP exacerbation/NN appearance/NN jerks/NNS myoclonic/JJ
LTG/NNP exacerbation/NN appearance/NN jerks/NNS
LTG/NNP exacerbation/NN appearance/NN jerks/NNS MJ/NNP
LTG/NNP exacerbated/VBD MJ/NNP
LTG/NNP dose/NNP decreased/VBN disappeared/VBD MJ/NNP
LTG/NNP exacerbated/VBD MJ/NNP
LTG/NNP exacerbated/VBD status/NN myoclonic/JJ
LTG/NNP exacerbated/VBD status/NN
LTG/NNP withdrawal/NN ceased/VBD status/NN exacerbated/VBD MJ/NNP
LTG/NNP withdrawal/NN ceased/VBD status/NN myoclonic/JJ
LTG/NNP withdrawal/NN ceased/VBD status/NN
cisplatin/NN injection/NN induced/VBN injury/NN acute/JJ
cisplatin/NN injection/NN induced/VBN injury/NN renal/JJ
cisplatin/NN injection/NN induced/VBN injury/NN
paracetamol/NNP developed/VBN bladder/NN epithelium/NN Papillomas/NNS bore/VBD carcinomas/NNS bladder/NN
paracetamol/NNP developed/VBN bladder/NN epithelium/NN Papillomas/NNS bore/VBD carcinomas/NNS
paracetamol/NNP %/NN treated/VBD developed/VBD hyperplasia/NN
paracetamol/NNP livers/NNS study/NN treated/VBD revealed/VBD hepatocytes/NNS resemble/VBP those/DT result/VBP variety/NN hepatocarcinogens/NNS
carrageenan/NN licking/NNP models/NNS induced/VBN hyperalgesia/NN thermal/JJ
carrageenan/NN licking/NNP models/NNS induced/VBN hyperalgesia/NN
carrageenan/NN licking/NNP models/NNS induced/VBN hyperalgesia/NN mechanical/JJ
carrageenan/NN licking/NNP models/NNS induced/VBN hyperalgesia/NN
capsaicin/NN hyperalgesia/NN thermal/JJ
capsaicin/NN hyperalgesia/NN
capsaicin/NN hyperalgesia/NN induced/VBN models/NNS induced/VBN hyperalgesia/NN mechanical/JJ
capsaicin/NN hyperalgesia/NN induced/VBN models/NNS induced/VBN hyperalgesia/NN
paclitaxel/NN received/VBD suffered/VBD edema/NN moderate/JJ brain/NN
paclitaxel/NN received/VBD suffered/VBD edema/NN
paclitaxel/NN total/NN received/VBD edema/NN moderate/JJ brain/NN
paclitaxel/NN total/NN received/VBD edema/NN
haloperidol/NN induced/VBN hyperprolactinemia/NN
haloperidol/NN induced/VBN hyperprolactinemia/NN
HAL/NNP haloperidol/NN induced/VBN hyperprolactinemia/NN
isoproterenol/NN Development/NNP hypertrophy/NN cardiac/JJ
isoproterenol/NN Development/NNP hypertrophy/NN
isoproterenol/NN injections/NNS rats/NNS studied/VBN development/NN hypertrophy/NN cardiac/JJ
isoproterenol/NN injections/NNS rats/NNS studied/VBN development/NN hypertrophy/NN
ISO/NNP isoproterenol/NN injections/NNS rats/NNS studied/VBN development/NN hypertrophy/NN cardiac/JJ
ISO/NNP isoproterenol/NN injections/NNS rats/NNS studied/VBN development/NN hypertrophy/NN
tranylcypromine/JJ interaction/NN syndrome/NN Serotonin/NN
tranylcypromine/JJ interaction/NN syndrome/NN
venlafaxine/NN syndrome/NN Serotonin/NN
venlafaxine/NN syndrome/NN
tranylcypromine/NN taking/VBG male/NN y/NN venlafaxine/NN interaction/NNP resulted/VBD syndrome/NN serotonin/NN
tranylcypromine/NN taking/VBG male/NN y/NN venlafaxine/NN interaction/NNP resulted/VBD syndrome/NN
venlafaxine/NN interaction/NNP resulted/VBD syndrome/NN serotonin/NN
venlafaxine/NN interaction/NNP resulted/VBD syndrome/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN of/IN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN bone/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN lead/VB disease/NN adynamic/JJ
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN lead/VB disease/NN bone/NN
Calcitriol/NNP therapy/NN suppresses/VBZ has/VBZ hypercalcemia/NN suppression/NN turnover/NN lead/VB disease/NN
OCT/NNP prevent/VB occurrence/NN hypercalcemia/NN
Ciprofloxacin/NNP induced/VBN nephritis/NNS interstitial/JJ
Ciprofloxacin/NNP induced/VBN nephritis/NNS
Ciprofloxacin/NNP associated/VBN effects/NNS nephritis/NNS anemia/NN hemolytic/JJ
Ciprofloxacin/NNP associated/VBN effects/NNS nephritis/NNS anemia/NN
Ciprofloxacin/NNP associated/VBN effects/NNS nephritis/NNS interstitial/JJ
Ciprofloxacin/NNP associated/VBN effects/NNS nephritis/NNS
ciprofloxacin/NN case/NN nephritis/NNS interstitial/JJ
ciprofloxacin/NN case/NN nephritis/NNS
trihexyphenidyl/JJ challenge/NN allele/VBP slowing/NN mental/JJ
trihexyphenidyl/JJ challenge/NN allele/VBP slowing/NN
trihexyphenidyl/NN dose/NN resulted/VBD ratings/NNS slowness/NNS mental/JJ
trihexyphenidyl/NN dose/NN resulted/VBD ratings/NNS slowness/NNS
trihexyphenidyl/JJ mg/NN ratings/NNS slowness/NNS mental/JJ
trihexyphenidyl/JJ mg/NN ratings/NNS slowness/NNS
trihexyphenidyl/JJ challenge/NN associated/VBN slowing/NN mental/JJ
trihexyphenidyl/JJ challenge/NN associated/VBN slowing/NN
puromycin/NN aminonucleoside/NN induced/VBN Plasma/NNP lipids/NNS development/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN induced/VBN Plasma/NNP lipids/NNS development/NN syndrome/NN
aminonucleoside/NN induced/VBN Plasma/NNP lipids/NNS development/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN induced/VBN Plasma/NNP lipids/NNS development/NN syndrome/NN
puromycin/NN aminonucleoside/NN induced/VBN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN induced/VBN syndrome/NN
aminonucleoside/NN induced/VBN syndrome/NN nephrotic/JJ
aminonucleoside/NN induced/VBN syndrome/NN
puromycin/NN aminonucleoside/NN induced/VBN syndrome/NN found/VBN lipoproteins/NNS alterations/NNS due/JJ syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN induced/VBN syndrome/NN found/VBN lipoproteins/NNS alterations/NNS due/JJ syndrome/NN
aminonucleoside/NN induced/VBN syndrome/NN found/VBN lipoproteins/NNS alterations/NNS due/JJ syndrome/NN nephrotic/JJ
aminonucleoside/NN induced/VBN syndrome/NN found/VBN lipoproteins/NNS alterations/NNS due/JJ syndrome/NN
aminonucleoside/NN or/CC syndrome/NN due/JJ alterations/NNS lipoproteins/NNS found/VBN syndrome/NN nephrotic/JJ
aminonucleoside/NN or/CC syndrome/NN due/JJ alterations/NNS lipoproteins/NNS found/VBN syndrome/NN
aminonucleoside/NN or/CC syndrome/NN nephrotic/JJ
aminonucleoside/NN or/CC syndrome/NN
puromycin/NN aminonucleoside/NN administration/NN development/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN administration/NN development/NN syndrome/NN
aminonucleoside/NN administration/NN development/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN administration/NN development/NN syndrome/NN
oral/JJ therapy/NN complications/NNS pretreatment/VB levels/NNS factors/NNS blood/NN
oral/JJ therapy/NN complications/NNS pretreatment/VB levels/NNS factors/NNS coagulation/NN
contraceptive/JJ therapy/NN complications/NNS pretreatment/VB levels/NNS factors/NNS blood/NN
contraceptive/JJ therapy/NN complications/NNS pretreatment/VB levels/NNS factors/NNS coagulation/NN
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP interval/NN of/IN
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP interval/NN the/DT
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP interval/NN QT/NNP
diltiazem/NN interaction/NN cisapride/VB related/VBD Prolongation/NNP interval/NN
cisapride/VB related/VBD Prolongation/NNP
cisapride/VB related/VBD Prolongation/NNP interval/NN of/IN
cisapride/VB related/VBD Prolongation/NNP interval/NN the/DT
cisapride/VB related/VBD Prolongation/NNP interval/NN QT/NNP
cisapride/VB related/VBD Prolongation/NNP interval/NN
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN sudden/JJ
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN cardiac/JJ
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS torsades/JJ
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS de/NNP
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS torsades/JJ
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS de/NNP
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP pointes/NNS
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP of/IN
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP QT/NNP
azole/JJ erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN sudden/JJ
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN cardiac/JJ
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP death/NN
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP of/IN
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP QT/NNP
erythromycin/NN agents/NNS reported/VBN Prolongation/NNP interval/NNP
MMC/NN m/NN developed/VBD failure/NN cardiac/JJ
MMC/NN m/NN developed/VBD failure/NN
doxorubicin/NN m/NN developed/VBD failure/NN cardiac/JJ
doxorubicin/NN m/NN developed/VBD failure/NN
lithium/NN treatment/NN hypothyroidism/VB
lithium/NN taking/VBG developed/VBD Hypothyroidism/NNP
gentamicin/VB resistance/NN responsible/JJ suggested/VBN failure/NN acute/JJ
gentamicin/VB resistance/NN responsible/JJ suggested/VBN failure/NN renal/JJ
gentamicin/VB resistance/NN responsible/JJ suggested/VBN failure/NN
gentamicin/VB resistance/NN responsible/JJ suggested/VBN failure/NN ARF/NNP
streptozotocin/NN mellitus/NNS diabetes/NN
streptozotocin/NN mellitus/NNS
streptozotocin/NN DM/NNP
gentamicin/NN ARF/NNP
ethambutol/NN due/JJ neuropathy/NN Bilateral/JJ
ethambutol/NN due/JJ neuropathy/NN optic/JJ
ethambutol/NN due/JJ neuropathy/NN
isoniazid/JJ treatment/NN ethambutol/NN due/JJ neuropathy/NN Bilateral/JJ
isoniazid/JJ treatment/NN ethambutol/NN due/JJ neuropathy/NN optic/JJ
isoniazid/JJ treatment/NN ethambutol/NN due/JJ neuropathy/NN
pemoline/JJ overdose/NN
lithium/NN therapy/NN insipidus/NNS nephrogenic/JJ
lithium/NN therapy/NN insipidus/NNS diabetes/NN
lithium/NN therapy/NN insipidus/NNS
lithium/NN induced/VBN insipidus/NNS nephrogenic/JJ
lithium/NN induced/VBN insipidus/NNS diabetes/NN
lithium/NN induced/VBN insipidus/NNS
lithium/NN therapy/NN discontinued/VBN diagnosed/VBN have/VB lithium/NN induced/VBN insipidus/NNS nephrogenic/JJ
lithium/NN therapy/NN discontinued/VBN diagnosed/VBN have/VB lithium/NN induced/VBN insipidus/NNS diabetes/NN
lithium/NN therapy/NN discontinued/VBN diagnosed/VBN have/VB lithium/NN induced/VBN insipidus/NNS
lithium/NN cessation/NN remained/VBD thirsty/JJ polyuric/JJ
lithium/NN cessation/NN remained/VBD showed/VBD evidence/NN insipidus/NNS nephrogenic/JJ
lithium/NN cessation/NN remained/VBD showed/VBD evidence/NN insipidus/NNS diabetes/NN
lithium/NN cessation/NN remained/VBD showed/VBD evidence/NN insipidus/NNS
Lithium/RB considered/VBN persisted/VBD polyuria/NN
lithium/NN stopped/VBN persisted/VBD polyuria/NN
Lithium/RB considered/VBN insipidus/NNS nephrogenic/JJ
Lithium/RB considered/VBN insipidus/NNS diabetes/NN
Lithium/RB considered/VBN insipidus/NNS
lithium/NN stopped/VBN persisted/VBD considered/VBN insipidus/NNS nephrogenic/JJ
lithium/NN stopped/VBN persisted/VBD considered/VBN insipidus/NNS diabetes/NN
lithium/NN stopped/VBN persisted/VBD considered/VBN insipidus/NNS
lithium/NN patients/NNS management/NN implications/NNS mechanisms/NNS insipidus/NNS nephrogenic/JJ
lithium/NN patients/NNS management/NN implications/NNS mechanisms/NNS insipidus/NNS diabetes/NN
lithium/NN patients/NNS management/NN implications/NNS mechanisms/NNS insipidus/NNS
rifampin/NN proteinuria/NN
rifampin/NN treated/VBN patients/NNS 9/CD found/VBN proteinuria/NN
puromycin/NN aminonucleoside/NN subunits/NNS targeting/VBG expression/NN syndrome/NN nephrotic/JJ
puromycin/NN aminonucleoside/NN subunits/NNS targeting/VBG expression/NN syndrome/NN
aminonucleoside/NN subunits/NNS targeting/VBG expression/NN syndrome/NN nephrotic/JJ
aminonucleoside/NN subunits/NNS targeting/VBG expression/NN syndrome/NN
PAN/NNP treatment/NN induced/VBN proteinuria/NN hypoalbuminemia/NN
PAN/NNP treatment/NN induced/VBN proteinuria/NN ascites/NNS
PAN/NNP treatment/NN induced/VBN proteinuria/NN
PAN/NNP associated/VBN syndrome/NN nephrotic/JJ
PAN/NNP associated/VBN syndrome/NN
sulphasalazine/JJ treatment/NN restarting/VBG developed/VBD eyes/NNS effusion/NN pleural/JJ
sulphasalazine/JJ treatment/NN restarting/VBG developed/VBD eyes/NNS effusion/NN
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD fever/NN effusions/NNS pleural/JJ
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD fever/NN effusions/NNS
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD initiated/VBD remained/VBD effusion/NN pleural/JJ
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD initiated/VBD remained/VBD effusion/NN
sulphasalazine/JJ treatment/NN cessation/NN resulted/VBD fever/NN
PGE/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
2/CD PGE/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
PGF/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
2/CD alpha/NN PGF/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
alpha/NN PGF/NNP NGF/NNP increased/VBN patients/NNS OAB/NNP
PGE/NNP OAB/NNP
2/CD PGE/NNP OAB/NNP
PGF/NNP alpha/NNP correlate/VB parameters/NNS patients/NNS OAB/NNP
2/CD alpha/NNP correlate/VB parameters/NNS patients/NNS OAB/NNP
alpha/NNP correlate/VB parameters/NNS patients/NNS OAB/NNP
iron/NN dextran/NN induced/VBN degeneration/NN
iron/NN dextran/NN induced/VBN degeneration/NN neurons/NNS of/IN
iron/NN dextran/NN induced/VBN degeneration/NN neurons/NNS dopaminergic/JJ
iron/NN dextran/NN induced/VBN degeneration/NN neurons/NNS
dextran/NN induced/VBN degeneration/NN
dextran/NN induced/VBN degeneration/NN neurons/NNS of/IN
dextran/NN induced/VBN degeneration/NN neurons/NNS dopaminergic/JJ
dextran/NN induced/VBN degeneration/NN neurons/NNS
iron/NN animals/NNS content/NN detection/NN study/VB degeneration/NN
iron/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS of/IN
iron/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS dopaminergic/JJ
iron/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS
dextran/NN animals/NNS content/NN detection/NN study/VB degeneration/NN
dextran/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS of/IN
dextran/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS dopaminergic/JJ
dextran/NN animals/NNS content/NN detection/NN study/VB degeneration/NN neurons/NNS
iron/NN dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN
iron/NN dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS of/IN
iron/NN dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS dopaminergic/JJ
iron/NN dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS
dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN
dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS of/IN
dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS dopaminergic/JJ
dextran/NN increase/VB SN/NNP causes/VBZ degeneration/NN neurons/NNS
Methylphenidate/NNP induced/VBN obsessive/JJ
Methylphenidate/NNP induced/VBN obsessive/JJ symptoms/NNS compulsive/JJ
Methylphenidate/NNP induced/VBN obsessive/JJ symptoms/NNS
methylphenidate/NN replaced/VBN diminished/VBN ensued/VBD obsessive/NN
methylphenidate/NN replaced/VBN diminished/VBN ensued/VBD behavior/NN compulsive/JJ
methylphenidate/NN replaced/VBN diminished/VBN ensued/VBD behavior/NN
LiCl/NNP administration/NN 2/CD mice/NNS led/VBN polyuria/NN
everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN microangiopathy/NN
tacrolimus/NNS everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN sinusoidal/JJ
tacrolimus/NNS everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN obstruction/NN
tacrolimus/NNS everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN
tacrolimus/NNS everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN microangiopathy/NN
everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN sinusoidal/JJ
everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN obstruction/NN
everolimus/NNS prophylaxis/NNS Graft/NNP associated/VBN incidence/NN syndrome/NN
pravastatin/NN use/NN associated/VBN myopathy/NN inflammatory/JJ
pravastatin/NN use/NN associated/VBN myopathy/NN
T/NNP had/VBD effect/NN locomotion/NN irritability/NN
T/NNP had/VBD increased/VBD preference/NN aggression/NN
enalapril/NN assigned/VBN Patients/NNS RESULTS/NNS had/VBD likelihood/NN function/NN decreased/VBN
enalapril/NN assigned/VBN Patients/NNS RESULTS/NNS had/VBD likelihood/NN function/NN renal/JJ
enalapril/NN assigned/VBN Patients/NNS RESULTS/NNS had/VBD likelihood/NN function/NN
enalapril/JJ groups/NNS placebo/NN associated/VBN function/NN decreased/VBN
enalapril/JJ groups/NNS placebo/NN associated/VBN function/NN renal/JJ
enalapril/JJ groups/NNS placebo/NN associated/VBN function/NN
diuretic/JJ therapy/NN age/NN associated/VBN function/NN decreased/VBN
diuretic/JJ therapy/NN age/NN associated/VBN function/NN renal/JJ
diuretic/JJ therapy/NN age/NN associated/VBN function/NN
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN decreased/VBN
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN renal/JJ
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN decreased/VBN
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN renal/JJ
enalapril/JJ group/NN significantly/RB %/NN 32/CD 1/CD 52/CD associated/VBN risk/NN developing/VBG function/NN
enalapril/NN 52/CD associated/VBN risk/NN developing/VBG function/NN decreased/VBN
enalapril/NN 52/CD associated/VBN risk/NN developing/VBG function/NN renal/JJ
enalapril/NN 52/CD associated/VBN risk/NN developing/VBG function/NN
enalapril/JJ group/NN function/NN decreased/VBN
enalapril/JJ group/NN function/NN renal/JJ
enalapril/JJ group/NN function/NN
Diuretic/JJ therapy/NN associated/VBN risk/NN function/NN decreased/VBN
Diuretic/JJ therapy/NN associated/VBN risk/NN function/NN renal/JJ
Diuretic/JJ therapy/NN associated/VBN risk/NN function/NN
Enalapril/JJ use/NN caused/VBN risk/NN function/NN decreased/VBN
Enalapril/JJ use/NN caused/VBN risk/NN function/NN renal/JJ
Enalapril/JJ use/NN caused/VBN risk/NN function/NN
enalapril/JJ group/NN reduced/VBN associated/VBN risk/NN impairment/NN renal/JJ
enalapril/JJ group/NN reduced/VBN associated/VBN risk/NN impairment/NN
scopolamine/NN cholinesterase/NN 247/VBN Effects/NNPS induced/VBN amnesia/NN
NIK/NNP Effects/NNPS induced/VBN amnesia/NN
247/VBN Effects/NNPS induced/VBN amnesia/NN
tacrine/NN 247/VBN induced/VBN examined/VBN amnesia/NN
scopolamine/RB 247/VBN induced/VBN examined/VBN amnesia/NN
E/NN tacrine/NN 247/VBN induced/VBN examined/VBN amnesia/NN
2020/VBZ effects/NNS 247/VBN induced/VBN examined/VBN amnesia/NN
NIK/NNP effects/NNS 247/VBN induced/VBN examined/VBN amnesia/NN
247/VBN induced/VBN examined/VBN amnesia/NN
scopolamine/NN induced/VBN amnesia/NN
scopolamine/NN induced/VBN amnesia/NN
NIK/NNP 247/NNP improves/VBZ scopolamine/NN induced/VBN amnesia/NN
-/NNP 247/NNP improves/VBZ scopolamine/NN induced/VBN amnesia/NN
247/NNP improves/VBZ scopolamine/NN induced/VBN amnesia/NN
capsaicin/NN injection/NN determined/VBN obtained/VBN stimuli/NNS hyperalgesia/NN mechanical/JJ
capsaicin/NN injection/NN determined/VBN obtained/VBN stimuli/NNS hyperalgesia/NN
capsaicin/NN injection/NN determined/VBN obtained/VBN stimuli/NNS hyperalgesia/NN allodynia/NN
capsaicin/NN injection/NN reduced/VBD hyperalgesia/NN mechanical/JJ
capsaicin/NN injection/NN reduced/VBD hyperalgesia/NN
capsaicin/NN injection/NN reduced/VBD hyperalgesia/NN allodynia/NN
dexamethasone/JJ treatment/NN years/NNS age/NN dysfunction/NN neurological/JJ
dexamethasone/JJ treatment/NN years/NNS age/NN dysfunction/NN
dexamethasone/JJ therapy/NN assess/VB dysfunction/NN neurological/JJ
dexamethasone/JJ therapy/NN assess/VB dysfunction/NN
dexamethasone/JJ treatment/NN showed/VBD rate/NN dysfunctions/NNS neurological/JJ
dexamethasone/JJ treatment/NN showed/VBD rate/NN dysfunctions/NNS
methotrexate/NN accident/NN leukoencephalopathy/JJ
methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
5/CD methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
fluorouracil/NN 5/CD methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
carmofur/NN fluorouracil/NN 5/CD methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
capecitabine/NN methotrexate/NN treated/VBN patients/NNS identified/VBD reports/NNS leukoencephalopathy/NN
scopolamine/NN MEASURES/NNP impairment/NN
scopolamine/NN MEASURES/NNP impairment/NN recall/NN in/IN
scopolamine/NN MEASURES/NNP impairment/NN recall/NN word/NN
scopolamine/NN MEASURES/NNP impairment/NN recall/NN
scopolamine/NN induced/VBN impairment/NN
scopolamine/NN induced/VBN impairment/NN recall/NN in/IN
scopolamine/NN induced/VBN impairment/NN recall/NN word/NN
scopolamine/NN induced/VBN impairment/NN recall/NN
Calcium/JJ toxicity/NN milk/NN
Calcium/JJ toxicity/NN alkali/VBZ
Calcium/JJ toxicity/NN alkali/VBZ syndrome/NN
carbonate/NN toxicity/NN milk/NN
carbonate/NN toxicity/NN alkali/VBZ
carbonate/NN toxicity/NN alkali/VBZ syndrome/NN
calcium/NN carbonate/NN describe/VB induced/VBN insights/NNS hypercalcemia/NN
carbonate/NN describe/VB induced/VBN insights/NNS hypercalcemia/NN
calcium/NN carbonate/NN describe/VB induced/VBN cause/NN milk/NN
calcium/NN carbonate/NN describe/VB alkali/VBG
calcium/NN carbonate/NN describe/VB alkali/VBG syndrome/NN
carbonate/NN describe/VB induced/VBN cause/NN milk/NN
carbonate/NN describe/VB alkali/VBG
carbonate/NN describe/VB alkali/VBG syndrome/NN
pamidronate/JJ intravenously/NN caused/VBD hypocalcemia/NN
calcium/NN carbonate/NN amounts/NNS precipitated/VBN cause/NN CONCLUSION/NNP Milk/NN
calcium/NN carbonate/NN amounts/NNS precipitated/VBN cause/NN syndrome/NN alkali/NN
calcium/NN carbonate/NN amounts/NNS precipitated/VBN cause/NN syndrome/NN
carbonate/NN amounts/NNS precipitated/VBN cause/NN CONCLUSION/NNP Milk/NN
carbonate/NN amounts/NNS precipitated/VBN cause/NN syndrome/NN alkali/NN
carbonate/NN amounts/NNS precipitated/VBN cause/NN syndrome/NN
calcium/NN carbonate/NN amounts/NNS precipitated/VBN cause/NN hypercalcemia/NN
carbonate/NN amounts/NNS precipitated/VBN cause/NN hypercalcemia/NN
Pamidronate/JJ treatment/NN associated/VBN risk/NN hypocalcemia/NN
sirolimus/NNS administration/NN association/NN syndrome/NN capillary/JJ
sirolimus/NNS administration/NN association/NN syndrome/NN leak/NN
sirolimus/NNS administration/NN association/NN syndrome/NN
rapamycin/NN sirolimus/NNS administration/NN association/NN syndrome/NN capillary/JJ
rapamycin/NN sirolimus/NNS administration/NN association/NN syndrome/NN leak/NN
rapamycin/NN sirolimus/NNS administration/NN association/NN syndrome/NN
sirolimus/NNS treatment/NN syndrome/NN capillary/JJ
sirolimus/NNS treatment/NN syndrome/NN leak/NN
sirolimus/NNS treatment/NN syndrome/NN
sirolimus/NNS specimen/NN OBSERVATIONS/NNP induced/VBN leak/NN capillary/JJ
sirolimus/NNS specimen/NN OBSERVATIONS/NNP induced/VBN leak/NN
sirolimus/NNS specimen/NN OBSERVATIONS/NNP induced/VBN leak/NN syndrome/NN
sirolimus/NNS fold/VB 3/CD syndrome/NN leak/NN capillary/JJ
sirolimus/NNS fold/VB 3/CD syndrome/NN leak/NN
sirolimus/NNS fold/VB 3/CD syndrome/NN
sirolimus/NNS effects/NNS include/VBP fever/NN syndrome/NN capillary/JJ
sirolimus/NNS effects/NNS include/VBP fever/NN syndrome/NN leak/NN
sirolimus/NNS effects/NNS include/VBP fever/NN syndrome/NN
diazepam/NN complications/NNS Venous/JJ
diazepam/NN complications/NNS
midazolam/NN complications/NNS Venous/JJ
midazolam/NN complications/NNS
diazepam/NN associated/VBN venous/NNS
diazepam/NN associated/VBN complications/NNS
midazolam/NN associated/VBN venous/NNS
midazolam/NN associated/VBN complications/NNS
diazepam/NN injection/NN evaluated/VBN incidence/NN complications/NNS venous/JJ
diazepam/NN injection/NN evaluated/VBN incidence/NN complications/NNS
midazolam/NN diazepam/NN injection/NN evaluated/VBN incidence/NN complications/NNS venous/JJ
midazolam/NN diazepam/NN injection/NN evaluated/VBN incidence/NN complications/NNS
diazepam/NN frequent/JJ complications/NNS venous/NNS
diazepam/NN frequent/JJ complications/NNS
midazolam/NN frequent/JJ complications/NNS venous/NNS
midazolam/NN frequent/JJ complications/NNS
theophylline/NN fenoldopam/NN induced/VBN arteritis/NNS
fenoldopam/NN induced/VBN arteritis/NNS
theophylline/NN vasodilators/NNS induced/VBN Arteritis/NNS
fenoldopam/NN vasodilators/NNS induced/VBN Arteritis/NNS
streptozotocin/NN role/NN nephropathy/NN diabetic/JJ
streptozotocin/NN role/NN nephropathy/NN
streptozotocin/NN tissues/NNS using/VBG nephropathy/NN diabetic/JJ
streptozotocin/NN tissues/NNS using/VBG nephropathy/NN
streptozotocin/NN tissues/NNS patients/NNS diabetic/JJ
streptozotocin/NN tissues/NNS patients/NNS nephropathy/NN
streptozotocin/NN tissues/NNS model/NN diabetic/JJ
streptozotocin/NN tissues/NNS model/NN nephropathy/NN
streptozocin/NN crocin/NN L/NNP constituents/NNS Effects/NNPS model/NN disease/NN Alzheimer/NNP
streptozocin/NN crocin/NN L/NNP constituents/NNS Effects/NNPS model/NN disease/NN Alzheimer/NNP '/POS
streptozocin/NN crocin/NN L/NNP constituents/NNS Effects/NNPS model/NN disease/NN s/JJ
streptozocin/NN crocin/NN L/NNP constituents/NNS Effects/NNPS model/NN disease/NN
streptozocin/NN induced/VBN disease/NN Alzheimer/NNP
streptozocin/NN induced/VBN disease/NN Alzheimer/NNP '/POS
streptozocin/NN induced/VBN disease/NN s/JJ
streptozocin/NN induced/VBN disease/NN
STZ/NNP streptozocin/NN induced/VBN disease/NN Alzheimer/NNP
STZ/NNP streptozocin/NN induced/VBN disease/NN Alzheimer/NNP '/POS
STZ/NNP streptozocin/NN induced/VBN disease/NN s/JJ
STZ/NNP streptozocin/NN induced/VBN disease/NN
STZ/NNP injected/VBN groups/NNS Alzheimer/NNP
STZ/NNP injected/VBN groups/NNS Alzheimer/NNP '/POS
STZ/NNP injected/VBN groups/NNS s/JJ
STZ/NNP injected/VBN groups/NNS disease/NN
STZ/NN repeated/VBN injected/VBN groups/NNS Alzheimer/NNP
STZ/NN repeated/VBN injected/VBN groups/NNS Alzheimer/NNP '/POS
STZ/NN repeated/VBN injected/VBN groups/NNS s/JJ
STZ/NN repeated/VBN injected/VBN groups/NNS disease/NN
STZ/NNP caused/VBN deficits/NNS cognitive/JJ
STZ/NNP caused/VBN deficits/NNS
STZ/NNP caused/VBN deficits/NNS antagonizing/VBG demonstrate/VBP disease/NN potential/NN treatment/NN diseases/NNS Alzheimer/NNP
STZ/NNP caused/VBN deficits/NNS antagonizing/VBG demonstrate/VBP disease/NN potential/NN treatment/NN diseases/NNS Alzheimer/NNP '/POS
STZ/NNP caused/VBN deficits/NNS antagonizing/VBG demonstrate/VBP disease/NN s/VBZ
STZ/NNP caused/VBN deficits/NNS antagonizing/VBG demonstrate/VBP disease/NN
streptozotocin/NN caused/VBN function/NN reverse/VB mellitus/VBZ diabetes/NNP
streptozotocin/NN caused/VBN function/NN reverse/VB mellitus/VBZ
streptozotocin/NN function/VBP investigated/VBN rats/NNS diabetic/JJ
streptozotocin/NN diabetes/NNP
cocaine/NN use/NN delirium/JJ
cocaine/NN toxicity/NN mechanisms/NNS provide/VB Fatal/VB use/NN delirium/JJ
cocaine/NN induced/VBN delirium/NN
cocaine/NN induced/VBN delirium/NN EDDs/NNP
cocaine/NN registry/NN compared/VBN EDDs/NNS
cocaine/NN registry/NN compared/VBN delirium/NN
cocaine/NN overdose/NN victims/NNS compared/VBN EDDs/NNS
cocaine/NN overdose/NN victims/NNS compared/VBN delirium/NN
cocaine/NN concentrations/NNS had/VBD EDDs/NNS
cocaine/NN use/NN disrupts/VBZ precipitate/VB agitation/NN death/NN sudden/JJ
cocaine/NN use/NN disrupts/VBZ precipitate/VB agitation/NN death/NN
cocaine/NN use/NN coupled/VBN disrupts/VBZ precipitate/VB agitation/NN death/NN sudden/JJ
cocaine/NN use/NN coupled/VBN disrupts/VBZ precipitate/VB agitation/NN death/NN
cocaine/NN use/NN disrupts/VBZ precipitate/VB agitation/NN rhabdomyolysis/NNS
cocaine/NN use/NN coupled/VBN disrupts/VBZ precipitate/VB agitation/NN rhabdomyolysis/NNS
cocaine/NN use/NN disrupts/VBZ precipitate/VB agitation/NN delirium/NN
cocaine/NN use/NN coupled/VBN disrupts/VBZ precipitate/VB agitation/NN delirium/NN
cocaine/NN induce/VB sensitization/VB seizures/NNS
lidocaine/NN appearance/NN induced/VBN convulsions/NNS
lidocaine/NN appearance/NN induced/VBN convulsions/NNS
cocaine/NN that/DT decreased/VBN induced/VBN convulsions/NNS
cocaine/NN that/DT decreased/VBN induced/VBN appearance/NN induced/VBN convulsions/NNS
lidocaine/NN administration/NN reversed/VBD changes/NNS activity/NN convulsive/JJ
lidocaine/NN activity/NN convulsive/JJ
cocaine/NN lidocaine/NN activity/NN convulsive/JJ
lidocaine/JJ convulsions/NNS
lidocaine/JJ seizures/NNS
cocaine/NN administration/NN resulting/VBG kindling/VBG distinct/JJ have/VB sensitization/NN seizures/NNS
ACTH/NNP stimulation/NN dystonia/JJ
MSH/NNP ACTH/NNP stimulation/NN dystonia/JJ
succinylcholine/NN induced/VBN myalgia/NN postoperative/JJ
succinylcholine/NN induced/VBN myalgia/NN
succinylcholine/NN used/VBN proven/VBN agent/NN reduction/NN myalgia/NN postoperative/JJ
succinylcholine/NN used/VBN proven/VBN agent/NN reduction/NN myalgia/NN
corticosteroid/JJ therapy/NN resolved/VBN pressure/NN elevated/JJ
corticosteroid/JJ therapy/NN resolved/VBN pressure/NN intraocular/JJ
corticosteroid/JJ therapy/NN resolved/VBN pressure/NN
NH/IN 4/CD mmol/NN CL/NNP intraperitonealinjection/NN minutes/NNS rats/NNS produced/VBN coma/NNP
4/CD mmol/NN CL/NNP intraperitonealinjection/NN minutes/NNS rats/NNS produced/VBN coma/NNP
CL/NNP intraperitonealinjection/NN minutes/NNS rats/NNS produced/VBN coma/NNP
lignocaine/NN anaesthesia/NN syndrome/NN Cauda/NNP
lignocaine/NN anaesthesia/NN syndrome/NN equina/NN
lignocaine/NN anaesthesia/NN syndrome/NN
lignocaine/NN anaesthesia/NN syndrome/NN review/NN cases/NNS syndrome/NN cauda/NN
lignocaine/NN anaesthesia/NN syndrome/NN review/NN cases/NNS syndrome/NN equina/NN
lignocaine/NN anaesthesia/NN syndrome/NN review/NN cases/NNS syndrome/NN
carboplatin/NN dose/NN using/VBG induced/VBN Anemia/NNP
carboplatin/NN application/NN days/NNS administered/VBN rHuEPO/NN prevented/VBN development/NN anemia/NN
cidofovir/NN Use/NN associated/VBN failure/NN progressive/JJ
cidofovir/NN Use/NN associated/VBN failure/NN renal/JJ
cidofovir/NN Use/NN associated/VBN failure/NN
cidofovir/NN Use/NN associated/VBN failure/NN neutropenia/NN
Nicotine/JJ potentiation/NN catalepsy/NN
morphine/NN potentiation/NN catalepsy/NN
nicotine/NN catalepsy/NN
morphine/NN induced/VBN catalepsy/NN
nicotine/NNS Morphine/NNS induced/VBN dose/NN catalepsy/JJ
Morphine/NNS induced/VBN dose/NN catalepsy/JJ
nicotine/NN reduced/VBD induced/NNS catalepsy/JJ
morphine/NN combination/NN reduced/VBD induced/NNS catalepsy/JJ
nicotine/NNP morphine/NNP induced/VBN catalepsy/RB
morphine/NNP induced/VBN catalepsy/RB
nicotine/NN induced/VBN morphine/NN potentiation/NN mediated/VBN concluded/VBN elicited/VBN catalepsy/NN
morphine/JJ catalepsy/NN
morphine/NN potentiation/NN mediated/VBN concluded/VBN elicited/VBN catalepsy/NN
N/NNP rats/NNS Production/NN cancer/NN prostate/NN
N/NNP rats/NNS Production/NN cancer/NN
nitroso/NN rats/NNS Production/NN cancer/NN prostate/NN
nitroso/NN rats/NNS Production/NN cancer/NN
N/NNP rats/NNS Production/NN cancer/NN prostate/NN
N/NNP rats/NNS Production/NN cancer/NN
methylurea/NN rats/NNS Production/NN cancer/NN prostate/NN
methylurea/NN rats/NNS Production/NN cancer/NN
N/NNP treatments/NNS adenocarcinomas/NNS prostate/NN
N/NNP treatments/NNS adenocarcinomas/NNS
nitroso/NN treatments/NNS adenocarcinomas/NNS prostate/NN
nitroso/NN treatments/NNS adenocarcinomas/NNS
N/NNP treatments/NNS adenocarcinomas/NNS prostate/NN
N/NNP treatments/NNS adenocarcinomas/NNS
methylurea/NN treatments/NNS adenocarcinomas/NNS prostate/NN
methylurea/NN treatments/NNS adenocarcinomas/NNS
N/NNP treatments/NNS adenocarcinomas/NNS PAs/NNP
nitroso/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
N/NNP treatments/NNS adenocarcinomas/NNS PAs/NNP
methylurea/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS prostate/NN
testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS
propionate/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS prostate/NN
propionate/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS
testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
propionate/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
TP/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS prostate/NN
TP/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS
TP/NNP CAS/NNP testosterone/NN methylurea/NN treatments/NNS adenocarcinomas/NNS PAs/NNP
TP/NNP treated/VBN PA/VBP
TP/NNP acted/VBD development/NN cancer/NN prostate/NN
TP/NNP acted/VBD development/NN cancer/NN
alfentanil/JJ anesthesia/NN rigidity/NN muscle/NN
alfentanil/JJ anesthesia/NN rigidity/NN
alfentanil/JJ prevented/VBN MED/NNP D/NNP induced/VBN rigidity/NN muscle/NN
alfentanil/JJ prevented/VBN MED/NNP D/NNP induced/VBN rigidity/NN
levodopa/NN dyskinesias/NNS
Etoposide/NNP infarction/NN myocardial/JJ
Etoposide/NNP infarction/NN
etoposide/NN containing/VBG reported/VBN occurrence/NN infarction/NN myocardial/JJ
etoposide/NN containing/VBG reported/VBN occurrence/NN infarction/NN
tobramycin/NN netilmicin/NN treated/VBN patients/NNS proportion/NN occurred/VBD Nephrotoxicity/NNP
netilmicin/NN treated/VBN patients/NNS proportion/NN occurred/VBD Nephrotoxicity/NNP
piperacillin/NN netilmicin/NN four/CD occurred/VBD Ototoxicity/NNP
piperacillin/NN tobramycin/NN occurred/VBD Ototoxicity/NNP
tobramycin/NN occurred/VBD Ototoxicity/NNP
netilmicin/NN four/CD occurred/VBD Ototoxicity/NNP
tobramycin/NN severe/JJ ototoxicity/RB
netilmicin/NN severe/JJ ototoxicity/RB
fenoldopam/NN induced/VBN hypotension/NN
fenoldopam/NN used/VBN induce/VB hypotension/NN
fenoldopam/NN induced/VBN +/NNS hypotension/JJ
fenoldopam/NN increased/VBN flow/NN hypotension/NN
nitroprusside/NN cent/NN 8/CD flow/NN increased/VBN fenoldopam/NN induced/VBN +/NNS hypotension/JJ
nitroprusside/NN cent/NN 8/CD flow/NN hypotension/NN
nitroprusside/NNP non/NN arteriolar/NN produce/VB kidney/NN hypotension/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN infarction/NN stroke/NN
inhibitors/NNS treatment/NN failure/NN infarction/NN stroke/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN myocardial/JJ
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN infarction/NN
inhibitors/NNS treatment/NN failure/NN myocardial/JJ
inhibitors/NNS treatment/NN failure/NN infarction/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN infarction/NN hypertension/NN
inhibitors/NNS treatment/NN failure/NN infarction/NN hypertension/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN infarction/NN heart/NN
cyclooxygenase/JJ inhibitors/NNS treatment/NN failure/NN
inhibitors/NNS treatment/NN failure/NN infarction/NN heart/NN
inhibitors/NNS treatment/NN failure/NN
pilocarpine/NN neurons/NNS containing/VBG induced/VBN seizures/NNS
pilocarpine/NN injected/VBN studied/VBN 1/CD seizures/NNS
pilocarpine/NN intervals/NNS 1/CD seizures/NNS
digitalis/NN stage/VB induced/VBN arrhythmias/NNS ventricular/NN
digitalis/NN stage/VB induced/VBN arrhythmias/NNS
digitalis/NN stage/VB induced/VBN two/CD Using/VBG examined/VBN determined/VBN concentration/NN model/NN arrhythmia/NN
adrenaline/VB stage/VB induced/VBN arrhythmias/NNS ventricular/NN
adrenaline/VB stage/VB induced/VBN arrhythmias/NNS
adrenaline/VB stage/VB induced/VBN two/CD Using/VBG examined/VBN determined/VBN concentration/NN model/NN arrhythmia/NN
digitalis/NN ligation/NN concentrations/NNS arrhythmias/NNS
digitalis/NN ligation/NN concentrations/NNS arrhythmias/NNS
adrenaline/NN concentrations/NNS arrhythmias/NNS
adrenaline/NN concentrations/NNS arrhythmias/NNS
adrenaline/NN concentration/NN higher/JJR arrhythmia/NNP
adrenaline/NN concentration/NN higher/JJR those/DT types/NNS arrhythmias/NNS
scopolamine/NN model/NN amnesia/NN
scopolamine/NN amnesia/NN
levodopa/JJ dyskinesias/NNS
mannitol/JJ lower/JJR elevated/VBD
mannitol/JJ lower/JJR elevated/VBD ICP/NNP
cyclosporine/NN showed/VBD decrease/NN therapy/NN secondary/JJ nephrotoxicity/RB
cyclosporine/NN dosages/NNS cause/VB nephrotoxicity/NN
M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN
M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN of/IN
M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN food/NN
M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN
T/NNP M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN
T/NNP M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN of/IN
T/NNP M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN food/NN
T/NNP M/NNP %/NN groups/NNS treated/VBN steroid/NN showed/VBD reduction/NN intake/NN
T/NNP showed/VBD IIa/NNS atrophy/JJ
T/NNP showed/VBD IIa/NNS atrophy/RB
T/NNP C/NNP rats/NNS performed/VBN study/NN showed/VBD pronounced/JJ atrophy/NN muscle/NN
T/NNP C/NNP rats/NNS performed/VBN study/NN showed/VBD pronounced/JJ atrophy/NN
T/NNP pronounced/JJ atrophy/NN muscle/NN
T/NNP pronounced/JJ atrophy/NN
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/NN induced/VBN catalepsy/NN
Haloperidol/NNP challenged/VBN catalepsy/RB
haloperidol/NN injections/NNS previous/JJ attenuated/VBD catalepsy/NN
haloperidol/NN mechanisms/NNS glutamate/NN induced/VBN catalepsy/RB
Acetazolamide/NNP induced/VBN syndrome/NN Gerstmann/JJ
Acetazolamide/NNP induced/VBN syndrome/NN
acetazolamide/NN case/NN report/VBP induced/VBN syndrome/NN Gerstmann/JJ
acetazolamide/NN case/NN report/VBP induced/VBN syndrome/NN
oral/JJ contraception/NN associated/VBN Chorea/NNP
contraception/NN associated/VBN Chorea/NNP
oral/JJ contraceptives/NNS receiving/VBG developed/VBD chorea/NN
contraceptives/NNS receiving/VBG developed/VBD chorea/NN
amphetamine/NN induced/VBN chorea/NN
oral/JJ contraception/NN induced/VBN chorea/NN
contraception/NN induced/VBN chorea/NN
azithromycin/NN associated/VBN hiccups/NNS
azithromycin/NN therapy/NN associated/VBN hiccups/NNS
azithromycin/NN beginning/VBG presented/VBN hiccups/NNS
azithromycin/NN Discontinuation/NNP resolved/VBD hiccups/NNS
baclofen/NN azithromycin/NN Discontinuation/NNP resolved/VBD hiccups/NNS
azithromycin/NN mediated/VBN mechanism/NN pathogenesis/NNS hiccups/NNS
Ketamine/NNP elicited/VBD psychosis/NNS
warfarin/NN trends/NNS hemorrhage/NN
warfarin/NN incidence/NN bleeding/NN
haloperidol/NN induced/VBN rigidity/NN Muscle/JJ
haloperidol/NN induced/VBN rigidity/NN
haloperidol/NN rigidity/NN muscle/NN
haloperidol/NN rigidity/NN
valsartan/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
valsartan/NN %/NN %/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
amlodipine/JJ group/NN higher/JJR incidence/NN drug/NN edema/NN
amlodipine/NN %/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
amlodipine/NN %/NN %/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
amlodipine/NN %/NN %/NN day/NN mg/NN dose/NN higher/JJR incidence/NN drug/NN edema/NN
CLZ/NNP ingestion/NN accompanying/VBG flush/NN nausea/NN
CLZ/NNP ingestion/NN accompanying/VBG duration/NN headache/NN
CLZ/NNP ingestion/NN accompanying/VBG flush/NN facial/JJ
CLZ/NNP ingestion/NN accompanying/VBG flush/NN
5/CD flourouracil/NN induced/VBN syndrome/NN apical/JJ
5/CD flourouracil/NN induced/VBN syndrome/NN ballooning/VBG
5/CD flourouracil/NN induced/VBN syndrome/NN
flourouracil/NN induced/VBN syndrome/NN apical/JJ
flourouracil/NN induced/VBN syndrome/NN ballooning/VBG
flourouracil/NN induced/VBN syndrome/NN
fentanyl/NN neurotransmission/NN Involvement/NNP rigidity/NN muscular/JJ
fentanyl/NN neurotransmission/NN Involvement/NNP rigidity/NN
fentanyl/JJ anesthesia/NN dose/NN effect/NN well/NN rigidity/NN muscular/JJ
fentanyl/JJ anesthesia/NN dose/NN effect/NN well/NN rigidity/NN
fentanyl/NN rigidity/NN muscular/JJ
fentanyl/NN rigidity/NN
iohexol/NN study/NN comparing/VBG effects/NNS nephrotoxic/JJ
Isoproterenol/NNP induces/VBZ loss/NN correlation/NN injury/NN myocardial/JJ
Isoproterenol/NNP induces/VBZ loss/NN correlation/NN injury/NN
isoproterenol/NN demand/NN unknown/JJ damage/NN myocardial/JJ
isoproterenol/NN demand/NN unknown/JJ damage/NN
isoproterenol/NN demand/NN hypotension/NN hyperactivity/NN myocardial/JJ
isoproterenol/NN demand/NN hypotension/NN hyperactivity/NN
isoproterenol/NN induced/VBN injury/NN integrity/NN alterations/NNS explain/VBP changes/NNS related/VBN injury/NN ischaemic/JJ
isoproterenol/NN induced/VBN injury/NN integrity/NN alterations/NNS explain/VBP changes/NNS related/VBN injury/NN
fluocinolone/JJ implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN elevated/JJ
fluocinolone/JJ implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN intraocular/JJ
fluocinolone/JJ implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN
acetonide/NN implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN elevated/JJ
acetonide/NN implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN intraocular/JJ
acetonide/NN implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN
FA/NNP implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN elevated/JJ
FA/NNP implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN intraocular/JJ
FA/NNP implant/NN treated/VBN uveitis/NNS patients/NNS report/VB incidence/NN pressure/NN
haloperidol/NN antagonist/NN beta/NN induced/VBN catalepsy/RB
haloperidol/NN induced/VBN catalepsy/RB
haloperidol/NN induced/VBN catalepsy/RB
DFP/NNP TOTP/NNP given/VBN chickens/NNS exacerbated/VBD induced/VBN neuropathy/JJ
TOTP/NNP effects/NNS had/VBN corticosterone/NN concentrations/NNS induced/VBN neuropathy/JJ
TOTP/NNP given/VBN chickens/NNS exacerbated/VBD induced/VBN neuropathy/JJ
DFP/NNP TOTP/NNP evident/JJ fibers/NNS Degenerating/VBG
DFP/NNP TOTP/NNP evident/JJ fibers/NNS myelinated/JJ
DFP/NNP TOTP/NNP evident/JJ fibers/NNS
TOTP/NNP evident/JJ fibers/NNS Degenerating/VBG
TOTP/NNP evident/JJ fibers/NNS myelinated/JJ
TOTP/NNP evident/JJ fibers/NNS
carbon/NN tetrachloride/NN effects/NNS hepatotoxic/JJ
tetrachloride/NN effects/NNS hepatotoxic/JJ
CCl/NNP tetrachloride/NN effects/NNS hepatotoxic/JJ
4/CD CCl/NNP tetrachloride/NN effects/NNS hepatotoxic/JJ
acetaminophen/CD CHCl/NNP CCl/NNP effects/NNS hepatotoxic/JJ
CCl/NNP effects/NNS hepatotoxic/JJ
4/CD CCl/NNP effects/NNS hepatotoxic/JJ
CHCl/NNP CCl/NNP effects/NNS hepatotoxic/JJ
3/CD CHCl/NNP CCl/NNP effects/NNS hepatotoxic/JJ
galactosamine/NN CCl/NNP effects/NNS hepatotoxic/JJ
adriamycin/NN administration/NN effect/NN cardiotoxic/JJ
galactosamine/JJ hepatotoxicity/NN
streptomycin/NN edaravone/NN effect/NN vestibulotoxicity/NN
streptomycin/NN induced/VBN vestibulotoxicity/RB
streptomycin/NN induced/VBN vestibulotoxicity/RB
indomethacin/NN misoprostol/NN effect/NN induced/VBN dysfunction/NN renal/JJ
indomethacin/NN misoprostol/NN effect/NN induced/VBN dysfunction/NN
indomethacin/NN dysfunction/NN renal/JJ
indomethacin/NN dysfunction/NN
cyclosporine/NN nephrotoxicity/NN
cyclosporine/NN role/NN role/NN' combination/NN chemotherapeutics/NNS development/NN toxicity/NN renal/JJ
cyclosporine/NN role/NN role/NN' combination/NN chemotherapeutics/NNS development/NN toxicity/NN
CSA/NNP cyclosporine/NN role/NN role/NN' combination/NN chemotherapeutics/NNS development/NN toxicity/NN renal/JJ
CSA/NNP cyclosporine/NN role/NN role/NN' combination/NN chemotherapeutics/NNS development/NN toxicity/NN
CSA/NNP administration/NN potential/NN nephrotoxic/JJ
CSA/NNP toxicity/NN aggravate/VB administration/NN potential/NN nephrotoxic/JJ
CSA/NNP increased/VBD nephrotoxicity/RB
CSA/NNP induced/VBN nephrotoxicity/NN
levodopa/NN Tiapride/NNP movements/NNS involuntary/JJ
levodopa/NN Tiapride/NNP movements/NNS
levodopa/NN Tiapride/NNP induced/VBN movements/NNS involuntary/JJ
levodopa/NN Tiapride/NNP induced/VBN movements/NNS
levodopa/NN dyskinesias/NNS
Aspirin/NNP induces/VBZ anomalies/NNS developmental/JJ
Aspirin/NNP induces/VBZ anomalies/NNS
acetylsalicylic/JJ -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS developmental/JJ
acetylsalicylic/JJ -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS
acid/NNP -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS developmental/JJ
acid/NNP -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS
ASA/NNP -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS developmental/JJ
ASA/NNP -RSB-/NNP Aspirin/NNP induces/VBZ anomalies/NNS
ASA/NNP administered/VBN strains/NNS Dawley/NNP Sprague/NNP results/NNS compare/VB test/VB confounds/VBZ detection/NN malformations/NNS
ASA/NNP malformations/NNS
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS ventricular/NN
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS septal/NN
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS VSDs/NNP
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS VSDs/NNP
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS defects/NNS rats/NNS hernia/NN diaphragmatic/JJ
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS defects/NNS rats/NNS hernia/NN
ASA/NNP induces/VBZ focused/VBD suggested/VBD induce/VB defects/NNS defects/NNS rats/NNS DH/NNP
ASA/NNP induces/VBZ focused/VBD malformations/NNS
ASA/NNP induces/VBZ low/NN malformations/NNS
ASA/NNP administered/VBN similar/JJ Variations/NNS malformations/NNS
ASA/NNP induced/VBN titrating/VBG dose/NN achieve/VB dose/NN malformations/NNS
haloperidol/NN doses/NNS higher/JJR incidence/NN parkinsonism/NN
dexmedetomidine/JJ sedation/NN associated/VBN incidence/NN bradycardia/NN
sulindac/JJ group/NN experienced/VBD loss/NN hearing/NN
sulindac/JJ group/NN experienced/VBD loss/NN
oral/JJ contraceptives/NNS women/NNS liver/NN hyperplasia/NN focal/JJ
oral/JJ contraceptives/NNS women/NNS liver/NN hyperplasia/NN nodular/NN
oral/JJ contraceptives/NNS women/NNS liver/NN hyperplasia/NN
contraceptives/NNS women/NNS liver/NN hyperplasia/NN focal/JJ
contraceptives/NNS women/NNS liver/NN hyperplasia/NN nodular/NN
contraceptives/NNS women/NNS liver/NN hyperplasia/NN
oral/JJ contraceptives/NNS women/NNS liver/NN hyperplasia/NN adenomas/NNS
contraceptives/NNS women/NNS liver/NN hyperplasia/NN adenomas/NNS
oral/JJ contraceptives/NNS use/NN associated/VBN hyperplasia/NN focal/JJ
oral/JJ contraceptives/NNS use/NN associated/VBN hyperplasia/NN nodular/NN
oral/JJ contraceptives/NNS use/NN associated/VBN hyperplasia/NN
contraceptives/NNS use/NN associated/VBN hyperplasia/NN focal/JJ
contraceptives/NNS use/NN associated/VBN hyperplasia/NN nodular/NN
contraceptives/NNS use/NN associated/VBN hyperplasia/NN
oral/JJ contraceptives/NNS use/NN associated/VBN hyperplasia/NN one/CD adenoma/NN
contraceptives/NNS use/NN associated/VBN hyperplasia/NN one/CD adenoma/NN
suprofen/NN epidemiology/NN syndrome/NN flank/NN
suprofen/NN epidemiology/NN syndrome/NN pain/NN
CGS/NNP agonist/NN manner/NN induced/VBN responses/NNS cataleptic/JJ
21680/CD CGS/NNP agonist/NN manner/NN induced/VBN responses/NNS cataleptic/JJ
reserpine/NN induced/VBN' induced/VBN catalepsy/NN
haloperidol/NN induced/VBN catalepsy/NN
methamphetamine/NN associated/VBN gene/NN psychosis/NNS
methamphetamine/NN psychosis/NNS
METH/NNP methamphetamine/NN psychosis/NNS
METH/NNP gene/NN 5/CD induced/VBN psychosis/NNS
METH/NNS patients/NNS psychosis/NNS
METH/NNP associated/VBN rs/NN RESULTS/NNS patients/NNS psychosis/NNS
METH/CD HTR/NNP association/NN psychosis/NNS
METH/NNP pathophysiology/NN play/VB HTR/NNP CONCLUSION/NNP psychosis/NNS
ketamine/NN induced/VBN tachycardia/NN
sulpiride/NN induced/VBN catalepsy/RB
fluphenazine/NN sulpiride/NN induced/VBN catalepsy/RB
SCH/NNP 23390/NNS fluphenazine/NN sulpiride/NN induced/VBN catalepsy/RB
23390/NNS fluphenazine/NN sulpiride/NN induced/VBN catalepsy/RB
sulpiride/NN Combination/NNP induce/VB potentiation/NN catalepsy/JJ
SCH/NNP Combination/NNP induce/VB potentiation/NN catalepsy/JJ
23390/CD SCH/NNP Combination/NNP induce/VB potentiation/NN catalepsy/JJ
sulpiride/NN fluphenazine/NN induced/VBN catalepsy/NN
fluphenazine/NN induced/VBN catalepsy/NN
SCH/NNP fluphenazine/NN induced/VBN catalepsy/NN
23390/CD SCH/NNP fluphenazine/NN induced/VBN catalepsy/NN
tacrolimus/NNS induced/VBN hypertrophy/NN myocardial/JJ
tacrolimus/NNS induced/VBN hypertrophy/NN
tacrolimus/NNS induced/VBN Herein/NNP describe/VBP myocardial/NN
tacrolimus/NNS induced/VBN hypertrophy/RB
tacrolimus/NNS concentration/NN reducing/VBG resolved/VBD hypertrophy/NN Myocardial/JJ
tacrolimus/NNS concentration/NN reducing/VBG resolved/VBD hypertrophy/NN
tacrolimus/NNS induces/VBZ hypertrophy/NN myocardial/JJ
tacrolimus/NNS induces/VBZ hypertrophy/NN
dobutamine/NN glucagon/NN induced/VBN ischemia/NN myocardial/JJ
dobutamine/NN glucagon/NN induced/VBN ischemia/NN
dobutamine/JJ testing/NN attenuates/VBZ evidence/NN ischemia/NN myocardial/JJ
dobutamine/JJ testing/NN attenuates/VBZ evidence/NN ischemia/NN
gold/NN caused/VBN anemia/NN aplastic/JJ
gold/NN caused/VBN anemia/NN
D/NNP case/NN caused/VBN anemia/NN aplastic/JJ
D/NNP case/NN caused/VBN anemia/NN
penicillamine/NN anemia/NN aplastic/JJ
penicillamine/NN anemia/NN
mepivacaine/VB seen/VBN addition/NN damage/NN muscle/NN
mepivacaine/VB seen/VBN addition/NN damage/NN
lidocaine/VB mepivacaine/VB seen/VBN addition/NN damage/NN muscle/NN
lidocaine/VB mepivacaine/VB seen/VBN addition/NN damage/NN
dipyridamole/NN hyperemia/NN
dipyridamole/NN resulted/VBD stenosis/NNS hyperemia/NN
dipyridamole/NN analyzed/VBD demonstrated/VBD Thallium/NNP induced/VBN hyperemia/NN
aspirin/NN users/NNS users/NNS higher/JJR risk/NN Thrombotic/JJ
aspirin/NN nonusers/NNS higher/JJR risk/NN Thrombotic/JJ
bromocriptine/NN induced/VBN psychosis/NNS
bromocriptine/JJ received/VBN seen/VBN psychosis/NNS
Bromocriptine/NNP associated/VBN psychosis/NNS
bromocriptine/NN cause/VB psychosis/NNS
nitric/JJ oxide/NN levels/NNS gene/NN headache/NN
oxide/NN levels/NNS gene/NN headache/NN
nitric/JJ oxide/NN induced/VBN headache/NN
oxide/NN induced/VBN headache/NN
NO/RB oxide/NN induced/VBN headache/NN
glyceryl/JJ trinitrate/NN induced/VBN headache/NN
trinitrate/NN induced/VBN headache/NN
GTN/NNP trinitrate/NN induced/VBN headache/NN
NO/DT donor/NN glyceryl/JJ trinitrate/NN induced/VBN headache/NN
GTN/NNP headache/NN
GTN/NNP day/NN developed/VBD headache/NN
GTN/NNP day/NN developed/VBD pronounced/JJ headache/NN
NO/DT headache/NN
Levodopa/NNP induced/VBN dystonia/NN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN of/IN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN inappropriate/JJ
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN hormone/NN of/IN
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
sodium/NN Contribution/NNP valproate/VBP syndrome/NN secretion/NN hormone/NN
valproate/VBP syndrome/NN
valproate/VBP syndrome/NN secretion/NN of/IN
valproate/VBP syndrome/NN secretion/NN inappropriate/JJ
valproate/VBP syndrome/NN secretion/NN
valproate/VBP syndrome/NN secretion/NN hormone/NN of/IN
valproate/VBP syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
valproate/VBP syndrome/NN secretion/NN hormone/NN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN of/IN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN inappropriate/JJ
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN of/IN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN
valproate/NN administered/VBN developed/VBD syndrome/NN
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN of/IN
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN inappropriate/JJ
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN of/IN
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN
sodium/NN valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN SIADH/NNP
valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN SIADH/NNP
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN of/IN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN inappropriate/JJ
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN of/IN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN antidiuretic/JJ
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN
VPA/NNP valproate/NN administered/VBN developed/VBD syndrome/NN secretion/NN hormone/NN SIADH/NNP
VPA/NNP administration/NN consider/VBP episode/NN SIADH/NNP
furosemide/NN pretreated/VBD function/NN Renal/JJ
furosemide/NN pretreated/VBD function/NN
furosemide/NN pretreated/VBD function/NN deteriorated/VBN significantly/RB
furosemide/NN pretreated/VBD function/NN deteriorated/VBN
cocaine/NN Stroke/NNP
amphetamine/NN cocaine/NN Stroke/NNP
cocaine/NN use/NN stroke/NN
amphetamine/NN cocaine/NN use/NN stroke/NN
cocaine/NN stroke/NN
amphetamine/NN cocaine/NN stroke/NN
cocaine/NN 8/CD using/VBG admitted/VBD women/NNS matched/VBD ratio/NN stroke/NN
amphetamine/NN //NN cocaine/NN 8/CD using/VBG admitted/VBD women/NNS matched/VBD ratio/NN stroke/NN
cocaine/NN use/NN factor/NN stroke/NN
amphetamine/NN cocaine/NN use/NN factor/NN stroke/NN
pyrazinamide/NN induced/VBN dysosmia/NNP
pyrazinamide/VB related/VBN disorder/NN olfactory/NN
pyrazinamide/VB related/VBN disorder/NN
pyrazinamide/JJ withdrawal/NN disappeared/VBD Dysosmia/NNP
lovastatin/NN dose/NN associated/VBN rare/JJ Myopathy/RB
levodopa/NN exhibit/VB primed/VBN induced/VBN dyskinesias/NNS
levodopa/NN exhibit/VB primed/VBN induced/VBN evaluate/VB locomotor/NN effects/NNS dyskinetic/JJ
levodopa/NNP induced/VBN MPTP/NNP alleviating/VBG efficacious/JJ induced/VBN dyskinesias/NNS
levodopa/NN reproduce/VB likely/JJ efficacious/JJ induced/VBN dyskinesias/NNS
levodopa/NN challenge/NN 171555/CD 86929/CD efficacious/JJ induced/VBN dyskinesias/NNS
MPTP/NNP induced/VBN parkinsonism/NN
capsaicin/NN elicited/VBD pain/NN
capsaicin/NN amount/NN administered/VBN evoke/VB sensation/NN painful/JJ
fluoxetine/JJ prenatally/NN increases/VBZ prevalence/NN syndrome/NN pulmonary/JJ
fluoxetine/JJ prenatally/NN increases/VBZ prevalence/NN syndrome/NN hypertension/NN
fluoxetine/JJ prenatally/NN increases/VBZ prevalence/NN syndrome/NN
fluoxetine/NN effect/NN pulmonary/JJ
fluoxetine/NN effect/NN hypertension/NN
fluoxetine/JJ exposure/NN induces/VBZ hypertension/NN pulmonary/JJ
fluoxetine/JJ exposure/NN induces/VBZ hypertension/NN
ketoprofen/NN administration/NN decreased/VBD aggregation/NN platelet/NN
ketoprofen/NN administration/NN decreased/VBD aggregation/NN
ketoprofen/NN group/NN patient/NN developed/VBD hematoma/NN
risperidone/NN syndrome/NN Neuroleptic/JJ
risperidone/NN syndrome/NN malignant/JJ
risperidone/NN syndrome/NN
risperidone/NN developed/VBD syndrome/NN neuroleptic/JJ
risperidone/NN developed/VBD syndrome/NN malignant/JJ
risperidone/NN developed/VBD syndrome/NN
risperidone/NN observed/VBN effects/NNS protection/NN ensure/VB syndrome/NN neuroleptic/JJ
risperidone/NN observed/VBN effects/NNS protection/NN ensure/VB syndrome/NN malignant/JJ
risperidone/NN observed/VBN effects/NNS protection/NN ensure/VB syndrome/NN
Quinidine/JJ phenylethylbarbiturate/NN induced/VBN hepatitis/NN
phenylethylbarbiturate/NN induced/VBN hepatitis/NN
quinidine/JJ phenylethylbarbiturate/NN administration/NN year/NN patient/NN affected/VBN hepatitis/NN
phenylethylbarbiturate/NN administration/NN year/NN patient/NN affected/VBN hepatitis/NN
phenylethylbarbiturate/NN itself/PRP responsible/JJ hepatitis/NN
cytosine/NN treatment/NN neuropathy/NN Peripheral/JJ
cytosine/NN treatment/NN neuropathy/NN
arabinoside/NN treatment/NN neuropathy/NN Peripheral/JJ
arabinoside/NN treatment/NN neuropathy/NN
cytosine/NN arabinoside/NN therapy/NN play/VB unclear/JJ mechanisms/NNS neuropathy/NN peripheral/JJ
cytosine/NN arabinoside/NN therapy/NN play/VB unclear/JJ mechanisms/NNS neuropathy/NN
arabinoside/NN therapy/NN play/VB unclear/JJ mechanisms/NNS neuropathy/NN peripheral/JJ
arabinoside/NN therapy/NN play/VB unclear/JJ mechanisms/NNS neuropathy/NN
Sorafenib/NNP induced/VBN due/JJ spasm/NN coronary/JJ
Sorafenib/NNP induced/VBN due/JJ spasm/NN artery/NN
Sorafenib/NNP induced/VBN due/JJ spasm/NN
sorafenib/NN induced/VBN spasm/NN coronary/JJ
sorafenib/NN induced/VBN spasm/NN artery/NN
sorafenib/NN induced/VBN spasm/NN
acetaminophen/NN overdose/NN failure/NN associated/VBN edema/NN cerebral/JJ
acetaminophen/NN overdose/NN failure/NN associated/VBN edema/NN
acetaminophen/NN overdose/NN failure/NN hepatic/JJ
acetaminophen/NN overdose/NN failure/NN
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN signs/NNS edema/NN cerebral/JJ
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN signs/NNS edema/NN
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN fulminant/JJ
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN hepatic/JJ
acetaminophen/NN patient/NN present/VBP induced/VBN unresponsive/JJ failure/NN
D/NNP treated/VBN cirrhosis/NNS case/NN polymyositis/NNS
penicillamine/VBP case/NN polymyositis/NNS
D/NNP complications/NNS one/CD develop/VB Polymyositis/NNS
penicillamine/VBP Polymyositis/NNS
D/NNP receiving/VBG developed/VBD polymyositis/NNS
penicillamine/JJ therapy/NN D/NNP receiving/VBG developed/VBD polymyositis/NNS
D/NNP followed/VBN polymyositis/NNS
penicillamine/JJ therapy/NN followed/VBN polymyositis/NNS
salbutamol/NN triggered/VBN tachyarrhythmia/NN atrial/JJ
salbutamol/NN triggered/VBN tachyarrhythmia/NN
Salbutamol/NNP presented/VBN trigger/NN SIAT/NNP
alcohol/NN impairment/NN growth/NN
alcohol/NN impairment/NN
alcohol/NN recognition/NN resulted/VBD growth/NN reduced/JJ
alcohol/NN recognition/NN resulted/VBD growth/NN cerebellar/NN
alcohol/NN recognition/NN resulted/VBD growth/NN
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN decreased/VBN
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN growth/NN to/TO
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN growth/NN body/NN
alcohol/NN recognition/NN resulted/VBD growth/NN cranial/NN growth/NN
imipenem/JJ cilastatin/NN doses/NNS receiving/VBG developed/VBD seizures/NNS
//JJ cilastatin/NN doses/NNS receiving/VBG developed/VBD seizures/NNS
cilastatin/NN doses/NNS receiving/VBG developed/VBD seizures/NNS
oral/JJ contraceptives/NNS associated/VBN factors/NNS pathogenesis/NNS tumors/NNS liver/NN
oral/JJ contraceptives/NNS associated/VBN factors/NNS pathogenesis/NNS tumors/NNS
contraceptives/NNS associated/VBN factors/NNS pathogenesis/NNS tumors/NNS liver/NN
contraceptives/NNS associated/VBN factors/NNS pathogenesis/NNS tumors/NNS
oral/JJ steroids/NNS using/VBG seen/VBN tumors/NNS liver/NN
oral/JJ steroids/NNS using/VBG seen/VBN tumors/NNS
contraceptive/JJ steroids/NNS using/VBG seen/VBN tumors/NNS liver/NN
contraceptive/JJ steroids/NNS using/VBG seen/VBN tumors/NNS
Oral/NNP Contraceptives/NNP Associated/NNP Liver/NNP
Oral/NNP Contraceptives/NNP Associated/NNP Tumors/NNPS
Contraceptives/NNP Associated/NNP Liver/NNP
Contraceptives/NNP Associated/NNP Tumors/NNPS
digoxin/NN administration/NN assessment/NN dysfunction/NN sexual/JJ
digoxin/NN administration/NN assessment/NN dysfunction/NN
lithium/NN therapy/NN secondary/JJ block/VBP atrioventricular/NN
lithium/NN therapy/NN secondary/JJ block/VBP
lithium/NN effects/NNS reported/VBN dysfunction/NN Sinus/JJ
lithium/NN effects/NNS reported/VBN dysfunction/NN node/NN
lithium/NN effects/NNS reported/VBN dysfunction/NN
lithium/NN therapy/NN secondary/JJ developed/VBN attacks/NNS block/VBP atrioventricular/NN
lithium/NN therapy/NN secondary/JJ developed/VBN attacks/NNS block/VBP atrioventricular/NN AV/NNP
lithium/NN therapy/NN secondary/JJ developed/VBN attacks/NNS block/VBP
vancomycin/NN aminoglycoside/NN receiving/VBG patients/NNS confined/VBN occurred/VBD Thrombophlebitis/NNS
vancomycin/NN aminoglycoside/NN receiving/VBG patients/NNS confined/VBN nephrotoxicity/NN ototoxicity/NN
6/CD caused/VBN disease/NN veno/NN Hepatic/JJ
6/CD caused/VBN disease/NN veno/NN
6/CD caused/VBN disease/NN occlusive/JJ
6/CD caused/VBN disease/NN
thioguanine/VBP veno/NN Hepatic/JJ
thioguanine/VBP veno/NN
thioguanine/VBP veno/NN disease/NN occlusive/JJ
thioguanine/VBP veno/NN disease/NN
6/CD man/NN year/NN developed/VBN liver/NN disease/NN veno/NN
6/CD man/NN year/NN developed/VBN liver/NN disease/NN occlusive/JJ
6/CD man/NN year/NN developed/VBN liver/NN disease/NN
6/CD man/NN year/NN developed/VBN liver/NN of/IN
6/CD man/NN year/NN developed/VBN liver/NN the/DT
6/CD man/NN year/NN developed/VBN liver/NN
thioguanine/VBN year/NN developed/VBN liver/NN disease/NN veno/NN
thioguanine/VBN year/NN developed/VBN liver/NN disease/NN occlusive/JJ
thioguanine/VBN year/NN developed/VBN liver/NN disease/NN
thioguanine/VBN year/NN developed/VBN liver/NN of/IN
thioguanine/VBN year/NN developed/VBN liver/NN the/DT
thioguanine/VBN year/NN developed/VBN liver/NN
6/CD related/VBN occlusive/NN case/NN presented/VBD observe/VB features/NNS veno/NN hepatic/JJ
6/CD related/VBN occlusive/NN case/NN presented/VBD observe/VB features/NNS veno/NN
6/CD related/VBN occlusive/NN case/NN presented/VBD observe/VB features/NNS veno/NN disease/NN occlusive/JJ
6/CD related/VBN occlusive/NN case/NN presented/VBD observe/VB features/NNS veno/NN disease/NN
thioguanine/JJ case/NN presented/VBD observe/VB features/NNS veno/NN hepatic/JJ
thioguanine/JJ case/NN presented/VBD observe/VB features/NNS veno/NN
thioguanine/JJ case/NN presented/VBD observe/VB features/NNS veno/NN disease/NN occlusive/JJ
thioguanine/JJ case/NN presented/VBD observe/VB features/NNS veno/NN disease/NN
Heparin/NNP induced/VBN thrombocytopenia/NN
Heparin/NNP thrombocytopenia/NN
Heparin/NNP thrombocytopenia/NN HIT/NNP
heparin/NN reaction/NN Heparin/NNP thrombocytopenia/NN
heparin/NN reaction/NN Heparin/NNP thrombocytopenia/NN HIT/NNP
heparin/NN transplantation/NN HIT/NNP
heparin/NN antibody/NN antibody/NN HIT/NNP
UFH/NNP developed/VBD related/VBD HIT/NNP
dobutamine/VB related/VBN myocarditis/NNS
dobutamine/VB related/VBN myocarditis/NNS hypersensitivity/NN
dobutamine/VB related/VBN myocarditis/NNS eosinophilic/JJ
Succinylcholine/NNP induced/VBN rigidity/NN masseter/NN
Succinylcholine/NNP induced/VBN rigidity/NN muscle/NN
Succinylcholine/NNP induced/VBN rigidity/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN masseter/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN muscle/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN jaw/NN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN jaw/NN steel/NN of/IN
succinylcholine/JJ administration/NN describe/VBP case/NN rigidity/NN jaw/NN steel/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN masseter/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN muscle/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN jaw/NN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN jaw/NN steel/NN of/IN
Sch/NNP administration/NN describe/VBP case/NN rigidity/NN jaw/NN steel/NN
butylated/JJ hydroxyanisole/NN induced/VBN rats/NNS carcinogenesis/NNS forestomach/JJ
butylated/JJ hydroxyanisole/NN induced/VBN rats/NNS carcinogenesis/NNS
hydroxyanisole/NN induced/VBN rats/NNS carcinogenesis/NNS forestomach/JJ
hydroxyanisole/NN induced/VBN rats/NNS carcinogenesis/NNS
butylated/JJ hydroxyanisole/NN tumorigenesis/NNS forestomach/NN
butylated/JJ hydroxyanisole/NN tumorigenesis/NNS
hydroxyanisole/NN tumorigenesis/NNS forestomach/NN
hydroxyanisole/NN tumorigenesis/NNS
BHA/NNP hydroxyanisole/NN tumorigenesis/NNS forestomach/NN
BHA/NNP hydroxyanisole/NN tumorigenesis/NNS
BHA/NNP given/VBN groups/NNS increased/VBD incidence/NN tumors/NNS forestomach/JJ
BHA/NNP given/VBN groups/NNS increased/VBD incidence/NN tumors/NNS
BHA/NNP carcinogen/NN forestomach/VBP
BHA/NNP carcinogen/NN forestomach/VBP carcinogenesis/NNS
cocaine/NN marker/NN oscillation/NN pupillary/JJ
cocaine/NN marker/NN oscillation/NN
cocaine/NN marker/NN oscillation/NN measure/NN paranoia/NN
Cocaine/NNP induced/VBN remains/VBZ paranoia/NN
Cocaine/NNP induced/VBN remains/VBZ paranoia/NN CIP/NNP
Cocaine/NNP induced/VBN remains/VBZ drug/NN model/NN paranoia/NN
amiodarone/NN administration/NN pain/NN low/JJ
amiodarone/NN administration/NN pain/NN back/NN
amiodarone/NN administration/NN pain/NN
amiodarone/NN loading/NN initiation/NN experienced/VBD pain/NN low/JJ
amiodarone/NN loading/NN initiation/NN experienced/VBD pain/NN back/NN
amiodarone/NN loading/NN initiation/NN experienced/VBD pain/NN
aspirin/NN ingestion/NN salicylates/NNS association/NN lack/NN disappearing/VBG syndrome/NN Reye/JJ
aspirin/NN ingestion/NN salicylates/NNS association/NN lack/NN disappearing/VBG syndrome/NN
Penicillamine/NNP induced/VBN glomerulonephritis/NNS
D/NNP months/NNS presented/VBN rapidly/RB glomerulonephritis/NNS
penicillamine/JJ treatment/NN woman/NN arthritis/NN presented/VBN rapidly/RB glomerulonephritis/NNS
D/NNP months/NNS presented/VBN rapidly/RB glomerulonephritis/NNS RPGN/NNP
penicillamine/JJ treatment/NN woman/NN arthritis/NN presented/VBN rapidly/RB glomerulonephritis/NNS RPGN/NNP
D/NNP course/NN case/NN RPGN/NNP
penicillamine/JJ treatment/NN emphasizes/VBZ case/NN RPGN/NNP
nitroglycerin/NN caused/VBN impairment/NN hypotension/NN
nitroglycerin/NN caused/VBN impairment/NN memory/NN
nitroglycerin/NN caused/VBN impairment/NN
nitroglycerin/NN onset/NN administered/VBN tested/VBD preserve/VB hypotension/NN
NTG/NNP nitroglycerin/NN onset/NN administered/VBN tested/VBD preserve/VB hypotension/NN
NTG/NNP NIMO/NNP saline/NN injected/VBN those/DT showed/VBD Mice/NNS subjected/VBN hypotensive/VB
NTG/NNP delayed/VBN injected/VBN those/DT showed/VBD Mice/NNS subjected/VBN hypotensive/VB
NTG/NNP injection/NN produced/VBD impairment/NN memory/NN mice/NNS had/VBD hypotension/NN
NTG/NNP caused/VBD improve/VB absence/NN hypotension/NN
isoniazid/NN pretreated/VBD induced/VBN bradycardia/NNP
isoniazid/JJ hypotension/NN doses/NNS induced/VBN tachycardia/NN bradycardia/NN
isoniazid/JJ hypotension/NN
isoniazid/NN bradycardia/NN
Isoniazid/NNP increased/VBD bradycardia/NN
Ammonia/NNP higher/JJR patients/NNS complained/VBD drowsiness/NNS
NH/CD 3/CD Ammonia/NNP higher/JJR patients/NNS complained/VBD drowsiness/NNS
3/CD Ammonia/NNP higher/JJR patients/NNS complained/VBD drowsiness/NNS
VPA/NNP levels/NNS similar/JJ higher/JJR patients/NNS complained/VBD drowsiness/NNS
puromycin/NN amino/NNS injection/NN induced/VBN NS/NNP
amino/NNS injection/NN induced/VBN NS/NNP
nucleoside/NN amino/NNS injection/NN induced/VBN NS/NNP
PAN/NNP amino/NNS injection/NN induced/VBN NS/NNP
PAN/NNP injection/NN observed/JJ established/VBN NS/NNP
PAN/NNP induced/VBN NS/NN
Doxorubicin/NN cardiomyopathy/NN
doxorubicin/NN bed/NN experienced/VBD cardiomyopathy/NN
doxorubicin/NN interaction/NN fact/NN attributed/VBN cardiomyopathy/NN
lithium/NN therapy/NN years/NNS hypothyroidism/NN
lithium/NN therapy/NN onset/NN years/NNS hypothyroidism/NN
lithium/NN therapy/NN factor/NN hypothyroidism/NN
Doxorubicin/NN cardiomyopathy/NN
DOX/NNP cardiomyopathy/NN
DOX/NNP cardiomyopathy/NN development/NN elucidate/VB studied/VBD B/NNP induced/VBN cardiomyopathy/RB
DOX/NNP induction/NN investigating/VBG mice/NNS B/NNP studied/VBD elucidate/VB development/NN cardiomyopathy/NN
DOX/NNP induction/NN investigating/VBG mice/NNS B/NNP induced/VBN cardiomyopathy/RB
DOX/NNP cardiomyopathy/NN
DOX/NNP treatment/NN antagonists/NNS utilizing/VBG cardiomyopathy/RB
paroxetine/NN fluoxetine/NN receiving/VBG women/NNS sexually/RB
paroxetine/NN fluoxetine/NN receiving/VBG women/NNS dysfunctional/JJ
sertraline/NN fluoxetine/NN receiving/VBG women/NNS sexually/RB
sertraline/NN fluoxetine/NN receiving/VBG women/NNS dysfunctional/JJ
fluoxetine/NN receiving/VBG women/NNS sexually/RB
fluoxetine/NN receiving/VBG women/NNS dysfunctional/JJ
Pilocarpine/JJ age/NN impairment/NN
Pilocarpine/JJ age/NN impairment/NN discrimination/NN in/IN
Pilocarpine/JJ age/NN impairment/NN discrimination/NN auditory/JJ
Pilocarpine/JJ age/NN impairment/NN discrimination/NN location/NN
Pilocarpine/JJ age/NN impairment/NN discrimination/NN
Pilocarpine/NNP induced/VBN epilepticus/NNS status/NN
Pilocarpine/NNP induced/VBN epilepticus/NNS
Pilocarpine/NNP induced/VBN resulted/VBD epilepticus/NNS status/NN
Pilocarpine/NNP induced/VBN resulted/VBD epilepticus/NNS
muscimol/NN drugs/NNS jerks/NNS myoclonic/JJ
muscimol/NN drugs/NNS jerks/NNS
muscimol/NN produced/VBD jerks/NNS myoclonic/JJ
muscimol/NN produced/VBD jerks/NNS
muscimol/NN myoclonus/NNS
muscimol/NN myoclonus/NNS management/NN beneficial/JJ found/VBN seems/VBZ myoclonus/NNS
phenytoin/NN administration/NN developed/VBD bradycardia/NN
fat/JJ diet/NN sensitive/JJ rats/NNS obese/NN
fat/JJ diet/NN induces/VBZ obesity/RB
doxorubicin/NN dose/NN administered/VBN day/NN regimen/NN led/VBN cardiotoxicity/NN dysfunction/NN cardiac/JJ
doxorubicin/NN dose/NN administered/VBN day/NN regimen/NN led/VBN cardiotoxicity/NN dysfunction/NN
risperidone/JJ hyperprolactinemia/NN
risperidone/NN treated/VBN %/NN present/JJ Hyperprolactinemia/NNP
risperidone/NNP started/VBN occurred/VBD occurred/VBD hyperprolactinemia/NN
risperidone/NN link/VB study/NN induced/VBN treatment/NN hyperprolactinemia/NNP
ketamine/VB buffers/VBZ decreases/VBZ duration/NN hallucinations/NNS
haloperidol/NN potentiation/NN induced/VBN catalepsy/NN
apomorphine/NN prevention/NN catalepsy/NN induced/VBN potentiation/NN induced/VBN hyperactivity/RB
pilocarpine/JJ acid/NN seizures/NNS
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS
acid/NN seizures/NNS
pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS status/NN
pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS status/NN
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS
acid/NN seizures/NNS epilepticus/NNS status/NN
acid/NN seizures/NNS epilepticus/NNS
pilocarpine/NN activity/NN evaluated/VBN beta/NN metabolites/NNS seizures/NNS
kainic/JJ acid/NN beta/NN metabolites/NNS seizures/NNS
acid/NN beta/NN metabolites/NNS seizures/NNS
pilocarpine/NN protecting/VBG effective/JJ Steroids/NNS induced/VBZ seizures/NNS
pilocarpine/NN protecting/VBG effective/JJ Steroids/NNS induced/VBZ seizures/NNS epilepticus/NNS status/NN
pilocarpine/NN protecting/VBG effective/JJ Steroids/NNS induced/VBZ seizures/NNS epilepticus/NNS
pilocarpine/JJ seizures/NNS
pilocarpine/JJ seizures/NNS protecting/VBG potent/JJ had/VBD values/NNS TD/NNP divided/VBN protection/NN seizure/NN
kainic/JJ acid/NN induced/VBN seizures/NNS
acid/NN induced/VBN seizures/NNS
kainic/JJ acid/NN induced/VBN seizures/NNS onset/NN produced/VBD protect/VB seizures/NNS
acid/NN induced/VBN seizures/NNS onset/NN produced/VBD protect/VB seizures/NNS
kainic/JJ acid/NN administered/VBN However/RB obtained/VBN seizures/NNS
acid/NN administered/VBN However/RB obtained/VBN seizures/NNS
kainic/JJ acid/NN administered/VBN However/RB obtained/VBN seizures/NNS epilepticus/NNS status/NN
kainic/JJ acid/NN administered/VBN However/RB obtained/VBN seizures/NNS epilepticus/NNS
acid/NN administered/VBN However/RB obtained/VBN seizures/NNS epilepticus/NNS status/NN
acid/NN administered/VBN However/RB obtained/VBN seizures/NNS epilepticus/NNS
pilocarpine/JJ acid/NN seizures/NNS
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS
acid/NN seizures/NNS
pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS status/NN
pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS
pilocarpine/JJ acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS status/NN
pilocarpine/JJ acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS status/NN
kainic/JJ pilocarpine/JJ acid/NN seizures/NNS epilepticus/NNS
acid/NN seizures/NNS epilepticus/NNS status/NN
acid/NN seizures/NNS epilepticus/NNS
kainic/JJ pilocarpine/JJ acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS status/NN
kainic/JJ pilocarpine/JJ acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS
acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS status/NN
acid/NN protecting/VBG effective/JJ utility/NN treatment/NN forms/NNS epilepticus/NNS
oxacillin/NN associated/VBN vasculitis/NNS Cutaneous/JJ
oxacillin/NN associated/VBN vasculitis/NNS leucocytoclastic/JJ
oxacillin/NN associated/VBN vasculitis/NNS
oxacillin/NN treated/VBN man/NN year/NN developed/VBD failure/NN renal/JJ
oxacillin/NN treated/VBN man/NN year/NN developed/VBD failure/NN
Oxacillin/NNP included/VBN drugs/NNS cause/VB vasculitis/NNS leucocytoclastic/JJ
Oxacillin/NNP included/VBN drugs/NNS cause/VB vasculitis/NNS
DX/NNP treated/VBN those/DT treated/VBN animals/NNS appeared/VBD proteinuria/NN
doxorubicin/NN treatment/NN prolonged/JJ intense/JJ 2/CD appeared/VBD Proteinuria/NNP
DX/NNP DXNP/NNP difference/NN 2/CD appeared/VBD Proteinuria/NNP
morphine/VB analgesia/NN hypothermia/NN
morphine/VB analgesia/NN catalepsy/NN
morphine/JJ bradycardia/NN
morphine/JJ induced/VBN bradycardia/NN
morphine/JJ bradycardia/NN induced/VBN hypotension/NN
morphine/JJ induced/VBN hypotension/NN
methylprednisolone/NN Hypotension/NN
methylprednisolone/NN Hypotension/NN bradycardia/NN
methylprednisolone/NN Hypotension/NN asystole/NN
methylprednisolone/NN year/NN administration/NN hypotension/NN
methylprednisolone/NN year/NN administration/NN hypotension/NN bradycardia/NN
methylprednisolone/NN year/NN administration/NN hypotension/NN asystole/NN
amiodarone/NN Hepatotoxicity/NNP
amiodarone/JJ treatment/NN due/JJ hepatitis/NN presented/VBN given/VBN review/NN hepatotoxicity/NN
amiodarone/NN hepatotoxicity/NN
amiodarone/JJ treatment/NN due/JJ injury/NN exists/VBZ concluded/VBN alterations/VBZ hepatitis/NN hepatitis/NN cirrhosis/NNS
amiodarone/JJ treatment/NN due/JJ injury/NN exists/VBZ concluded/VBN alterations/VBZ hepatitis/NN hepatitis/NN liver/NN of/IN
amiodarone/JJ treatment/NN due/JJ injury/NN exists/VBZ concluded/VBN alterations/VBZ hepatitis/NN hepatitis/NN liver/NN the/DT
amiodarone/JJ treatment/NN due/JJ injury/NN exists/VBZ concluded/VBN alterations/VBZ hepatitis/NN hepatitis/NN liver/NN
amiodarone/JJ treatment/NN due/JJ injury/NN steatosis/NNS
amiodarone/JJ treatment/NN due/JJ injury/NN hepatic/JJ
amiodarone/JJ treatment/NN due/JJ injury/NN
levodopa/NN involved/VBN unclear/JJ dyskinesia/NNP
3/CD induced/VBN anaemia/NN
azido/NN 3/CD induced/VBN anaemia/NN
3/CD dideoxythymidine/NN understood/VBN induced/VBN anaemia/NN
'/POS 3/CD dideoxythymidine/NN understood/VBN induced/VBN anaemia/NN
dideoxythymidine/NN understood/VBN induced/VBN anaemia/NN
AZT/NNP dideoxythymidine/NN understood/VBN induced/VBN anaemia/NN
AZT/NNP anaemia/NN
AZT/NNP produced/VBD anaemia/NN
AZT/NNP treated/NNP increased/VBD number/NN fold/VBP anaemia/NN
AZT/NNP treated/VBN appropriate/JJ observed/VBD degree/NN anaemia/NN
AZT/NNP treated/VBN degrees/NNS anaemia/NN
AZT/NNP observed/VBN anaemia/NN
AZT/NNP induced/VBN anaemia/NN
amisulpride/NN mg/NN doses/NNS man/NN hypertension/NN
tiapride/NN mg/NN mg/NN doses/NNS man/NN headache/NN vomiting/NN
tiapride/NN mg/NN mg/NN doses/NNS man/NN headache/NN
amisulpride/NN mg/NN doses/NNS man/NN headache/NN
tiapride/NN mg/NN mg/NN doses/NNS man/NN hypertension/NN
amisulpride/NN mg/NN doses/NNS man/NN headache/NN vomiting/NN
amisulpride/JJ therapy/NN crisis/NN hypertensive/JJ
tiapride/JJ amisulpride/JJ therapy/NN crisis/NN hypertensive/JJ
amisulpride/JJ crisis/NN hypertensive/JJ
tiapride/JJ amisulpride/JJ crisis/NN hypertensive/JJ
melatonin/NN effects/NNS narcosis/NNS
Melatonin/NNP affects/VBZ clear/JJ influence/VB drug/NN narcosis/NNS
Melatonin/NNP pre/NNP affected/VBD narcosis/NNS
melatonin/NN dose/NN caused/VBD produced/VBD reduction/NN duration/NN narcosis/NNS
ketamine/JJ narcosis/NNS
diazepam/JJ ketamine/JJ narcosis/NNS
Melatonin/RB 0/CD 5/CD kg/NN influenced/VBN duration/NN latency/NN narcosis/NNS
melatonin/NN narcosis/NNS
AZT/NNP induced/VBN cardiomyopathy/RB
zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
3/CD azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
'/POS 3/CD azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
-/NN azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
2/CD azido/NNS zidovudine/VBP investigate/VB triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
3/CD triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
deoxythymidine/JJ 3/CD triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
AZT/NNP 3/CD triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
AZT/NNP concentrations/NNS containing/VBG libitum/NN received/VBD triggers/VBZ Fas/NNP pathway/NN model/NN DCM/NNP
AZT/NNP -/NNP treated/VBD developed/VBD dilation/NN cardiac/JJ
AZT/NNP -/NNP treated/VBD developed/VBD dilation/NN
ribavirin/JJ treatment/NN b/NNS case/NN parasitosis/NNS delusional/JJ
ribavirin/JJ treatment/NN b/NNS case/NN parasitosis/NNS
pegylated/JJ alpha/NNS patient/NN parasitosis/NNS delusional/JJ
pegylated/JJ alpha/NNS patient/NN parasitosis/NNS
interferon/NN alpha/NNS patient/NN parasitosis/NNS delusional/JJ
interferon/NN alpha/NNS patient/NN parasitosis/NNS
alpha/NNS patient/NN parasitosis/NNS delusional/JJ
alpha/NNS patient/NN parasitosis/NNS
2/CD b/NNS case/NN parasitosis/NNS delusional/JJ
2/CD b/NNS case/NN parasitosis/NNS
b/NNS case/NN parasitosis/NNS delusional/JJ
b/NNS case/NN parasitosis/NNS
ribavirin/NNP b/NNS year/NN woman/NN developed/VBD parasitosis/NNS delusional/JJ
ribavirin/NNP b/NNS year/NN woman/NN developed/VBD parasitosis/NNS
pegylated/JJ alpha/NNS developed/VBD parasitosis/NNS delusional/JJ
pegylated/JJ alpha/NNS developed/VBD parasitosis/NNS
interferon/NN alpha/NNS developed/VBD parasitosis/NNS delusional/JJ
interferon/NN alpha/NNS developed/VBD parasitosis/NNS
alpha/NNS developed/VBD parasitosis/NNS delusional/JJ
alpha/NNS developed/VBD parasitosis/NNS
2/CD b/NNS year/NN woman/NN developed/VBD parasitosis/NNS delusional/JJ
2/CD b/NNS year/NN woman/NN developed/VBD parasitosis/NNS
b/NNS year/NN woman/NN developed/VBD parasitosis/NNS delusional/JJ
b/NNS year/NN woman/NN developed/VBD parasitosis/NNS
MPTP/NN rendered/VBN parkinsonian/NN
MDMA/NNP users/NNS observed/VBN evidence/NN impairment/NN memory/NN
MDMA/NNP users/NNS observed/VBN evidence/NN impairment/NN
MDMA/NNP use/NN associated/VBN functioning/NN impaired/VBN
MDMA/NNP use/NN associated/VBN functioning/NN memory/NN
MDMA/NNP use/NN associated/VBN functioning/NN
MDMA/NNP use/NN associated/VBN lead/VB impairments/NNS memory/NN
MDMA/NNP use/NN associated/VBN lead/VB impairments/NNS
MDMA/NNP use/NN use/NN lead/VB associated/VBN functioning/NN impaired/VBN
MDMA/NNP use/NN use/NN lead/VB associated/VBN functioning/NN memory/NN
MDMA/NNP use/NN use/NN lead/VB associated/VBN functioning/NN
MDMA/NNP use/NN use/NN lead/VB impairments/NNS memory/NN
MDMA/NNP use/NN use/NN lead/VB impairments/NNS
lidocaine/JJ group/NN %/NN fatal/JJ' fatal/JJ dose/NN convulsions/NNS
lidocaine/JJ group/NN %/NN fatal/JJ' fatal/JJ %/NN bupivacaine/NN induced/VBN seizures/NNS
chloroprocaine/JJ group/NN %/NN induced/VBN bupivacaine/NN %/NN fatal/JJ dose/NN convulsions/NNS
chloroprocaine/JJ group/NN %/NN induced/VBN seizures/NNS
bupivacaine/NN %/NN fatal/JJ dose/NN convulsions/NNS
bupivacaine/NN induced/VBN seizures/NNS
testosterone/NN implanted/VBN rats/NNS developed/VBD incidence/NN cancer/NN prostate/NN
testosterone/NN implanted/VBN rats/NNS developed/VBD incidence/NN cancer/NN
testosterone/NN developed/VBD cancer/NN prostate/NN
testosterone/NN developed/VBD cancer/NN
testosterone/JJ prostatitis/NNS
5/CD presented/VBD pain/NN chest/NN
5/CD presented/VBD pain/NN
fluorouracil/JJ administration/NN metastasis/NNS presented/VBD pain/NN chest/NN
fluorouracil/JJ administration/NN metastasis/NNS presented/VBD pain/NN
5/CD administration/NN metastasis/NNS presented/VBD pain/NN chest/NN
5/CD administration/NN metastasis/NNS presented/VBD pain/NN
FU/NNP 5/CD administration/NN metastasis/NNS presented/VBD pain/NN chest/NN
FU/NNP 5/CD administration/NN metastasis/NNS presented/VBD pain/NN
paroxetine/NN related/VBD syndrome/NN neuroleptic/JJ
paroxetine/NN related/VBD syndrome/NN malignant/JJ
paroxetine/NN related/VBD syndrome/NN
alprazolam/NN paroxetine/NN related/VBD syndrome/NN neuroleptic/JJ
alprazolam/NN paroxetine/NN related/VBD syndrome/NN malignant/JJ
alprazolam/NN paroxetine/NN related/VBD syndrome/NN
paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN malignant/JJ neuroleptic/JJ
paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN malignant/JJ
paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN
paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN NMS/NNP
paroxetine/NN occur/VB presented/VBN demonstrating/VBG NMS/NNP
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN malignant/JJ neuroleptic/JJ
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN malignant/JJ
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN symptoms/NNS syndrome/NN NMS/NNP
alprazolam/NN treatment/NN paroxetine/NN occur/VB presented/VBN demonstrating/VBG NMS/NNP
Quinidine/NNP hepatitis/NNP
quinidine/NN had/VBD hepatotoxicity/RB
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS polymyositis/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS erythematosus/NNS systemic/JJ
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS erythematosus/NNS lupus/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS erythematosus/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS Skin/NN
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS gravis/NNS myasthenia/NN
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS gravis/NNS
penicillamine/JJ therapy/NN complications/NNS recorded/VBN rashes/NNS proteinuria/NN
chloramphenicol/NN administration/NN anemia/NN aplastic/JJ
chloramphenicol/NN administration/NN anemia/NN
chloramphenicol/NN beginning/VBG undergoing/VBG died/VBD anemia/NN aplastic/JJ
chloramphenicol/NN beginning/VBG undergoing/VBG died/VBD anemia/NN
chloramphenicol/VB associated/VBN pattern/NN anemia/NN aplastic/JJ
chloramphenicol/VB associated/VBN pattern/NN anemia/NN
chloramphenicol/NN treatment/NN report/NN anemia/NN aplastic/JJ
chloramphenicol/NN treatment/NN report/NN anemia/NN
ifosfamide/NN Hallucinations/NNS
ifosfamide/NN effect/NN Hallucinations/NNP
ifosfamide/NN cases/NNS reported/VBN hallucinations/NNS
ifosfamide/NN interviewed/VBN authors/NNS METHODS/NNS hallucinations/NNS
ifosfamide/NN hallucinations/NNS
picrotoxin/NN pentetrazol/NN induced/VBN convulsions/NNS inhibitors/NNS effects/NNS induction/NN seizure/NN
picrotoxin/NN pentetrazol/NN induced/VBN convulsions/NNS
flurothyl/NN pentetrazol/NN induced/VBN convulsions/NNS inhibitors/NNS effects/NNS induction/NN seizure/NN
flurothyl/NN pentetrazol/NN induced/VBN convulsions/NNS
pentetrazol/NN induced/VBN convulsions/NNS inhibitors/NNS effects/NNS induction/NN seizure/NN
pentetrazol/NN induced/VBN convulsions/NNS
PTZ/NNP prostaglandins/NNS induction/NN seizure/NN
PTZ/NNP prostaglandins/NNS induction/NN effects/NNS inhibitors/NNS convulsions/NNS
bicuculline/NN electroshock/NN evaluated/VBN investigate/VB relationship/NN prostaglandins/NNS induction/NN seizure/NN
bicuculline/NN electroshock/NN evaluated/VBN investigate/VB relationship/NN prostaglandins/NNS induction/NN effects/NNS inhibitors/NNS convulsions/NNS
picrotoxin/JJ convulsions/NNS fluorthyl/NN induced/VBN convulsions/NNS
picrotoxin/JJ convulsions/NNS
fluorthyl/NN induced/VBN convulsions/NNS
fluorthyl/NN convulsions/NNS
PTZ/NNP fluorthyl/NN induced/VBN convulsions/NNS
PTZ/NNP fluorthyl/NN convulsions/NNS
bicuculline/JJ picrotoxin/JJ convulsions/NNS fluorthyl/NN induced/VBN convulsions/NNS
bicuculline/JJ picrotoxin/JJ convulsions/NNS
azidothymidine/NN induced/VBN suppression/NN marrow/NN
azidothymidine/NN induced/VBN suppression/NN
AZT/NNP induced/VBN anemia/NN leukopenia/NN
AZT/NNP induced/VBN anemia/NN
AZT/NNP administration/NN rendered/VBN anemic/JJ leukopenic/JJ
AZT/NNP administration/NN rendered/VBN reversed/VBD induced/VBN anemia/NN leukopenia/NN
AZT/NNP administration/NN water/NN drinking/VBG days/NNS reversed/VBD rendered/VBN anemic/JJ leukopenic/JJ
AZT/NNP administration/NN water/NN drinking/VBG days/NNS reversed/VBD induced/VBN anemia/NN leukopenia/NN
AZT/NNP induced/VBN reversed/VBD rendered/VBN anemic/JJ leukopenic/JJ
AZT/NNP induced/VBN anemia/NN leukopenia/NN
AZT/NNP administration/NN rendered/VBN anemic/JJ
AZT/NNP administration/NN rendered/VBN reversed/VBD induced/VBN anemia/NN
AZT/NNP administration/NN water/NN drinking/VBG days/NNS reversed/VBD rendered/VBN anemic/JJ
AZT/NNP administration/NN water/NN drinking/VBG days/NNS reversed/VBD induced/VBN anemia/NN
AZT/NNP induced/VBN reversed/VBD rendered/VBN anemic/JJ
AZT/NNP induced/VBN anemia/NN
AZT/NNP coadministered/VBD reduced/VBD AZT/NNP induced/VBN toxicity/NN marrow/NN
AZT/NNP coadministered/VBD reduced/VBD AZT/NNP induced/VBN toxicity/NN
AZT/NNP induced/VBN toxicity/NN marrow/NN
AZT/NNP induced/VBN toxicity/NN
levodopa/NN overflow/NN dyskinesias/NNS
levodopa/NN therapy/NN complications/NNS assessed/VBD dyskinesias/NNS
levodopa/NN therapy/NN complications/NNS assessed/VBD dyskinesias/NNS LID/NNP
levodopa/NN complications/NNS assessed/VBD dyskinesias/NNS
levodopa/NN complications/NNS assessed/VBD dyskinesias/NNS LID/NNP
levodopa/NN with/IN LID/VBP
levodopa/NN dyskinesias/NNS
levodopa/NN dyskinesias/NNS disease/NN LID/NNP
levodopa/JJ assessed/VBN lift/VBP score/VBP dyskinesia/NN
levodopa/NN increased/VBN LID/NNP
isoproterenol/NN status/NN mangiferin/NN Role/NNP infarction/NN myocardial/JJ
isoproterenol/NN status/NN mangiferin/NN Role/NNP infarction/NN
isoproterenol/NN Anacardiaceae/NNP induced/VBN infarction/NN myocardial/JJ
isoproterenol/NN Anacardiaceae/NNP induced/VBN infarction/NN
isoproterenol/NN Anacardiaceae/NNP induced/VBN infarction/NN MI/NNP
ISPH/NNP Anacardiaceae/NNP induced/VBN infarction/NN myocardial/JJ
ISPH/NNP Anacardiaceae/NNP induced/VBN infarction/NN
ISPH/NNP Anacardiaceae/NNP induced/VBN infarction/NN MI/NNP
ISPH/NNP induced/VBN rats/NNS MI/NNP
ISPH/NNP exerts/VBZ due/JJ MI/NNP
quipazine/NN aggressiveness/NN induced/VBN deprivation/NN induced/VBN twitches/NNS head/NN
quipazine/NN aggressiveness/NN induced/VBN deprivation/NN induced/VBN twitches/NNS
apomorphine/NN deprivation/NN induced/VBN aggressiveness/NN
quipazine/JJ increased/VBN reduced/VBN twitches/NNS head/NN
quipazine/JJ increased/VBN reduced/VBN twitches/NNS
apomorphine/JJ increased/VBN induced/VBN aggressiveness/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN embolism/NN stroke/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN embolism/NN gallbladder/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN
oestrogen/NN Long/NNP increased/VBD risk/NN thrombo/NN venous/JJ
oestrogen/NN Long/NNP increased/VBD risk/NN thrombo/NN
oestrogen/NN Long/NNP increased/VBD risk/NN disease/NN embolism/NN
ketamine/JJ catatonia/NN
ketamine/NN idolamines/NNS catatonia/NN
ketamine/NN increased/VBD duration/NN catatonia/NN
dopamine/NN pretreatment/NN increased/VBD duration/NN catatonia/NN
ketamine/JJ catatonia/NN
dopamine/NN appeared/VBD act/VB induction/NN catatonia/NN
adriamycin/NN dose/NN developed/VBD failure/NN congestive/JJ
adriamycin/NN dose/NN developed/VBD failure/NN heart/NN
adriamycin/NN dose/NN developed/VBD failure/NN
adriamycin/NN 2/CD mg/NN receiving/VBG developed/VBD leukemia/NN myeloblastic/JJ acute/JJ
adriamycin/NN 2/CD mg/NN receiving/VBG developed/VBD leukemia/NN myeloblastic/JJ
adriamycin/NN 2/CD mg/NN receiving/VBG developed/VBD leukemia/NN
Amphetamine/NNP similar/JJ locomotor/NN
Amphetamine/NNP similar/JJ hyperactivity/RB
Cyclophosphamide/JJ cancer/NN bladder/NN
Cyclophosphamide/JJ cancer/NN
cyclophosphamide/NN associated/VBN cancer/NN bladder/NN
cyclophosphamide/NN associated/VBN cancer/NN
Cyclophosphamide/NNP associated/VBN disease/NN tumor/NN bladder/NN
Cyclophosphamide/NNP associated/VBN disease/NN tumor/NN
Amisulpride/VB tic/NN
Amisulpride/VB symptoms/NNS like/IN
Amisulpride/VB symptoms/NNS
amisulpride/NN dose/NN reduced/VBD resolved/VBN symptoms/NNS tic/NN
amisulpride/NN dose/NN reduced/VBD resolved/VBN symptoms/NNS like/JJ
amisulpride/NN dose/NN reduced/VBD resolved/VBN symptoms/NNS
amisulpride/JJ quetiapine/JJ occur/VB suggests/VBZ tic/NN
amisulpride/JJ quetiapine/JJ occur/VB symptoms/NNS like/JJ
amisulpride/JJ quetiapine/JJ occur/VB symptoms/NNS
carrageenan/NN model/NN writhing/VBG
carrageenan/NN model/NN writhing/VBG induced/VBN acid/NN paw/NN model/NN edema/NN
